Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),A1BG,Alpha-1B-glycoprotein,43988,277,1.04 [0.53-2.02],0.9196335470365492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AAMDC,Mth938 domain-containing protein,42761,275,0.99 [0.79-1.23],0.9151900546921508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AARSD1,Alanyl-tRNA editing protein Aarsd1,50286,339,0.98 [0.82-1.16],0.7799935921484911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABCA2,ATP-binding cassette sub-family A member 2,42474,270,1.06 [0.77-1.46],0.731320845199567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABHD14B,Protein ABHD14B,49978,340,1.09 [0.92-1.29],0.3218400084131768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABL1,Tyrosine-protein kinase ABL1,50286,339,1.13 [0.98-1.30],0.0826129901797556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABO,Histo-blood group ABO system transferase,43959,278,1.01 [0.93-1.09],0.7852678525667133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABRAXAS2,BRISC complex subunit Abraxas 2,42474,270,0.99 [0.83-1.18],0.87637291217023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",49332,331,1.16 [1.04-1.30],0.0103924003934627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",43124,274,1.07 [0.91-1.24],0.4180623993754553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",43925,280,1.07 [0.94-1.21],0.3129973145635862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAN,Aggrecan core protein,50038,339,1.14 [0.81-1.60],0.4546131326165319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE,Angiotensin-converting enzyme,43959,278,1.49 [0.97-2.27],0.0671623483478606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE2,Angiotensin-converting enzyme 2,49594,325,1.27 [1.07-1.50],0.0052657735983169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACHE,Acetylcholinesterase,42966,266,1.05 [0.73-1.49],0.8048875662595241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOT13,Acyl-coenzyme A thioesterase 13,43736,277,1.08 [0.97-1.19],0.1454934713081823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,50522,342,1.19 [1.00-1.41],0.0547395630832749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP1,Low molecular weight phosphotyrosine protein phosphatase,42650,268,0.64 [0.48-0.85],0.0023847036930242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP5,Tartrate-resistant acid phosphatase type 5,50747,341,1.34 [1.01-1.78],0.0434786635337287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP6,Lysophosphatidic acid phosphatase type 6,50876,341,1.06 [0.92-1.23],0.4037518972899147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRBP,Acrosin-binding protein,43716,280,1.26 [0.97-1.63],0.0807852693492208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRV1,Acrosomal protein SP-10,42650,268,1.10 [0.95-1.28],0.1845405642710899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACSL1,Long-chain-fatty-acid--CoA ligase 1,42474,270,1.06 [0.78-1.44],0.7024150744372581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",49594,325,1.35 [1.12-1.63],0.0013547083277785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN2,Alpha-actinin-2,42474,270,1.28 [1.07-1.52],0.0066261730576059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN4,Alpha-actinin-4,49560,327,1.10 [0.83-1.46],0.5162651121859102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,50052,339,2.08 [1.46-2.96],4.520046806908019e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY1,Aminoacylase-1,50522,342,1.04 [0.89-1.21],0.6024538536603684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,42474,270,1.25 [1.02-1.52],0.0289939007948625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACYP1,Acylphosphatase-1,42802,266,1.03 [0.86-1.23],0.768168752312868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA,Adenosine deaminase,51074,342,1.00 [0.76-1.31],0.996302088171701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,50231,342,1.71 [1.39-2.10],3.969704859765811e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,42650,268,1.54 [1.19-1.98],0.0009502396725864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,49594,325,1.29 [0.94-1.77],0.1163031145340685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,50135,340,1.19 [0.91-1.55],0.2089286748193966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,51074,342,0.92 [0.71-1.20],0.5592686338024531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,50884,342,1.49 [1.08-2.06],0.0147039764751419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,43736,277,1.88 [1.34-2.63],0.0002545496981976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,42650,268,1.19 [0.83-1.69],0.3418721074300427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,51146,343,0.76 [0.51-1.14],0.1864573406893112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,50286,339,1.20 [0.96-1.51],0.1091834554116285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,49594,325,1.06 [0.79-1.44],0.6827796560959832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,42650,268,1.09 [0.79-1.51],0.5963607818133974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,50678,342,0.74 [0.60-0.91],0.0038517489383126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL2,ADAMTS-like protein 2,43926,275,1.67 [1.22-2.28],0.0014025202845923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL4,ADAMTS-like protein 4,42761,275,0.87 [0.53-1.42],0.5816959919801812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL5,ADAMTS-like protein 5,43925,280,0.94 [0.70-1.25],0.6551318365195402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,49332,331,1.06 [0.82-1.37],0.632457884035587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADD1,Alpha-adducin,42966,266,0.97 [0.82-1.14],0.696687869647399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRB3,Adhesion G protein-coupled receptor B3,50052,339,1.35 [1.02-1.79],0.0387997374482803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRD1,Adhesion G-protein coupled receptor D1,42966,266,1.49 [1.11-1.99],0.0071306642087118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,43736,277,1.35 [1.11-1.65],0.0027223529592874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE2,Adhesion G protein-coupled receptor E2,50737,340,1.42 [1.02-1.97],0.0403792658136103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE5,Adhesion G protein-coupled receptor E5,50901,343,1.30 [0.96-1.76],0.0872212210074104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRF5,Adhesion G protein-coupled receptor F5,43925,280,1.34 [0.90-2.00],0.1493000585967075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG1,Adhesion G-protein coupled receptor G1,50286,339,1.23 [1.10-1.37],0.0001557693178661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG2,Adhesion G-protein coupled receptor G2,50522,342,0.80 [0.56-1.13],0.1973314289547693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRV1,Adhesion G-protein coupled receptor V1,42497,265,1.08 [0.92-1.26],0.3404144204409358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH1B,All-trans-retinol dehydrogenase,42966,266,1.09 [0.94-1.27],0.2456169796106365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,49594,325,1.01 [0.90-1.14],0.8754731433879834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADIPOQ,Adiponectin,43988,277,1.12 [0.95-1.32],0.191713088944282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,50950,341,2.03 [1.41-2.94],0.0001588229905958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADRA2A,Alpha-2A adrenergic receptor,42474,270,0.94 [0.79-1.12],0.4979331673648397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFAP1,Actin filament-associated protein 1,42966,266,0.90 [0.78-1.04],0.1523385858105213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFM,Afamin,43988,277,1.28 [0.72-2.28],0.4019110412789987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFP,Alpha-fetoprotein,49970,339,0.98 [0.85-1.13],0.800158686844263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGBL2,Cytosolic carboxypeptidase 2,42497,265,1.09 [0.95-1.24],0.2118332628170328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGER,Advanced glycosylation end product-specific receptor,50403,336,1.32 [1.05-1.66],0.0175661079185652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR2,Anterior gradient protein 2 homolog,48931,322,1.22 [1.11-1.35],3.418341080731005e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR3,Anterior gradient protein 3,49249,331,1.17 [1.00-1.36],0.0534649708812669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,50737,340,1.70 [1.33-2.17],2.208525520003513e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRP,Agouti-related protein,51074,342,1.26 [1.05-1.51],0.0146212865810393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGT,Angiotensinogen,43959,278,1.15 [0.71-1.88],0.5682633436058087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGXT,Serine--pyruvate aminotransferase,50522,342,1.13 [1.00-1.27],0.0508750151947701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHCY,Adenosylhomocysteinase,50522,342,1.06 [0.93-1.22],0.3819653340154494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK,Neuroblast differentiation-associated protein AHNAK,42761,275,1.13 [0.79-1.61],0.5072789045341306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK2,Protein AHNAK2,42761,275,1.43 [1.00-2.04],0.05095087579093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,43716,280,1.20 [1.04-1.39],0.012392059871147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSG,Alpha-2-HS-glycoprotein,43959,278,1.14 [0.75-1.74],0.5423957376466157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSP,Alpha-hemoglobin-stabilizing protein,50455,340,0.98 [0.87-1.09],0.6839439793469988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIDA,"Axin interactor, dorsalization-associated protein",42721,269,1.05 [0.92-1.20],0.4594696775096744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1,Allograft inflammatory factor 1,49332,331,1.21 [1.01-1.45],0.0438232092887663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1L,Allograft inflammatory factor 1-like,42761,275,1.07 [0.88-1.30],0.4793341832485246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",50202,339,1.12 [1.02-1.22],0.0160317398002555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK1,Adenylate kinase isoenzyme 1,50522,342,0.89 [0.77-1.04],0.1450892455921751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK2,"Adenylate kinase 2, mitochondrial",43820,278,1.11 [1.00-1.24],0.053749849486595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKAP12,A-kinase anchor protein 12,42966,266,0.98 [0.56-1.71],0.9516638970046885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B1,Aldo-keto reductase family 1 member B1,49332,331,1.12 [0.99-1.28],0.0751745156782096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B10,Aldo-keto reductase family 1 member B10,42721,269,1.16 [0.98-1.38],0.0838924653824186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1C4,Aldo-keto reductase family 1 member C4,49594,325,1.13 [0.96-1.34],0.1330326804967722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR7L,Aflatoxin B1 aldehyde reductase member 4,42650,268,1.20 [1.03-1.39],0.018591509954128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT1S1,Proline-rich AKT1 substrate 1,49337,326,1.07 [0.93-1.25],0.3467892326281075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT2,RAC-beta serine/threonine-protein kinase,43847,277,1.02 [0.93-1.11],0.7387763103949374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT3,RAC-gamma serine/threonine-protein kinase,49098,330,1.13 [0.96-1.34],0.1520302485852389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALCAM,CD166 antigen,51146,343,2.42 [1.52-3.87],0.0002049092957073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH1A1,Retinal dehydrogenase 1,50539,340,0.96 [0.80-1.14],0.6336810561160947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH2,"Aldehyde dehydrogenase, mitochondrial",43716,280,1.22 [1.03-1.45],0.0206020893823664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",50362,340,1.07 [0.94-1.22],0.3174630538931553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",43847,277,1.29 [1.03-1.61],0.0240864586001004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALMS1,Alstrom syndrome protein 1,43124,274,1.12 [0.88-1.42],0.3584953910301827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPI,Intestinal-type alkaline phosphatase,42650,268,1.02 [0.93-1.12],0.6886083981279373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPP,"Alkaline phosphatase, placental type",50286,339,1.03 [0.94-1.13],0.538448647694933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBN,Ameloblastin,49560,327,0.78 [0.53-1.15],0.2083205822643639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,50878,341,2.62 [1.66-4.13],3.6793347712443424e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,43926,275,0.95 [0.61-1.49],0.8311773614833559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,49337,326,1.27 [1.11-1.44],0.0003878949560366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO1,Amphoterin-induced protein 1,42721,269,1.27 [1.06-1.52],0.0090934684933196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO2,Amphoterin-induced protein 2,50286,339,1.67 [1.11-2.52],0.0145700404657126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMN,Protein amnionless,49560,327,1.20 [0.99-1.47],0.0662028725341587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOT,Angiomotin,42966,266,1.09 [0.81-1.47],0.5550015442728646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOTL2,Angiomotin-like protein 2,43552,277,1.04 [0.83-1.32],0.7202280415779065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMPD3,AMP deaminase 3,43820,278,0.83 [0.71-0.98],0.0230657208383471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,41184,264,0.79 [0.61-1.01],0.0610997360609172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2A,Pancreatic alpha-amylase,48588,332,0.88 [0.72-1.08],0.2341965995001849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2B,Alpha-amylase 2B,47099,324,0.88 [0.72-1.08],0.2361066300614782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANG,Angiogenin,50394,342,1.38 [1.06-1.81],0.0184689504712937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT1,Angiopoietin-1,50333,336,1.09 [0.97-1.22],0.1548315633859826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT2,Angiopoietin-2,50950,341,1.44 [1.12-1.83],0.0038796694845533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL1,Angiopoietin-related protein 1,49788,338,1.36 [0.98-1.90],0.0653882944595303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL2,Angiopoietin-related protein 2,50572,338,1.15 [0.90-1.45],0.258571697738208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL3,Angiopoietin-related protein 3,50559,342,1.14 [0.88-1.49],0.3243995406437078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL4,Angiopoietin-related protein 4,50654,338,1.38 [1.11-1.70],0.0032704398924625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL7,Angiopoietin-related protein 7,50950,341,1.24 [0.96-1.60],0.0927247542430864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANK2,Ankyrin-2,42474,270,0.96 [0.81-1.13],0.5957444039420025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,42650,268,1.11 [0.96-1.28],0.1775918722564485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRA2,Ankyrin repeat family A protein 2,42355,265,0.90 [0.72-1.12],0.3419007520345191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRD54,Ankyrin repeat domain-containing protein 54,49332,331,1.07 [0.91-1.26],0.3973342507958446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,42761,275,1.05 [0.80-1.39],0.7286596438071976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANPEP,Aminopeptidase N,50642,343,1.75 [1.28-2.40],0.000432894199995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA1,Annexin A1,42722,263,0.98 [0.75-1.29],0.8972629390571374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA10,Annexin A10,49337,326,1.23 [1.11-1.37],0.0001240931736113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA11,Annexin A11,50369,341,1.02 [0.88-1.18],0.7818210369148156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA2,Annexin A2,42109,266,1.04 [0.89-1.23],0.606719725023888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA3,Annexin A3,50884,342,1.09 [0.96-1.25],0.1925015863579956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA4,Annexin A4,50281,341,1.04 [0.91-1.19],0.5400559476830329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA5,Annexin A5,49174,326,1.28 [0.94-1.76],0.1206286837796531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC1,Amiloride-sensitive amine oxidase [copper-containing],49560,327,1.13 [0.97-1.32],0.1145380045983756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC3,Membrane primary amine oxidase,50722,343,1.57 [1.15-2.16],0.0048663456134553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP1G2,AP-1 complex subunit gamma-like 2,43716,280,1.04 [0.90-1.20],0.5724689759892663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP2B1,AP-2 complex subunit beta,42721,269,0.97 [0.76-1.23],0.7860110535162896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3B1,AP-3 complex subunit beta-1,43736,277,1.10 [0.95-1.27],0.2125126409689375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3S2,AP-3 complex subunit sigma-2,43820,278,1.10 [0.87-1.38],0.4437449633739708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,50286,339,1.21 [1.00-1.46],0.0555417303433656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APCS,Serum amyloid P-component,43593,274,0.75 [0.54-1.05],0.0937529202186893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,50791,340,1.06 [0.91-1.25],0.4556598828026691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APLP1,Amyloid-like protein 1,50522,342,0.92 [0.76-1.11],0.3629244070531755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA1,Apolipoprotein A-I,43988,277,0.55 [0.34-0.88],0.0123909273762285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA2,Apolipoprotein A-II,43959,278,1.24 [0.99-1.56],0.0655830381689276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA4,Apolipoprotein A-IV,43988,277,1.12 [0.82-1.53],0.4812857961476304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOB,Apolipoprotein B-100,43959,278,1.47 [0.88-2.46],0.1424015263852306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOBR,Apolipoprotein B receptor,42761,275,1.00 [0.77-1.32],0.9714599054525608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOC1,Apolipoprotein C-I,43904,275,0.64 [0.47-0.89],0.0073533468315571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOD,Apolipoprotein D,42005,258,0.74 [0.53-1.04],0.0869407800769639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOE,Apolipoprotein E,43988,277,0.93 [0.77-1.11],0.4025971287768358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOF,Apolipoprotein F,43959,278,0.58 [0.44-0.76],6.44529300802887e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOH,Beta-2-glycoprotein 1,50539,340,1.30 [1.01-1.67],0.0399490950658146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOL1,Apolipoprotein L1,43959,278,1.08 [0.91-1.29],0.3779806743696161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOM,Apolipoprotein M,50641,343,0.85 [0.61-1.20],0.3582324148701554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APP,Amyloid-beta precursor protein,50462,340,1.14 [0.99-1.31],0.0679120827761101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APPL2,DCC-interacting protein 13-beta,42966,266,1.02 [0.92-1.13],0.7088974735220661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APRT,Adenine phosphoribosyltransferase,50052,340,1.10 [0.90-1.35],0.3418818707746013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARAF,Serine/threonine-protein kinase A-Raf,43124,274,1.14 [0.97-1.34],0.1013774882605415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,50286,339,1.83 [1.54-2.19],1.2354016555669972e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARF6,ADP-ribosylation factor 6,43736,277,1.06 [0.95-1.18],0.301013311084472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARFIP1,Arfaptin-1,43847,277,1.02 [0.86-1.20],0.8137685425884358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,50212,336,0.75 [0.63-0.90],0.0021796603127261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG2,"Arginase-2, mitochondrial",43716,280,1.12 [0.88-1.44],0.3564822585823542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP1,Rho GTPase-activating protein 1,49332,331,1.03 [0.84-1.28],0.7559406490586462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP25,Rho GTPase-activating protein 25,49332,331,1.01 [0.86-1.19],0.9123060582648316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP30,Rho GTPase-activating protein 30,43124,274,1.13 [0.86-1.48],0.394095893135015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP45,Rho GTPase-activating protein 45,42966,266,1.01 [0.88-1.17],0.8399046166902715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP5,Rho GTPase-activating protein 5,42355,265,1.04 [0.90-1.21],0.581839877791499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF1,Rho guanine nucleotide exchange factor 1,43820,278,1.02 [0.90-1.16],0.7937920310405837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF10,Rho guanine nucleotide exchange factor 10,43847,277,1.03 [0.91-1.16],0.6793107720190898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF12,Rho guanine nucleotide exchange factor 12,50447,341,1.03 [0.93-1.12],0.597394804640204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF5,Rho guanine nucleotide exchange factor 5,42497,265,1.12 [0.96-1.30],0.1449823702470777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID3A,AT-rich interactive domain-containing protein 3A,42497,265,0.99 [0.73-1.33],0.924483217672336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID4B,AT-rich interactive domain-containing protein 4B,49337,326,0.93 [0.73-1.19],0.5533596217364127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL13B,ADP-ribosylation factor-like protein 13B,42474,270,1.10 [0.93-1.29],0.2623156631534469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,42474,270,1.03 [0.77-1.38],0.8267327376980557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARMCX2,Armadillo repeat-containing X-linked protein 2,42497,265,1.11 [0.94-1.32],0.2119623349192387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNT,Aryl hydrocarbon receptor nuclear translocator,49560,327,1.11 [0.86-1.43],0.4102419405966583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,42474,270,0.93 [0.73-1.18],0.5324846487037933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSA,Arylsulfatase A,50539,340,1.13 [0.92-1.38],0.25120301392699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSB,Arylsulfatase B,50286,339,1.18 [0.99-1.39],0.0582754446076478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART3,Ecto-ADP-ribosyltransferase 3,50722,343,1.04 [0.79-1.36],0.8010302053707248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART5,Ecto-ADP-ribosyltransferase 5,42497,265,0.99 [0.82-1.20],0.9530265849855636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARTN,Artemin,49560,327,1.15 [0.95-1.38],0.1494619173834413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH1,Acid ceramidase,43520,273,1.27 [1.02-1.58],0.0291312569721445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH2,Neutral ceramidase,50135,340,0.86 [0.73-1.02],0.0894527265817457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,50135,340,1.88 [1.40-2.52],2.423874697403996e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR2,Asialoglycoprotein receptor 2,43959,278,1.50 [0.98-2.28],0.0609141319660927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPN,Asporin,43925,280,0.90 [0.59-1.37],0.6126381756908935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPSCR1,Tether containing UBX domain for GLUT4,43847,277,1.04 [0.87-1.23],0.6750562501127357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASRGL1,Isoaspartyl peptidase/L-asparaginase,42761,275,0.99 [0.88-1.11],0.8399731223030475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASS1,Argininosuccinate synthase,42474,270,1.03 [0.89-1.20],0.687921352528285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF2,Cyclic AMP-dependent transcription factor ATF-2,49337,326,1.03 [0.90-1.19],0.6450034066517759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF4,Cyclic AMP-dependent transcription factor ATF-4,42355,265,1.21 [0.87-1.67],0.2607451486348282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG16L1,Autophagy-related protein 16-1,43736,277,1.08 [0.95-1.24],0.2422527563824322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG4A,Cysteine protease ATG4A,49332,331,0.99 [0.84-1.16],0.8663108480524806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATOX1,Copper transport protein ATOX1,50678,342,1.17 [1.02-1.34],0.0245748782331406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,42474,270,0.92 [0.71-1.20],0.5482903766989993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,42474,270,0.82 [0.56-1.20],0.2967043999665502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,42474,270,0.98 [0.73-1.32],0.8931656925686335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B4,Protein ATP1B4,42355,265,1.41 [1.12-1.78],0.0034526295825338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP2B4,Plasma membrane calcium-transporting ATPase 4,42474,270,1.00 [0.82-1.21],0.9772267676674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5F1D,"ATP synthase subunit delta, mitochondrial",42474,270,0.92 [0.72-1.18],0.5126406926414395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5IF1,"ATPase inhibitor, mitochondrial",50737,340,1.07 [0.98-1.16],0.1516989682750284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5PO,"ATP synthase subunit O, mitochondrial",49337,326,1.15 [0.93-1.43],0.1847828547301683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6AP2,Renin receptor,49332,331,1.34 [1.10-1.63],0.0032584425431813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1D,V-type proton ATPase subunit D,50286,339,0.79 [0.54-1.17],0.2438703282672045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1F,V-type proton ATPase subunit F,49254,326,1.05 [0.91-1.22],0.4978271896485533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G1,V-type proton ATPase subunit G 1,42761,275,1.01 [0.86-1.19],0.8699626284288169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G2,V-type proton ATPase subunit G 2,42474,270,1.03 [0.92-1.16],0.5816952868237258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRAID,All-trans retinoic acid-induced differentiation factor,43736,277,1.56 [1.27-1.91],1.8991294997627205e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRN,"Attractin, Isoform 2",43988,277,0.90 [0.46-1.79],0.7682031059782258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN10,Ataxin-10,49337,326,1.11 [0.97-1.27],0.1447066532133455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2,Ataxin-2,42497,265,1.09 [0.99-1.20],0.0787243585629255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2L,Ataxin-2-like protein,43847,277,0.97 [0.76-1.24],0.7846350961303299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN3,Ataxin-3,43820,278,0.95 [0.79-1.15],0.6126958707595093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXIN1,Axin-1,50447,341,1.04 [0.94-1.15],0.4152824170509572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXL,Tyrosine-protein kinase receptor UFO,50722,343,1.74 [1.25-2.42],0.0010562820513308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZI2,5-azacytidine-induced protein 2,43847,277,1.07 [0.87-1.31],0.5241428655741305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZU1,Azurocidin,48990,329,1.03 [0.91-1.17],0.6040067251303533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B2M,Beta-2-microglobulin,43988,277,1.44 [1.17-1.79],0.0007263956784922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,42474,270,0.75 [0.41-1.35],0.3340424167720364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",42761,275,1.65 [1.20-2.26],0.0018756027205172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",50737,340,2.05 [1.47-2.84],1.8664067483572546e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GAT1,"Beta-1,4-glucuronyltransferase 1",50539,340,1.00 [0.68-1.49],0.9876522672173954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BABAM1,BRISC and BRCA1-A complex member 1,42650,268,0.90 [0.59-1.37],0.6115622840215573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BACH1,Transcription regulator protein BACH1,50447,341,1.07 [0.94-1.22],0.2792363414379018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG3,BAG family molecular chaperone regulator 3,50052,339,1.38 [1.08-1.77],0.0099838361309335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG4,BAG family molecular chaperone regulator 4,42650,268,1.13 [0.90-1.42],0.2781330858716707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG6,Large proline-rich protein BAG6,49594,325,1.13 [0.86-1.48],0.3775733077076182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,49332,331,1.31 [1.14-1.51],0.000119113031848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,49332,331,1.98 [1.51-2.60],7.413120278897762e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BANK1,B-cell scaffold protein with ankyrin repeats,50447,341,1.02 [0.93-1.11],0.7211335114296537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAP18,Chromatin complexes subunit BAP18,43820,278,1.11 [0.95-1.29],0.1731465401076931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BATF,Basic leucine zipper transcriptional factor ATF-like,42721,269,1.02 [0.89-1.17],0.7553779178754367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAX,Apoptosis regulator BAX,49253,326,1.08 [0.96-1.20],0.1903401855288859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAM,Basal cell adhesion molecule,50539,340,1.67 [1.15-2.42],0.007076419462576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAN,Brevican core protein,50135,340,0.73 [0.56-0.97],0.0289261761885426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",43925,280,1.53 [1.10-2.12],0.0109639520925402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",42497,265,1.09 [0.89-1.33],0.4153411875228494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCHE,Cholinesterase,43148,273,0.97 [0.64-1.47],0.8888712305297235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2,Apoptosis regulator Bcl-2,43736,277,1.14 [0.95-1.37],0.1614830720719017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L1,Bcl-2-like protein 1,43820,278,1.04 [0.93-1.17],0.5058234329552318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",50447,341,1.36 [1.07-1.72],0.0113142455799033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L15,Bcl-2-like protein 15,42650,268,1.00 [0.82-1.22],0.982678328467494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7A,B-cell CLL/lymphoma 7 protein family member A,42355,265,1.00 [0.83-1.20],0.9846918604582894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7B,B-cell CLL/lymphoma 7 protein family member B,43716,280,1.04 [0.82-1.34],0.7303985427610287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCR,Breakpoint cluster region protein,50447,341,1.03 [0.92-1.14],0.6297542634401063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BDNF,Brain-derived neurotrophic factor,43926,275,1.00 [0.87-1.14],0.9664301761225088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BECN1,Beclin-1,42761,275,1.02 [0.85-1.24],0.8031913467411478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BEX3,Protein BEX3,42355,265,1.21 [0.99-1.49],0.066094443174996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGLAP,Osteocalcin,43926,275,1.07 [0.94-1.22],0.2930430626629814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGN,Biglycan,49251,331,0.94 [0.86-1.02],0.1173734240140401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHLHE40,Class E basic helix-loop-helix protein 40,42497,265,1.08 [0.92-1.26],0.3544698341646356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,42474,270,0.98 [0.62-1.54],0.918645613427201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BID,BH3-interacting domain death agonist,50447,341,1.05 [0.91-1.20],0.5115024932853771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIN2,Bridging integrator 2,50539,340,1.08 [0.97-1.19],0.17270853781034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIRC2,Baculoviral IAP repeat-containing protein 2,49332,331,1.16 [1.00-1.35],0.0548353438010249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLMH,Bleomycin hydrolase,51146,343,1.17 [0.88-1.58],0.2833952493714687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLNK,B-cell linker protein,42650,268,0.80 [0.58-1.11],0.1756550913619987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,42497,265,0.88 [0.73-1.05],0.1434518874038168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,43820,278,1.15 [0.88-1.51],0.3133878990917084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLVRB,Flavin reductase,50539,340,0.87 [0.75-1.01],0.0707394972601453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP10,Bone morphogenetic protein 10,42966,266,1.18 [0.78-1.79],0.4349351753850333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP4,Bone morphogenetic protein 4,50052,339,1.16 [0.95-1.42],0.1367336329303458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP6,Bone morphogenetic protein 6,49516,325,1.17 [0.92-1.49],0.1980877150909557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMPER,BMP-binding endothelial regulator protein,42966,266,1.75 [1.10-2.78],0.0171171007825826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,43925,280,1.20 [0.87-1.65],0.2735310695792784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,42650,268,1.31 [1.03-1.68],0.0283540777918231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOC,Brother of CDO,49594,325,1.37 [0.90-2.08],0.1437806708485034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA1,BolA-like protein 1,42497,265,1.16 [0.95-1.42],0.14415837889961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA2_BOLA2B,BolA-like protein 2,42761,275,0.88 [0.71-1.09],0.2323840816842057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFA2,BPI fold-containing family A member 2,41252,268,0.94 [0.85-1.05],0.2702014788391023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB1,BPI fold-containing family B member 1,50410,338,0.92 [0.79-1.07],0.2676708047247376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB2,BPI fold-containing family B member 2,43840,279,1.07 [0.90-1.26],0.4478438376460363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRAP,BRCA1-associated protein,43330,276,1.04 [0.93-1.15],0.5154941546977032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD1,Bromodomain-containing protein 1,43124,274,1.18 [0.82-1.69],0.3669440370066881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD2,Bromodomain-containing protein 2,42497,265,1.15 [0.84-1.58],0.3756595750321954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD3,Bromodomain-containing protein 3,42474,270,1.20 [0.98-1.46],0.0733552842021385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRDT,Bromodomain testis-specific protein,42474,270,1.34 [0.99-1.81],0.0623910773824673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRK1,Protein BRICK1,49337,326,1.42 [1.15-1.75],0.0011010398468012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRME1,Break repair meiotic recombinase recruitment factor 1,42497,265,1.07 [0.81-1.40],0.6426870290423999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRSK2,Serine/threonine-protein kinase BRSK2,43847,277,1.07 [0.80-1.43],0.6573466225985782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSG,Basigin,50991,340,1.94 [1.22-3.08],0.0050570013548941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSND,Barttin,42355,265,1.03 [0.73-1.45],0.8687411286384414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,50968,342,1.16 [0.92-1.45],0.2073284356689113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,50968,342,1.51 [1.31-1.73],1.2431865380867572e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTC,Probetacellulin,49332,331,1.04 [0.92-1.19],0.5160534058786118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTD,Biotinidase,43988,277,1.06 [0.61-1.85],0.8304472904896838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTLA,B- and T-lymphocyte attenuator,42355,265,1.04 [0.92-1.18],0.5208279027178665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN1A1,Butyrophilin subfamily 1 member A1,43632,280,0.98 [0.73-1.31],0.904509702045102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,50737,340,2.19 [1.59-3.03],1.8876538111555712e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,50447,341,1.64 [1.33-2.03],3.2357414349108577e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTNL10,Butyrophilin-like protein 10,42355,265,0.98 [0.73-1.32],0.9042273058904424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C19orf12,Protein C19orf12,49337,326,1.11 [0.96-1.27],0.1468461425599803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1GALT1C1,C1GALT1-specific chaperone 1,42474,270,1.33 [0.97-1.82],0.0721850671992175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QA,Complement C1q subcomponent subunit A,50823,337,1.49 [0.98-2.28],0.0648167373908312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",43847,277,1.07 [0.92-1.24],0.3944642335674903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QL2,Complement C1q-like protein 2,42650,268,0.95 [0.72-1.24],0.6843372545842461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,50722,343,1.07 [0.86-1.33],0.5556306334308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,42966,266,0.83 [0.61-1.12],0.2192985334275687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,43847,277,1.08 [0.76-1.53],0.6734325913039437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,42888,265,0.77 [0.62-0.97],0.0246877433038037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1R,Complement C1r subcomponent,43988,277,0.55 [0.27-1.11],0.0963880185569275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1RL,Complement C1r subcomponent-like protein,43911,277,1.37 [0.76-2.47],0.3013674101972487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1S,Complement C1s subcomponent,43988,277,0.95 [0.55-1.64],0.8521439873204608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2,Complement C2,50641,343,1.95 [1.22-3.11],0.0050881527952636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2CD2L,Phospholipid transfer protein C2CD2L,49254,326,1.06 [0.85-1.33],0.5863360539950745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2orf69,UPF0565 protein C2orf69,42721,269,1.04 [0.86-1.26],0.693020763315265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C3,Complement C3,41735,263,1.26 [1.00-1.57],0.04792805156255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C4BPB,C4b-binding protein beta chain,50678,342,1.12 [0.89-1.42],0.3390910462010705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C5,Complement C5,43988,277,1.58 [0.77-3.24],0.2076212547104375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,42938,268,2.17 [1.52-3.12],2.401815196067754e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7orf50,Uncharacterized protein C7orf50,43820,278,0.90 [0.53-1.52],0.6880066968302476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C8B,Complement component C8 beta chain,43988,277,0.99 [0.68-1.44],0.9708493287472658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9,Complement component C9,43959,278,1.10 [0.89-1.36],0.3845040781654834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9orf40,Uncharacterized protein C9orf40,43736,277,0.90 [0.78-1.04],0.1426397673352498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA1,Carbonic anhydrase 1,49410,337,0.82 [0.70-0.96],0.0137894485413334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA11,Carbonic anhydrase-related protein 11,49332,331,0.94 [0.69-1.30],0.7221138443745554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,50286,339,1.70 [1.31-2.21],7.216384325945947e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA13,Carbonic anhydrase 13,49963,337,1.04 [0.95-1.14],0.4046748891765829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA14,Carbonic anhydrase 14,50950,341,0.80 [0.61-1.04],0.0980356898442436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA2,Carbonic anhydrase 2,50371,340,0.91 [0.79-1.04],0.1788498611787699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA3,Carbonic anhydrase 3,51063,343,1.09 [0.94-1.27],0.266974051155315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA4,Carbonic anhydrase 4,51146,343,1.29 [0.87-1.92],0.2017039478568056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA5A,"Carbonic anhydrase 5A, mitochondrial",49594,325,1.12 [1.01-1.24],0.0266412654763138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,50380,339,0.80 [0.69-0.93],0.0035642534694087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA7,Carbonic anhydrase 7,43124,274,1.24 [0.92-1.66],0.1503945974682974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA8,Carbonic anhydrase-related protein,42650,268,0.80 [0.48-1.33],0.3924947807401185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA9,Carbonic anhydrase 9,50950,341,1.31 [1.08-1.59],0.0053638829715702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CABP2,Calcium-binding protein 2,42721,269,1.21 [1.03-1.42],0.022344206594389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,42497,265,1.18 [0.85-1.64],0.3267082980639966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,42474,270,0.95 [0.77-1.17],0.610858013795323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,42497,265,1.11 [0.93-1.34],0.2562127126667983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,43847,277,1.07 [0.94-1.23],0.3195589893349674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACYBP,Calcyclin-binding protein,42886,266,1.04 [0.93-1.17],0.4847792778910185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CADPS,Calcium-dependent secretion activator 1,42721,269,0.98 [0.74-1.29],0.8633664053899202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB1,Calbindin,50286,339,1.29 [1.03-1.61],0.0257818690959748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB2,Calretinin,49337,326,1.36 [1.08-1.71],0.0091596210712757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCA,Calcitonin,50052,340,1.21 [1.05-1.39],0.0092486424167294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCB,Calcitonin gene-related peptide 2,43820,278,1.32 [1.04-1.67],0.0228709937565171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,50791,340,1.03 [0.94-1.13],0.5679638238153091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,42761,275,1.06 [0.92-1.24],0.4152717793288308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALY,Neuron-specific vesicular protein calcyon,42474,270,1.05 [0.77-1.41],0.7720543209394641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,49332,331,1.28 [1.05-1.57],0.016945282289089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,42721,269,1.18 [0.97-1.43],0.1010903129260894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,43847,277,1.02 [0.92-1.13],0.7209289643698413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CANT1,Soluble calcium-activated nucleotidase 1,50369,341,2.01 [1.26-3.19],0.00323269652132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPG,Macrophage-capping protein,50141,336,0.99 [0.84-1.17],0.9013352978691532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,43716,280,1.40 [1.11-1.76],0.0041533880726007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPS,Calcyphosin,43820,278,1.09 [0.99-1.20],0.0935621758113009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CARHSP1,Calcium-regulated heat-stable protein 1,49337,326,0.87 [0.72-1.05],0.1550086597152316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASC3,Protein CASC3,42721,269,1.19 [0.91-1.56],0.1938685802617374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP1,Caspase-1,49337,326,1.09 [0.96-1.25],0.1865309893927079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP10,Caspase-10,49337,326,1.09 [0.95-1.25],0.223236747945021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP2,Caspase-2,50447,341,1.13 [0.98-1.29],0.0903237015671935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP3,Caspase-3,51146,343,1.04 [0.93-1.15],0.5254167578230482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP4,Caspase-4,43124,274,1.00 [0.93-1.07],0.985290276646912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP7,Caspase-7,43820,278,1.03 [0.90-1.18],0.7028124308205226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP8,Caspase-8,50804,341,1.05 [0.91-1.23],0.4943568337179753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP9,Caspase-9,42650,268,1.04 [0.86-1.25],0.7128385809321927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASQ2,Calsequestrin-2,42474,270,0.99 [0.77-1.26],0.9124299843887616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAT,Catalase,43302,269,0.83 [0.67-1.04],0.1048690048711795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLIF,Cobalamin binding intrinsic factor,50447,342,1.08 [0.95-1.22],0.2506340161886617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN1,Cerebellin-1,42497,265,0.98 [0.87-1.12],0.7897583414805518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN4,Cerebellin-4,50950,341,0.67 [0.50-0.90],0.0084340400830428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBS,Cystathionine beta-synthase,42761,275,1.10 [0.88-1.36],0.3980538831408168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBX2,Chromobox protein homolog 2,42474,270,0.98 [0.73-1.31],0.8671832854334736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,50135,340,1.08 [0.95-1.22],0.2679414134271864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCAR2,Cell cycle and apoptosis regulator protein 2,43820,278,0.88 [0.70-1.12],0.312008172109717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC134,Coiled-coil domain-containing protein 134,43716,280,1.10 [0.88-1.38],0.4205728970351375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC28A,Coiled-coil domain-containing protein 28A,42721,269,1.07 [0.72-1.59],0.7330553149593309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC50,Coiled-coil domain-containing protein 50,43847,277,1.17 [1.04-1.33],0.0117601144868895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,50522,342,1.52 [1.18-1.95],0.0010546715649498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,42761,275,1.19 [0.99-1.42],0.0597738114820547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL11,Eotaxin,51074,342,1.47 [1.14-1.90],0.0026855341897164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL13,C-C motif chemokine 13,50989,342,0.96 [0.84-1.10],0.574651799950433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL14,C-C motif chemokine 14,50394,342,1.35 [1.09-1.67],0.0061513213888733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL15,C-C motif chemokine 15,51146,343,1.39 [1.13-1.70],0.001439184966598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL16,C-C motif chemokine 16,51146,343,1.19 [0.99-1.44],0.058986573012799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL17,C-C motif chemokine 17,50405,337,1.08 [0.97-1.20],0.1480157600371736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL18,C-C motif chemokine 18,49835,340,1.17 [1.04-1.32],0.0092507442691867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL19,C-C motif chemokine 19,50968,342,1.04 [0.97-1.11],0.3067237886454366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL2,C-C motif chemokine 2,50052,339,0.96 [0.80-1.15],0.6263933094729057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL20,C-C motif chemokine 20,51074,342,1.14 [1.04-1.25],0.0076262461143124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,50737,340,1.43 [1.20-1.70],5.39633303705102e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,49997,335,1.16 [0.96-1.39],0.116540197936823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL23,C-C motif chemokine 23,50737,340,1.07 [0.85-1.34],0.5510499684330218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL24,C-C motif chemokine 24,50654,338,0.94 [0.83-1.05],0.2621475545744904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL25,C-C motif chemokine 25,51074,342,1.37 [1.13-1.67],0.0012883577436776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL26,C-C motif chemokine 26,50447,341,1.01 [0.92-1.12],0.7920891024241983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL27,C-C motif chemokine 27,50522,342,1.01 [0.86-1.18],0.8926808843157541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL28,C-C motif chemokine 28,50281,340,1.08 [0.92-1.27],0.3388115694618637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL3,C-C motif chemokine 3,50447,341,1.19 [1.06-1.33],0.0022544714393571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL4,C-C motif chemokine 4,50573,340,1.09 [0.96-1.24],0.1755291158590498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL5,C-C motif chemokine 5,50722,343,1.08 [0.98-1.18],0.1085249383626415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL7,C-C motif chemokine 7,50447,341,1.22 [1.06-1.41],0.0070744285374575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL8,C-C motif chemokine 8,50878,341,1.14 [0.97-1.34],0.1019589252013265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN1,CCN family member 1,50204,339,1.10 [0.96-1.25],0.159213399137109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN2,CCN family member 2,50486,338,1.13 [0.95-1.33],0.1589262778057277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,51061,342,1.81 [1.41-2.32],3.280758897430017e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,50950,341,1.59 [1.28-1.97],2.5263200992718903e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN5,CCN family member 5,50539,340,1.24 [0.98-1.59],0.07780823506527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCND2,G1/S-specific cyclin-D2,43124,274,1.16 [0.85-1.60],0.3497957640865469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCNE1,G1/S-specific cyclin-E1,42650,268,1.00 [0.87-1.14],0.9686516455772658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCS,Copper chaperone for superoxide dismutase,50135,340,0.92 [0.75-1.12],0.4007844944453037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCT5,T-complex protein 1 subunit epsilon,49332,331,1.18 [0.97-1.45],0.1060632300342745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD101,Immunoglobulin superfamily member 2,43736,277,1.14 [0.87-1.49],0.3493237206517962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD109,CD109 antigen,50539,340,0.92 [0.69-1.22],0.5506880363906532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD14,Monocyte differentiation antigen CD14,49503,336,1.46 [1.17-1.83],0.0008329048387776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD160,CD160 antigen,51074,342,1.22 [1.01-1.49],0.0431080796330326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,50722,343,1.49 [1.21-1.83],0.0002139660058516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164,Sialomucin core protein 24,50539,340,1.35 [1.05-1.74],0.0199373731681306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164L2,CD164 sialomucin-like 2 protein,42721,269,1.00 [0.73-1.38],0.9978805373492452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD177,CD177 antigen,50454,339,1.03 [0.95-1.11],0.4493140456346645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD1C,T-cell surface glycoprotein CD1c,50678,342,1.02 [0.69-1.50],0.929332911358247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2,T-cell surface antigen CD2,42474,270,1.10 [0.84-1.45],0.4940432068662528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200,OX-2 membrane glycoprotein,50447,341,1.06 [0.74-1.52],0.7312569401381928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200R1,Cell surface glycoprotein CD200 receptor 1,50278,340,0.92 [0.69-1.21],0.5321496693879795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD207,C-type lectin domain family 4 member K,49415,334,1.16 [0.90-1.49],0.2458828287634622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD209,CD209 antigen,50658,340,1.08 [0.84-1.38],0.5467586771552676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD22,B-cell receptor CD22,51074,342,1.10 [0.88-1.37],0.424706368420492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD226,CD226 antigen,42650,268,1.22 [0.92-1.60],0.1615131115792635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,51074,342,1.71 [1.22-2.40],0.0019195903340988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD248,Endosialin,43926,275,0.99 [0.75-1.32],0.9697722637274808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,50678,342,1.77 [1.44-2.17],5.764565818148934e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,50135,340,1.68 [1.32-2.15],2.974457194055487e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,50485,337,1.63 [1.24-2.14],0.0004562688661328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,49332,331,1.50 [1.19-1.88],0.000504593346611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2AP,CD2-associated protein,50522,342,1.02 [0.88-1.18],0.7813073397131872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300A,CMRF35-like molecule 8,42966,266,1.71 [1.17-2.49],0.0053624455611077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,50968,342,1.84 [1.42-2.37],3.0037842515267364e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,50786,341,1.86 [1.51-2.30],7.615762614851181e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LF,CMRF35-like molecule 1,50950,341,1.21 [1.03-1.43],0.0189034503809631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LG,CMRF35-like molecule 9,50539,340,1.27 [0.99-1.64],0.0598483019062336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,50286,339,1.95 [1.48-2.57],2.3297203575188767e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD33,Myeloid cell surface antigen CD33,50678,342,1.03 [0.91-1.16],0.6547009405417193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD34,Hematopoietic progenitor cell antigen CD34,50807,342,0.85 [0.57-1.26],0.405543915690841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD36,Platelet glycoprotein 4,42650,268,1.11 [0.86-1.43],0.4260715527768881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,50286,339,1.44 [1.07-1.93],0.015114390496622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3D,T-cell surface glycoprotein CD3 delta chain,42497,265,1.39 [1.09-1.78],0.0080857354283116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3E,T-cell surface glycoprotein CD3 epsilon chain,43124,274,1.13 [0.84-1.50],0.4195635506651161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3G,T-cell surface glycoprotein CD3 gamma chain,42650,268,1.12 [1.00-1.25],0.0417353283036526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,50366,341,1.60 [1.26-2.02],8.463408440554217e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40,Tumor necrosis factor receptor superfamily member 5,50490,338,1.41 [1.18-1.68],0.0001709911363056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40LG,CD40 ligand,51074,342,1.10 [0.97-1.24],0.1376078292869906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD46,Membrane cofactor protein,50229,342,1.76 [1.31-2.36],0.0001797349350932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,50654,338,2.12 [1.57-2.87],1.1796582037240082e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5,T-cell surface glycoprotein CD5,50878,341,1.36 [1.06-1.75],0.0167918326777273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD55,Complement decay-accelerating factor,48751,332,1.43 [1.01-2.01],0.0435507614360725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD58,Lymphocyte function-associated antigen 3,50400,337,1.05 [0.61-1.81],0.8645078299525956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD59,CD59 glycoprotein,48696,322,2.02 [1.41-2.91],0.0001377298851658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5L,CD5 antigen-like,43744,275,1.24 [0.98-1.58],0.074643898795398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD6,T-cell differentiation antigen CD6,50991,340,0.96 [0.80-1.15],0.651800921929377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD63,CD63 antigen,50052,339,1.11 [0.92-1.35],0.2647620177554497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD69,Early activation antigen CD69,50278,342,1.07 [0.96-1.19],0.2221891049332622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD7,T-cell antigen CD7,42571,268,1.23 [0.95-1.60],0.1140677322554429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD70,CD70 antigen,50447,341,1.17 [0.94-1.46],0.1618629940872941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD72,B-cell differentiation antigen CD72,42966,266,1.24 [0.95-1.62],0.1161081581219862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,50968,342,1.86 [1.44-2.40],1.8335067861999247e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD79B,B-cell antigen receptor complex-associated protein beta chain,51074,342,1.48 [1.22-1.79],7.340347537510492e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,43925,280,2.08 [1.56-2.78],6.520144971928154e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD82,CD82 antigen,43124,274,1.11 [0.86-1.44],0.4175361961156579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,50447,341,1.83 [1.42-2.37],4.315295099163462e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD84,SLAM family member 5,50447,341,1.29 [0.95-1.74],0.1036634199929273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD86,T-lymphocyte activation antigen CD86,43736,277,1.41 [0.96-2.06],0.0807581521628209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD8A,T-cell surface glycoprotein CD8 alpha chain,50968,342,1.10 [0.92-1.33],0.2985348070846637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD93,Complement component C1q receptor,48626,331,1.48 [1.09-2.00],0.0117587377512252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,50539,340,2.48 [1.57-3.92],0.0001042705539825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99L2,CD99 antigen-like protein 2,50539,340,1.89 [1.29-2.79],0.0011973561740455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDA,Cytidine deaminase,43840,280,0.94 [0.74-1.20],0.6114776129009657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDAN1,Codanin-1,43820,278,0.99 [0.61-1.61],0.9646865278107972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC123,Cell division cycle protein 123 homolog,42355,265,0.83 [0.67-1.02],0.0786835610076336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC25A,M-phase inducer phosphatase 1,42355,265,1.09 [0.82-1.44],0.5569483042366179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC26,Anaphase-promoting complex subunit CDC26,43655,277,1.12 [0.96-1.32],0.1573749816603984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC27,Cell division cycle protein 27 homolog,49332,331,1.07 [0.91-1.25],0.4204456973829511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC37,Hsp90 co-chaperone Cdc37,50678,342,1.09 [0.98-1.22],0.1233576701990258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC42BPB,Serine/threonine-protein kinase MRCK beta,43736,277,1.06 [0.95-1.18],0.3346070067931572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,50135,340,1.58 [1.35-1.85],1.937189997625104e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,48843,339,1.51 [1.25-1.82],2.205843838893052e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH15,Cadherin-15,50885,342,0.97 [0.83-1.14],0.7193227199412857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH17,Cadherin-17,50522,342,1.10 [0.96-1.26],0.1715121630474204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH2,Cadherin-2,50522,342,1.55 [1.19-2.01],0.0011763621333934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH22,Cadherin-22,43124,274,1.08 [0.72-1.60],0.7176541229608755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH23,Cadherin-23,43820,278,1.14 [0.75-1.74],0.5448720735886006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH3,Cadherin-3,50968,342,1.27 [0.99-1.64],0.0642898080773139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH4,Cadherin-4,42497,265,1.22 [0.99-1.51],0.0658898417121696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH5,Cadherin-5,51146,343,1.17 [0.86-1.60],0.3069452927138716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH6,Cadherin-6,50522,342,1.20 [0.94-1.54],0.1388409198325414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR1,Cadherin-related family member 1,49337,326,1.01 [0.81-1.27],0.9073694517601076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR2,Cadherin-related family member 2,50286,339,1.02 [0.89-1.16],0.8070043877744082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR5,Cadherin-related family member 5,50522,342,0.88 [0.69-1.12],0.292216399426201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK1,Cyclin-dependent kinase 1,42355,265,1.01 [0.73-1.40],0.9494245443230804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,43847,277,1.03 [0.85-1.24],0.7938005024141196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKL5,Cyclin-dependent kinase-like 5,42497,265,1.13 [0.92-1.38],0.2311883424266349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN1A,Cyclin-dependent kinase inhibitor 1,50286,339,1.05 [0.96-1.15],0.3028032723961134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,50286,339,1.04 [0.94-1.15],0.4393763372595457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDNF,Cerebral dopamine neurotrophic factor,50286,339,1.25 [0.95-1.65],0.1043927133189789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,50569,337,1.27 [0.88-1.84],0.1936869769183306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDSN,Corneodesmosin,50915,341,1.19 [0.96-1.48],0.1090425861639478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,50598,342,1.72 [1.13-2.62],0.0110491335458244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,43736,277,0.90 [0.78-1.04],0.1458843500571722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,43124,274,1.09 [0.94-1.26],0.2657445424135987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,43736,277,1.24 [0.94-1.64],0.1315315226730831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,43124,274,1.45 [1.19-1.76],0.0001793693886073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,50447,341,1.20 [1.08-1.33],0.0006439139442682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,49332,331,1.15 [0.95-1.39],0.1534453892685171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,48696,329,1.11 [0.96-1.30],0.1558843508945264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,43926,275,1.27 [0.97-1.66],0.0866330873451894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,49594,325,1.13 [0.94-1.37],0.1966860112214837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPA,CCAAT/enhancer-binding protein alpha,42650,268,1.13 [0.85-1.51],0.387339103619872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPB,CCAAT/enhancer-binding protein beta,49594,325,0.98 [0.76-1.27],0.904319568412004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA2A,Chymotrypsin-like elastase family member 2A,43926,275,0.80 [0.67-0.96],0.0145411781085826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA3A,Chymotrypsin-like elastase family member 3A,51061,342,0.94 [0.80-1.11],0.4887684689787562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,42966,266,1.02 [0.68-1.53],0.9192875336944564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEMIP2,Cell surface hyaluronidase,42650,268,1.15 [0.84-1.57],0.3916265308174016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEND1,Cell cycle exit and neuronal differentiation protein 1,42497,265,1.00 [0.82-1.22],0.98897329593911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPF,Centromere protein F,43124,274,0.94 [0.76-1.17],0.5992830154135791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPJ,Centromere protein J,43124,274,0.97 [0.82-1.15],0.7325738134895265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP112,Centrosomal protein of 112 kDa,42474,270,1.04 [0.80-1.33],0.7893104776150045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP152,Centrosomal protein of 152 kDa,42355,265,0.99 [0.75-1.31],0.940078458784815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP164,Centrosomal protein of 164 kDa,49560,327,1.05 [0.91-1.22],0.4661071738344784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP170,Centrosomal protein of 170 kDa,42761,275,1.02 [0.88-1.19],0.8023202009242736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP20,Centrosomal protein 20,49332,331,1.17 [1.03-1.33],0.0149328906273842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP290,Centrosomal protein of 290 kDa,43124,274,1.00 [0.81-1.25],0.9716657284133386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP350,Centrosome-associated protein 350,42355,265,1.01 [0.74-1.38],0.947791356097266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP43,Centrosomal protein 43,49200,320,1.05 [0.91-1.21],0.506594795138023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP85,Centrosomal protein of 85 kDa,49332,331,1.18 [1.02-1.36],0.0272612886218546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CERT,Ceramide transfer protein,49337,326,1.04 [0.88-1.22],0.6377806254137359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES1,Liver carboxylesterase 1,50647,342,1.08 [0.97-1.20],0.1753983414884354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES2,Cocaine esterase,50286,339,1.01 [0.85-1.19],0.9529156114305471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES3,Carboxylesterase 3,50286,339,1.02 [0.89-1.17],0.737650732274425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN2,Centrin-2,49337,326,1.12 [0.97-1.29],0.1148162256577497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN3,Centrin-3,43736,277,1.12 [0.97-1.29],0.1294851017738545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFB,Complement factor B,43181,273,1.28 [0.90-1.83],0.174430238608333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFC1,Cryptic protein,49332,331,1.25 [1.03-1.51],0.0239595946236325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFD,Complement factor D,43988,277,1.30 [0.75-2.23],0.3493560136142508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFH,Complement factor H,41420,263,1.42 [0.85-2.38],0.1770858257159533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR2,Complement factor H-related protein 2,43668,277,1.35 [1.08-1.68],0.0084077274921648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR4,Complement factor H-related protein 4,43904,276,1.33 [1.12-1.57],0.001023254607387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR5,Complement factor H-related protein 5,43383,273,0.99 [0.75-1.31],0.9556249987976944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFI,Complement factor I,43988,277,0.88 [0.50-1.56],0.6634152879046006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFP,Properdin,43988,277,0.58 [0.33-1.00],0.0507969043795525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGA,Glycoprotein hormones alpha chain,50539,340,1.12 [0.98-1.28],0.1097197562749778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,43959,278,1.25 [1.01-1.54],0.0402220579242767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGN,Cingulin,42721,269,1.13 [0.86-1.48],0.3800735731301022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,50522,342,1.58 [1.27-1.96],3.0565468439110665e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,49332,331,1.05 [0.89-1.23],0.5627074416830702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAD,Chondroadherin,42966,266,0.88 [0.70-1.10],0.2501036946980778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",43820,278,1.63 [1.29-2.06],5.0054352256592966e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD6,MICOS complex subunit MIC25,43716,280,1.51 [1.10-2.08],0.0108346257829695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHEK2,Serine/threonine-protein kinase Chk2,49594,325,0.85 [0.63-1.15],0.2920105082656263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGA,Chromogranin-A,43926,275,1.14 [1.02-1.27],0.0256102605535457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGB,Secretogranin-1,50805,342,1.30 [1.03-1.63],0.0240937035951795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,49409,337,1.22 [1.10-1.37],0.0003375501265995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHIT1,Chitotriosidase-1,50735,342,1.04 [0.97-1.11],0.2415453495185638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHL1,Neural cell adhesion molecule L1-like protein,50643,342,0.96 [0.70-1.31],0.8020885184310478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHM,Rab proteins geranylgeranyltransferase component A 1,42721,269,0.99 [0.81-1.20],0.89167174219051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP1A,Charged multivesicular body protein 1a,50135,340,1.07 [0.95-1.21],0.2558069804530286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP6,Charged multivesicular body protein 6,43925,280,1.04 [0.85-1.27],0.7076391255730696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHP1,Calcineurin B homologous protein 1,42497,265,1.05 [0.90-1.23],0.5078661400274463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,50654,338,1.91 [1.42-2.57],1.6681949823602347e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL2,Chordin-like protein 2,50522,342,1.01 [0.84-1.22],0.9017872134459411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRM1,Muscarinic acetylcholine receptor M1,42721,269,1.25 [0.96-1.63],0.1032075082966175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIAPIN1,Anamorsin,50678,342,1.13 [0.97-1.31],0.1206315824521641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CILP,Cartilage intermediate layer protein 1,43926,275,1.15 [0.92-1.42],0.214812330944897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CINP,Cyclin-dependent kinase 2-interacting protein,43124,274,0.89 [0.67-1.18],0.4215260309143666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIRBP,Cold-inducible RNA-binding protein,43736,277,1.08 [0.96-1.22],0.1959257830861047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIT,Citron Rho-interacting kinase,42721,269,0.98 [0.76-1.27],0.8942602303916996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,50829,340,1.88 [1.41-2.53],2.235170466459596e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKB,Creatine kinase B-type,43926,275,1.23 [1.02-1.49],0.0323868713005695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",50321,338,1.16 [1.00-1.34],0.0556545950187479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLASP1,CLIP-associating protein 1,42355,265,1.03 [0.88-1.21],0.7243876596984493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLC,Galectin-10,50444,341,1.03 [0.89-1.18],0.7078918268432702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC10A,C-type lectin domain family 10 member A,50135,340,1.03 [0.79-1.35],0.814879864554202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC11A,C-type lectin domain family 11 member A,50456,340,1.33 [1.09-1.62],0.0056532592142288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC12A,C-type lectin domain family 12 member A,42650,268,1.26 [0.73-2.19],0.4106104850772274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,50539,340,1.68 [1.26-2.24],0.0003668762530221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1A,C-type lectin domain family 1 member A,49594,325,1.34 [1.00-1.79],0.0462698504883342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1B,C-type lectin domain family 1 member B,50968,342,1.08 [0.98-1.19],0.1110708214282008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC2L,C-type lectin domain family 2 member L,42721,269,1.15 [0.93-1.41],0.1866129807985651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC3B,Tetranectin,42950,272,0.66 [0.38-1.15],0.1451703264488794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4A,C-type lectin domain family 4 member A,50447,341,0.74 [0.57-0.95],0.0208921154984441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4C,C-type lectin domain family 4 member C,50447,341,1.09 [0.89-1.33],0.4139196048581451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4D,C-type lectin domain family 4 member D,50447,341,1.21 [1.04-1.41],0.0117030043931644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4G,C-type lectin domain family 4 member G,50447,341,1.51 [1.14-2.01],0.0043097418371391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4M,C-type lectin domain family 4 member M,43850,275,1.06 [0.84-1.35],0.6049738956880825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC5A,C-type lectin domain family 5 member A,50359,342,1.66 [1.22-2.25],0.0011669550403067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,49332,331,1.50 [1.23-1.81],3.920095517405213e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,51074,342,1.49 [1.22-1.82],0.0001046899130465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLGN,Calmegin,42721,269,1.32 [1.05-1.66],0.0193541548339157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIC5,Chloride intracellular channel protein 5,42721,269,1.18 [0.84-1.64],0.3450921085698739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLINT1,Clathrin interactor 1,42355,265,0.85 [0.64-1.13],0.2690864274330269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIP2,CAP-Gly domain-containing linker protein 2,50447,341,1.07 [0.98-1.17],0.1138021253085451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLMP,CXADR-like membrane protein,50950,341,1.74 [1.12-2.68],0.0127803669731007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLNS1A,Methylosome subunit pICln,42721,269,0.99 [0.70-1.39],0.9422259553244184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",50052,340,1.14 [1.03-1.26],0.0092921836685797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPS,Colipase,50455,340,1.02 [0.89-1.17],0.7813381487760112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSPN,Claspin,49254,326,0.96 [0.71-1.28],0.7727190739406627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN1,Calsyntenin-1,49337,326,0.90 [0.74-1.10],0.3078748671468706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN2,Calsyntenin-2,51074,342,1.26 [1.01-1.58],0.0416056909715268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN3,Calsyntenin-3,43820,278,1.57 [1.11-2.21],0.0100662543726721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLTA,Clathrin light chain A,49594,325,1.16 [0.95-1.41],0.1432977342756347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLU,Clusterin,43988,277,0.74 [0.44-1.23],0.2396485842261389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLUL1,Clusterin-like protein 1,50439,342,1.05 [0.85-1.29],0.6717770318757998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMC1,COX assembly mitochondrial protein homolog,43925,280,1.09 [0.97-1.24],0.1526855629344457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMIP,C-Maf-inducing protein,43716,280,1.08 [0.94-1.24],0.263807053110102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,50722,343,0.73 [0.61-0.88],0.0011957064855192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNGB3,Cyclic nucleotide-gated cation channel beta-3,42497,265,0.89 [0.69-1.13],0.3336188556919857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",42682,275,1.05 [0.90-1.21],0.5395497104962796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY2,Protein canopy homolog 2,49594,325,1.10 [0.95-1.27],0.2001193804840621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY4,Protein canopy homolog 4,50286,339,1.07 [0.94-1.21],0.3290579772015505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNST,Consortin,50522,342,1.04 [0.95-1.13],0.4396541340525596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTF,Ciliary neurotrophic factor,42497,265,1.10 [0.78-1.54],0.5961187429028889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN1,Contactin-1,51146,343,0.70 [0.50-0.99],0.0412440166930797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN2,Contactin-2,50950,341,0.95 [0.77-1.18],0.6400214325587188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN3,Contactin-3,50539,340,0.81 [0.60-1.09],0.1632173173989434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN4,Contactin-4,50539,340,1.32 [0.88-1.96],0.1797233133887557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN5,Contactin-5,50647,342,0.58 [0.45-0.76],5.628684833162279e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP2,Contactin-associated protein-like 2,50447,341,0.97 [0.77-1.23],0.824175881398002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP4,Contactin-associated protein-like 4,42721,269,1.07 [0.96-1.18],0.2316424655915455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COCH,Cochlin,43925,280,1.30 [1.03-1.65],0.0252684430950714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL15A1,Collagen alpha-1(XV) chain,43926,275,0.95 [0.62-1.46],0.8183929383414308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,50739,342,2.48 [1.67-3.67],6.705515835890074e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL1A1,Collagen alpha-1(I) chain,51146,343,1.07 [0.73-1.57],0.7309541841151219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL24A1,Collagen alpha-1(XXIV) chain,43736,277,1.16 [0.94-1.42],0.1717657046553548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,42721,269,0.75 [0.64-0.88],0.0004284725994817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL2A1,Collagen alpha-1(II) chain,42761,275,1.14 [0.99-1.31],0.0645447143753729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL3A1,Collagen alpha-1(III) chain,43926,275,1.66 [1.04-2.67],0.0349444719801688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A1,Collagen alpha-1(IV) chain,50522,342,1.49 [1.18-1.88],0.0007315186829785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A4,Collagen alpha-4(IV) chain,43053,274,0.98 [0.79-1.21],0.837179852786811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL5A1,Collagen alpha-1(V) chain,42966,266,1.54 [1.18-2.00],0.00126210640646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,51146,343,2.05 [1.62-2.60],2.1316199551395342e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A1,Collagen alpha-1(IX) chain,50447,341,1.04 [0.85-1.26],0.7268861959501492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A2,Collagen alpha-2(IX) chain,43124,274,1.25 [1.01-1.53],0.0383825844311713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,50485,337,2.49 [1.78-3.46],7.891202390244174e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD1,COMM domain-containing protein 1,42761,275,1.14 [0.94-1.37],0.1751402019333569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD9,COMM domain-containing protein 9,43716,280,1.12 [0.86-1.46],0.4131442434197344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMP,Cartilage oligomeric matrix protein,49986,341,1.05 [0.79-1.40],0.7391525795429508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMT,Catechol O-methyltransferase,49058,322,1.09 [0.96-1.22],0.1739638504670471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPB2,Coatomer subunit beta',42474,270,0.90 [0.68-1.18],0.4357153818688032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPE,Coatomer subunit epsilon,49337,326,1.00 [0.81-1.23],0.9868161147915864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",42761,275,1.08 [0.83-1.39],0.5751172960454887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO1A,Coronin-1A,49500,329,1.08 [0.98-1.20],0.1230730456849282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO6,Coronin-6,42497,265,1.21 [0.91-1.61],0.197619480338025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",50286,339,1.17 [1.03-1.34],0.0179419277818442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX6B1,Cytochrome c oxidase subunit 6B1,43925,280,1.24 [0.88-1.73],0.2191979890875009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA1,Carboxypeptidase A1,51146,343,0.98 [0.84-1.14],0.7524008829733524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA2,Carboxypeptidase A2,50803,342,1.03 [0.89-1.18],0.7202697376737561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA4,Carboxypeptidase A4,42106,259,1.15 [0.87-1.52],0.3137010580563945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB1,Carboxypeptidase B,51146,343,1.03 [0.88-1.20],0.7363305273785339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB2,Carboxypeptidase B2,43904,275,0.79 [0.48-1.32],0.3655670567121042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPE,Carboxypeptidase E,50557,338,0.76 [0.60-0.95],0.015913767597778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPLX2,Complexin-2,42355,265,0.93 [0.63-1.37],0.7239993939892189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPM,Carboxypeptidase M,50723,342,1.53 [1.18-2.00],0.0014986063457917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",42650,268,1.22 [0.82-1.81],0.3368797209376895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPPED1,Serine/threonine-protein phosphatase CPPED1,50968,342,1.04 [0.90-1.19],0.6349545597122556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPQ,Carboxypeptidase Q,43847,275,1.06 [0.78-1.45],0.7006838410868702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPTP,Ceramide-1-phosphate transfer protein,42474,270,1.03 [0.77-1.38],0.8281933874727091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPVL,Probable serine carboxypeptidase CPVL,50866,341,1.18 [0.93-1.50],0.1719461212832587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM1,Probable carboxypeptidase X1,50678,342,1.18 [1.03-1.35],0.017346093093302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM2,Inactive carboxypeptidase-like protein X2,43925,280,1.78 [1.21-2.61],0.0035494837953979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR1,Complement receptor type 1,43790,276,1.32 [0.96-1.81],0.0897869050502847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR2,Complement receptor type 2,50722,343,1.15 [0.94-1.41],0.1790855095052301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,49332,331,1.08 [0.97-1.21],0.1667340487992406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRADD,Death domain-containing protein CRADD,50052,340,1.06 [0.93-1.21],0.3647769146372648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREB3,Cyclic AMP-responsive element-binding protein 3,42355,265,1.25 [1.05-1.49],0.0130726656703978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREBZF,CREB/ATF bZIP transcription factor,42355,265,1.44 [0.96-2.17],0.0801830315707148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREG1,Protein CREG1,49865,340,1.05 [0.82-1.34],0.715564567771076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD1,Protein disulfide isomerase CRELD1,42966,266,1.40 [1.03-1.91],0.0327428682012067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD2,Protein disulfide isomerase CRELD2,50654,338,1.25 [1.05-1.50],0.0142474339532243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRH,Corticoliberin,49248,331,0.99 [0.88-1.11],0.8713789513404187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,50485,337,1.92 [1.36-2.71],0.0001984895029674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHR1,Corticotropin-releasing factor receptor 1,49594,325,0.96 [0.82-1.13],0.6459587797841684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIM1,Cysteine-rich motor neuron 1 protein,50737,340,2.30 [1.47-3.61],0.0002712065536492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,50135,340,1.43 [1.14-1.79],0.0019335857074796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP2,Cysteine-rich secretory protein 2,50950,341,0.88 [0.75-1.04],0.125965418208872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP3,Cysteine-rich secretory protein 3,43550,275,0.73 [0.48-1.11],0.1417897690305427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRKL,Crk-like protein,50569,338,1.05 [0.96-1.15],0.261344756614416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRLF1,Cytokine receptor-like factor 1,50737,340,1.67 [1.14-2.43],0.007896431219751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRNN,Cornulin,49070,332,1.13 [0.98-1.30],0.1043928355407409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAC1,Cartilage acidic protein 1,51146,343,0.81 [0.59-1.10],0.1823976927623462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,50135,340,1.42 [1.18-1.72],0.0001966339131349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAP,Cartilage-associated protein,42721,269,1.01 [0.79-1.28],0.9314284267296452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRX,Cone-rod homeobox protein,49594,325,0.93 [0.84-1.03],0.1645489960795313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB1,Beta-crystallin B1,43925,280,1.24 [1.04-1.47],0.0155279214616655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,43820,278,1.43 [1.32-1.55],2.5126642745875567e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYGD,Gamma-crystallin D,43820,278,1.02 [0.90-1.15],0.7657388059611185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYM,Ketimine reductase mu-crystallin,42497,265,1.09 [0.94-1.26],0.2714268614581681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYZL1,Quinone oxidoreductase-like protein 1,42761,275,1.04 [0.92-1.19],0.5091973510812469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSDE1,Cold shock domain-containing protein E1,42474,270,1.06 [0.97-1.17],0.2089956542439055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,50737,340,2.27 [1.64-3.15],9.112625731818268e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,43959,278,1.63 [1.25-2.13],0.0002948419675052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2,Granulocyte-macrophage colony-stimulating factor,42474,270,0.99 [0.72-1.37],0.9631858757131592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,50135,340,1.18 [1.02-1.37],0.0293502048654001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RB,Cytokine receptor common subunit beta,42650,268,1.19 [0.90-1.56],0.2183449367150938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3,Granulocyte colony-stimulating factor,49560,327,0.97 [0.79-1.18],0.7383606006591059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3R,Granulocyte colony-stimulating factor receptor,42650,268,0.97 [0.67-1.42],0.8889321456656383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSH1,Chorionic somatomammotropin hormone 1,43959,278,0.96 [0.65-1.41],0.829019575660427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK1D,Casein kinase I isoform delta,42650,268,1.04 [0.87-1.25],0.6628803762800874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK2A1,Casein kinase II subunit alpha,43847,277,1.18 [0.92-1.52],0.1903370118391738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG4,Chondroitin sulfate proteoglycan 4,43926,275,1.31 [0.93-1.85],0.1269100598871195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG5,Chondroitin sulfate proteoglycan 5,42497,265,0.93 [0.73-1.19],0.5772616008052445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSRP3,Cysteine and glycine-rich protein 3,42474,270,1.13 [1.02-1.26],0.0227658410125166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST1,Cystatin-SN,38126,232,0.95 [0.83-1.08],0.4129580218051243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,50637,343,2.23 [1.66-3.00],1.213717061863298e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST5,Cystatin-D,49579,334,0.98 [0.82-1.17],0.8282983497442065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST6,Cystatin-M,49196,329,1.02 [0.83-1.24],0.8616973291684535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST7,Cystatin-F,50573,340,1.09 [0.99-1.19],0.0652245562146465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSTB,Cystatin-B,49835,334,1.45 [1.17-1.80],0.000626094074309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTAG1A_CTAG1B,Cancer/testis antigen 1,43042,274,1.13 [0.91-1.42],0.2679381998172947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTBS,Di-N-acetylchitobiase,43316,275,1.23 [0.80-1.90],0.350952023362317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTF1,Cardiotrophin-1,49594,325,1.04 [0.92-1.16],0.538334912773725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTHRC1,Collagen triple helix repeat-containing protein 1,43926,275,1.91 [1.31-2.77],0.0006987344779729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTLA4,Cytotoxic T-lymphocyte protein 4,43926,275,1.08 [0.74-1.57],0.6965447896877739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTNNA1,Catenin alpha-1,42497,265,1.10 [0.81-1.49],0.5506182251918947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRB1,Chymotrypsinogen B,50539,340,0.96 [0.81-1.14],0.6574921125444282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRC,Chymotrypsin-C,50488,337,0.89 [0.77-1.03],0.1113494166190676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRL,Chymotrypsin-like protease CTRL-1,43820,278,0.95 [0.81-1.12],0.5502703527534465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSB,Cathepsin B,50576,342,1.03 [0.86-1.23],0.7814186951055153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSC,Dipeptidyl peptidase 1,50400,340,1.14 [0.92-1.42],0.2233994775141132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSD,Cathepsin D,47235,328,1.42 [1.15-1.75],0.0010949999408814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSE,Cathepsin E,42966,266,1.21 [0.97-1.51],0.0866189834731907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSF,Cathepsin F,50678,342,0.87 [0.69-1.11],0.2584424475277325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSH,Pro-cathepsin H,49430,324,1.10 [0.96-1.26],0.1534267634337932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSL,Cathepsin L1,50522,342,2.10 [1.45-3.05],8.394470994666554e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSO,Cathepsin O,51074,342,1.26 [0.93-1.71],0.130925465621155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSS,Cathepsin S,39709,275,2.07 [1.29-3.32],0.0024344574859824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSV,Cathepsin L2,50783,341,0.77 [0.61-0.97],0.0267582458119522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSZ,Cathepsin Z,50559,343,1.64 [1.22-2.19],0.0009502363736488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CUZD1,CUB and zona pellucida-like domain-containing protein 1,42721,269,1.00 [0.74-1.35],0.9863393884240044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CWC15,Spliceosome-associated protein CWC15 homolog,43488,274,1.17 [0.99-1.38],0.0600370661273803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CX3CL1,Fractalkine,50135,340,1.46 [1.11-1.92],0.0064460774940537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,50447,341,1.45 [1.22-1.71],1.5268998850610235e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL1,Growth-regulated alpha protein,50411,340,1.01 [0.92-1.12],0.8178005143214369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL10,C-X-C motif chemokine 10,50737,340,1.26 [1.11-1.43],0.0003609959791672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL11,C-X-C motif chemokine 11,50968,342,1.14 [1.02-1.28],0.0165551351481532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL12,Stromal cell-derived factor 1,49560,327,1.21 [0.95-1.54],0.113416832328396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL13,C-X-C motif chemokine 13,50968,342,1.16 [1.02-1.33],0.023646191362226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL14,C-X-C motif chemokine 14,49560,327,1.15 [1.00-1.32],0.0538999087422189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL16,C-X-C motif chemokine 16,51064,343,1.96 [1.32-2.90],0.0007558021140148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL17,C-X-C motif chemokine 17,51074,342,1.23 [0.99-1.53],0.0561161795635138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL3,C-X-C motif chemokine 3,50490,338,1.01 [0.91-1.11],0.8921767532136006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL5,C-X-C motif chemokine 5,50358,341,1.02 [0.94-1.11],0.6095493896853705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL6,C-X-C motif chemokine 6,51074,342,1.07 [0.95-1.22],0.2492826660667584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL8,Interleukin-8,50128,338,0.98 [0.86-1.13],0.8282805496080596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,50737,340,1.31 [1.15-1.48],3.006707280427516e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5A,Cytochrome b5,42355,265,0.86 [0.71-1.03],0.1045114948508531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5R2,NADH-cytochrome b5 reductase 2,43246,274,1.10 [0.90-1.35],0.3432312123037703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",42474,270,0.98 [0.85-1.12],0.727975995151333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTH3,Cytohesin-3,42355,265,0.85 [0.71-1.02],0.0751584587423305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTL1,Cytokine-like protein 1,43926,275,0.96 [0.60-1.54],0.8565845827046027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAAM1,Disheveled-associated activator of morphogenesis 1,42966,266,1.02 [0.88-1.17],0.8199553662221877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAB2,Disabled homolog 2,50950,341,1.06 [0.97-1.16],0.1828877287225365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAG1,Dystroglycan,50737,340,1.30 [1.06-1.58],0.0111551937775757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAND5,DAN domain family member 5,42650,268,1.08 [0.89-1.31],0.4555866490809327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPK2,Death-associated protein kinase 2,42650,268,1.04 [0.84-1.27],0.7230257591470147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,50447,341,1.01 [0.93-1.09],0.7919854366699434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DARS1,"Aspartate--tRNA ligase, cytoplasmic",50052,340,1.03 [0.91-1.18],0.6252798674404325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBH,Dopamine beta-hydroxylase,43874,278,1.03 [0.92-1.15],0.5974617636928969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBI,Acyl-CoA-binding protein,50297,338,1.13 [1.00-1.28],0.0437582661325949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBN1,Drebrin,42650,268,1.08 [0.86-1.36],0.5153862795102518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBNL,Drebrin-like protein,50737,340,1.07 [0.97-1.19],0.1899779009459138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",50678,342,1.55 [1.19-2.02],0.0012894382497633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCC,Netrin receptor DCC,42721,269,1.00 [0.59-1.68],0.986667408864079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCDC2C,Doublecortin domain-containing protein 2C,42355,265,1.06 [0.89-1.27],0.5170602647736628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCLRE1C,Protein artemis,42355,265,1.05 [0.72-1.54],0.7899523248031206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCN,Decorin,49594,325,1.20 [0.78-1.83],0.407604444003862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTD,Deoxycytidylate deaminase,42966,266,1.02 [0.90-1.16],0.7473720134310103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN1,Dynactin subunit 1,50950,341,1.04 [0.90-1.20],0.5922673477225047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN2,Dynactin subunit 2,50286,339,1.08 [0.97-1.19],0.1448677902973128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN6,Dynactin subunit 6,49337,326,1.04 [0.91-1.19],0.5929601126677344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTPP1,dCTP pyrophosphatase 1,50522,342,1.12 [0.83-1.52],0.4698799828213418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D1,DCN1-like protein 1,42497,265,1.00 [0.86-1.17],0.9617175754938156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D2,DCN1-like protein 2,42355,265,0.97 [0.83-1.13],0.683585890119035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCXR,L-xylulose reductase,50678,342,0.97 [0.81-1.16],0.7355426225253161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDA1,DET1- and DDB1-associated protein 1,42474,270,1.07 [0.81-1.42],0.632109612265864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",50286,339,1.36 [1.11-1.66],0.0025873434542292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDC,Aromatic-L-amino-acid decarboxylase,50447,342,1.10 [0.91-1.34],0.3280368180137512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDHD2,Phospholipase DDHD2,43847,277,1.02 [0.86-1.22],0.8163532195882028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDI2,Protein DDI1 homolog 2,42966,266,0.84 [0.73-0.98],0.0296694172696317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDR1,Epithelial discoidin domain-containing receptor 1,50968,342,1.99 [1.35-2.93],0.0004898578385398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDT,D-dopachrome decarboxylase,43926,275,0.88 [0.66-1.16],0.3607482620287241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX1,ATP-dependent RNA helicase DDX1,43736,277,1.10 [0.89-1.36],0.396289094490368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX25,ATP-dependent RNA helicase DDX25,42721,269,0.98 [0.71-1.34],0.877287008332996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX39A,ATP-dependent RNA helicase DDX39A,42650,268,0.88 [0.52-1.50],0.6464299784636063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX4,Probable ATP-dependent RNA helicase DDX4,42650,268,1.08 [0.88-1.32],0.4733688909897734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX53,Probable ATP-dependent RNA helicase DDX53,42721,269,0.96 [0.69-1.34],0.8292064762661233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX58,Antiviral innate immune response receptor RIG-I,49332,331,1.04 [0.88-1.23],0.6325020149798742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",50447,341,1.10 [1.00-1.22],0.0540302123629786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFA1_DEFA1B,Neutrophil defensin 1,49496,338,1.12 [0.94-1.32],0.2026335503926844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB103A_DEFB103B,Beta-defensin 103,42324,265,1.36 [1.11-1.67],0.0028936990136242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB104A_DEFB104B,Beta-defensin 104,42497,265,1.07 [0.87-1.31],0.5379383349149629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB116,Beta-defensin 116,42497,265,1.08 [0.94-1.25],0.2775057552973683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB118,Beta-defensin 118,42497,265,1.01 [0.82-1.24],0.9193214730977852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB4A_DEFB4B,Beta-defensin 4A,49798,338,1.03 [0.97-1.10],0.31659914862602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENND2B,DENN domain-containing protein 2B,42474,270,1.11 [0.90-1.38],0.3197840082513693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENR,Density-regulated protein,42650,268,1.01 [0.82-1.24],0.9267216377252446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DFFA,DNA fragmentation factor subunit alpha,51074,342,1.07 [0.93-1.23],0.3309875957089118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGCR6,Protein DGCR6,42497,265,1.20 [0.96-1.51],0.1082184066687706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKA,Diacylglycerol kinase alpha,42650,268,1.11 [0.89-1.37],0.3548305449060254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKZ,Diacylglycerol kinase zeta,49560,327,1.10 [0.84-1.45],0.4900472074979705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHODH,Dihydroorotate dehydrogenase,42474,270,0.91 [0.70-1.18],0.4659524950819652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHPS,Deoxyhypusine synthase,43716,280,0.96 [0.72-1.28],0.7923889955098595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,43820,278,1.20 [0.96-1.49],0.1048155046135139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIABLO,"Diablo homolog, mitochondrial",50359,342,1.05 [0.96-1.14],0.3048588831275178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK1C,Divergent protein kinase domain 1C,42721,269,1.08 [0.83-1.42],0.5639348059811011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK2B,Divergent protein kinase domain 2B,42966,266,0.92 [0.60-1.41],0.7175073931612375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK1,Dickkopf-related protein 1,50968,342,1.13 [0.96-1.32],0.1391620168718687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK3,Dickkopf-related protein 3,51146,343,1.15 [0.84-1.58],0.3919732382113322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK4,Dickkopf-related protein 4,50053,340,1.17 [0.95-1.43],0.1335307088009115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKKL1,Dickkopf-like protein 1,50286,339,1.05 [0.94-1.18],0.3754116293775476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLG4,Disks large homolog 4,43820,278,1.10 [0.94-1.28],0.2539797575470928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLGAP5,Disks large-associated protein 5,43847,277,1.00 [0.80-1.25],0.9972419335483388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLK1,Protein delta homolog 1,51146,343,0.99 [0.84-1.17],0.9079963237143048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,50678,342,1.80 [1.33-2.44],0.0001250840713863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL4,Delta-like protein 4,42761,275,0.97 [0.84-1.12],0.6841476037898102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMD,Dystrophin,42761,275,1.29 [1.06-1.55],0.0092694193499277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMP1,Dentin matrix acidic phosphoprotein 1,42761,275,0.89 [0.74-1.06],0.1954466898108026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA1,DnaJ homolog subfamily A member 1,42355,265,0.78 [0.58-1.04],0.0953032090483612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA2,DnaJ homolog subfamily A member 2,50912,342,1.08 [0.96-1.21],0.2071624310985331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA4,DnaJ homolog subfamily A member 4,43820,278,0.92 [0.78-1.07],0.2774168258119315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB1,DnaJ homolog subfamily B member 1,50286,339,1.01 [0.91-1.13],0.8283059352728301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB14,DnaJ homolog subfamily B member 14,43736,277,1.08 [0.91-1.29],0.3834568304198439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB2,DnaJ homolog subfamily B member 2,42966,266,0.91 [0.73-1.13],0.3943792074451208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB6,DnaJ homolog subfamily B member 6,42560,263,1.01 [0.88-1.16],0.8865025014251215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB8,DnaJ homolog subfamily B member 8,49594,325,1.06 [0.90-1.25],0.5075274423113043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC21,DnaJ homolog subfamily C member 21,43820,278,0.95 [0.70-1.28],0.7186637333632204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC6,Putative tyrosine-protein phosphatase auxilin,42761,275,1.03 [0.89-1.18],0.7175516777495139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC9,DnaJ homolog subfamily C member 9,43736,277,1.03 [0.89-1.19],0.7241109231402894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNER,Delta and Notch-like epidermal growth factor-related receptor,50403,337,0.70 [0.48-1.02],0.0627799689715055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNLZ,DNL-type zinc finger protein,42497,265,1.00 [0.87-1.14],0.9765960280748194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM1,Dynamin-1,43736,277,1.04 [0.94-1.15],0.4329802278667611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM3,Dynamin-3,43847,277,1.13 [0.92-1.37],0.2369185859708875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNMBP,Dynamin-binding protein,50135,340,1.13 [0.97-1.32],0.1057411809723369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPEP,Aspartyl aminopeptidase,43820,278,1.10 [0.90-1.34],0.3718764321270454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,50652,340,0.92 [0.76-1.10],0.366077532392005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOC2B,Double C2-like domain-containing protein beta,42721,269,1.20 [0.91-1.58],0.1980487724065072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOCK9,Dedicator of cytokinesis protein 9,42497,265,1.01 [0.92-1.12],0.7755084771856591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK1,Docking protein 1,43820,278,1.02 [0.94-1.11],0.6183146418844683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK2,Docking protein 2,50522,342,1.04 [0.97-1.13],0.2773665159548055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP1,Dipeptidase 1,50052,340,0.86 [0.71-1.04],0.1256080642403322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP2,Dipeptidase 2,50286,339,1.19 [0.86-1.65],0.2861752074926814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP10,Inactive dipeptidyl peptidase 10,50447,341,1.15 [0.89-1.49],0.28637684784645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP4,Dipeptidyl peptidase 4,49586,339,0.96 [0.69-1.34],0.8065631385510557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP6,Dipeptidyl aminopeptidase-like protein 6,50286,339,0.95 [0.71-1.26],0.7081380525535459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP7,Dipeptidyl peptidase 2,50113,341,1.06 [0.91-1.25],0.433637543713859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPT,Dermatopontin,51146,343,1.38 [0.94-2.02],0.0954856349715325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPY30,Protein dpy-30 homolog,50791,340,1.25 [1.08-1.44],0.0028318000622329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRAXIN,Draxin,50135,340,1.25 [1.00-1.56],0.0456911973659894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRG2,Developmentally-regulated GTP-binding protein 2,50286,339,1.10 [0.93-1.30],0.2583673275364113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,49975,333,1.91 [1.50-2.44],2.168417502909677e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSCAM,Down syndrome cell adhesion molecule,43847,277,1.16 [0.84-1.59],0.3628485525146157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG2,Desmoglein-2,50539,340,1.31 [0.93-1.85],0.125567788217583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG3,Desmoglein-3,50780,339,1.26 [0.96-1.66],0.0976083733850736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG4,Desmoglein-4,50125,339,0.92 [0.76-1.12],0.4177974167073143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTD1,D-aminoacyl-tRNA deacylase 1,42966,266,1.10 [0.96-1.25],0.1789126827347122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTNB,Dystrobrevin beta,43635,280,1.55 [1.23-1.95],0.0001969366485963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX2,Probable E3 ubiquitin-protein ligase DTX2,42721,269,0.97 [0.80-1.18],0.785917572466755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX3,Probable E3 ubiquitin-protein ligase DTX3,50286,339,1.48 [1.02-2.15],0.0369753240605535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTYMK,Thymidylate kinase,43925,280,1.00 [0.85-1.18],0.961335189119186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUOX2,Dual oxidase 2,49594,325,1.02 [0.89-1.17],0.7510194770030514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP13,Dual specificity protein phosphatase 13 isoform A,43716,280,0.86 [0.65-1.14],0.2964164252356633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP29,Dual specificity phosphatase 29,42721,269,1.01 [0.85-1.20],0.8930157318852453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP3,Dual specificity protein phosphatase 3,49337,326,1.00 [0.90-1.13],0.936428682099251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",43736,277,1.09 [0.97-1.21],0.1373143596392929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DXO,Decapping and exoribonuclease protein,43820,278,1.15 [0.89-1.47],0.282595528411633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,43716,280,1.12 [0.90-1.39],0.3261517414862679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT1,Dynein light chain Tctex-type 1,42721,269,0.98 [0.85-1.13],0.7801227494975616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT3,Dynein light chain Tctex-type 3,43716,280,1.02 [0.79-1.32],0.8676941781698597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,50135,340,1.09 [0.98-1.21],0.0958499398479764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBI3_IL27,Interleukin-27,50876,341,1.46 [1.08-1.97],0.0149266386699109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECE1,Endothelin-converting enzyme 1,49337,326,1.38 [1.07-1.79],0.012406490826211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",43925,280,1.15 [0.99-1.32],0.0644143556025183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHS1,"Enoyl-CoA hydratase, mitochondrial",42761,275,1.13 [1.01-1.27],0.0389082272043591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECI2,Enoyl-CoA delta isomerase 2,42474,270,1.05 [0.88-1.27],0.5808957888025533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECM1,Extracellular matrix protein 1,42778,266,0.89 [0.65-1.21],0.4517099191688767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECSCR,Endothelial cell-specific chemotaxis regulator,42497,265,1.00 [0.79-1.26],0.9971816046591744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,50950,341,2.02 [1.62-2.52],5.657881163766122e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDAR,Tumor necrosis factor receptor superfamily member EDAR,50447,341,0.99 [0.90-1.10],0.9172324228368854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDDM3B,Epididymal secretory protein E3-beta,43716,280,0.91 [0.73-1.14],0.4212722407376676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,42474,270,1.05 [0.77-1.43],0.7569885980808128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDF1,Endothelial differentiation-related factor 1,43847,277,1.01 [0.85-1.19],0.9327701692231491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,49594,325,1.07 [0.81-1.41],0.6502814286053225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDN1,Endothelin-1,42761,275,1.50 [1.01-2.20],0.0421542216066218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDNRB,Endothelin receptor type B,42650,268,0.98 [0.75-1.29],0.9066163924631596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EEF1D,Elongation factor 1-delta,43925,280,1.06 [0.94-1.20],0.3673377765489003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB14,EF-hand calcium-binding domain-containing protein 14,43736,277,1.58 [1.17-2.14],0.0026956768834795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB2,Dynein regulatory complex protein 8,43124,274,1.24 [0.90-1.69],0.1869873198294118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,50640,343,1.85 [1.38-2.47],3.5967423429860995e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFHD1,EF-hand domain-containing protein D1,43847,277,1.34 [1.00-1.79],0.0483311670549665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,50457,340,2.36 [1.75-3.17],1.611038323920483e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,50052,339,2.51 [1.98-3.18],3.58267755232479e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNB2,Ephrin-B2,42721,269,1.18 [0.99-1.40],0.0573348898546246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGF,Pro-epidermal growth factor,50406,336,1.06 [0.97-1.17],0.2114378264180894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFL7,Epidermal growth factor-like protein 7,49332,331,1.22 [0.96-1.54],0.1014023498253332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFLAM,Pikachurin,43736,277,1.37 [0.98-1.92],0.067708799438476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFR,Epidermal growth factor receptor,51146,343,0.35 [0.20-0.62],0.0003058964879817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGLN1,Egl nine homolog 1,50447,341,1.10 [0.95-1.29],0.2062700287621401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHBP1,EH domain-binding protein 1,43925,280,1.07 [0.92-1.24],0.396328103869938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHD3,EH domain-containing protein 3,42761,275,0.98 [0.88-1.08],0.6425814510647538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",43820,278,1.14 [0.94-1.37],0.1887994936673565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",43573,274,1.07 [0.96-1.19],0.2140715478562224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,42474,270,1.01 [0.84-1.20],0.9353698008958892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,42761,275,1.13 [0.86-1.47],0.3780462423186129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4B,Eukaryotic translation initiation factor 4B,50135,340,1.13 [0.95-1.34],0.1573155983397255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4E,Eukaryotic translation initiation factor 4E,42650,268,1.05 [0.92-1.20],0.4484336304563006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,50522,342,1.03 [0.89-1.19],0.7227029030761875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,51074,342,1.08 [0.98-1.19],0.106687757721358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,43847,277,1.07 [0.90-1.26],0.4612965316870551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5,Eukaryotic translation initiation factor 5,42474,270,1.02 [0.79-1.33],0.8582809172478709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5A,Eukaryotic translation initiation factor 5A-1,49560,327,1.11 [0.81-1.52],0.5333678361286529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAC1,Zinc phosphodiesterase ELAC protein 1,43847,277,1.06 [0.92-1.21],0.4072197104791228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAVL4,ELAV-like protein 4,42497,265,1.13 [0.99-1.28],0.0631341590164253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELN,Elastin,43925,280,1.73 [1.27-2.36],0.0004819544066873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOA,Elongin-A,50286,339,1.05 [0.89-1.25],0.5346779982408302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOB,Elongin-B,42474,270,1.49 [1.22-1.82],0.0001157714255411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENAH,Protein enabled homolog,49560,327,1.39 [1.15-1.67],0.0006832835709545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENDOU,Poly(U)-specific endoribonuclease,40547,256,0.88 [0.70-1.11],0.2760883161966604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENG,Endoglin,51146,343,1.05 [0.60-1.81],0.8747482402465921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO1,Alpha-enolase,50472,341,1.09 [0.96-1.23],0.1811304347170055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO2,Gamma-enolase,50968,342,1.10 [0.95-1.27],0.2064306716353249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO3,Beta-enolase,42761,275,0.90 [0.73-1.10],0.3032609007511932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOPH1,Enolase-phosphatase E1,43716,280,0.92 [0.73-1.17],0.4947950866079225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,42474,270,0.69 [0.44-1.09],0.109257826570214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPEP,Glutamyl aminopeptidase,42474,270,1.04 [0.81-1.34],0.7377772256181773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,51146,343,1.64 [1.18-2.28],0.0034115393167069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,50737,340,0.85 [0.69-1.04],0.1172633769009948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,42761,275,0.88 [0.64-1.20],0.4157296914170046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,48959,332,1.04 [0.92-1.16],0.5491766708071892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENSA,Alpha-endosulfine,43716,280,1.29 [1.07-1.55],0.0071810072592448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,49332,331,1.25 [1.01-1.55],0.0405026931538249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,49594,325,1.18 [0.75-1.88],0.4730587036408571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,49594,325,1.53 [1.04-2.26],0.0329034841944708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTR1,Endosome-associated-trafficking regulator 1,42761,275,0.98 [0.80-1.19],0.8108001079321635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EP300,Histone acetyltransferase p300,42650,268,1.26 [0.90-1.75],0.1735816219499666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPB41L5,Band 4.1-like protein 5,42721,269,0.89 [0.73-1.09],0.2491623089842421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPCAM,Epithelial cell adhesion molecule,50486,337,0.99 [0.89-1.09],0.787705132282011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPGN,Epigen,43716,280,1.20 [0.98-1.46],0.0718554016784838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA1,Ephrin type-A receptor 1,50652,340,1.40 [1.05-1.88],0.0232790476393531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA10,Ephrin type-A receptor 10,49337,326,1.03 [0.89-1.19],0.6969335751652193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,48684,325,2.25 [1.79-2.82],2.7376446003584e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA4,Ephrin type-A receptor 4,42966,266,1.20 [0.80-1.81],0.3733763160565365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,51146,343,2.44 [1.75-3.40],1.3356232343745146e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB6,Ephrin type-B receptor 6,50052,340,1.56 [1.17-2.09],0.0026690667204172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHX2,Bifunctional epoxide hydrolase 2,49594,325,1.00 [0.85-1.17],0.996506719342376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPN1,Epsin-1,43124,274,1.19 [0.94-1.51],0.1372470179451036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPO,Erythropoietin,50447,341,1.05 [0.93-1.19],0.4395824160802242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPPK1,Epiplakin,42761,275,1.10 [0.95-1.28],0.2083863335884727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,50865,340,1.58 [1.18-2.12],0.002000884345211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB2,Receptor tyrosine-protein kinase erbB-2,50678,342,1.22 [0.83-1.80],0.306435252106904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB3,Receptor tyrosine-protein kinase erbB-3,50320,337,1.22 [0.75-1.99],0.4274324784533515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB4,Receptor tyrosine-protein kinase erbB-4,50678,342,0.82 [0.55-1.22],0.3258924204624969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBIN,Erbin,50286,339,1.07 [0.97-1.17],0.1750474157205301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERC2,ERC protein 2,42721,269,0.98 [0.83-1.15],0.7602326272550786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERCC1,DNA excision repair protein ERCC-1,42355,265,1.01 [0.71-1.45],0.94237699662996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EREG,Proepiregulin,50052,340,1.05 [0.94-1.18],0.3956222938420484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERI1,3'-5' exoribonuclease 1,43124,274,1.04 [0.74-1.46],0.819732865405912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERMAP,Erythroid membrane-associated protein,42650,268,1.22 [0.94-1.59],0.1258452502761626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,43716,280,1.21 [0.91-1.62],0.1847855241665718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP29,Endoplasmic reticulum resident protein 29,42966,266,1.04 [0.95-1.15],0.3905521291309897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP44,Endoplasmic reticulum resident protein 44,50204,339,1.17 [0.81-1.69],0.4102865543228661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,42474,270,0.79 [0.59-1.05],0.1027294059957574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,51146,343,1.74 [1.31-2.30],0.0001039651477373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESM1,Endothelial cell-specific molecule 1,50485,337,1.24 [0.94-1.64],0.1271253297890258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESPL1,Separin,42355,265,1.13 [0.94-1.36],0.1913300611474798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESR1,Estrogen receptor,42650,268,1.04 [0.85-1.27],0.7377728745625469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESYT2,Extended synaptotagmin-2,43820,278,1.08 [0.94-1.24],0.2601562888636823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI2B,Protein EVI2B,42355,265,0.87 [0.62-1.20],0.3936310987442196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI5,Ecotropic viral integration site 5 protein homolog,42650,268,1.05 [0.92-1.19],0.4902155254947477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVPL,Envoplakin,43124,274,1.48 [1.12-1.95],0.0056444035473778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXOSC10,Exosome component 10,42474,270,0.92 [0.75-1.14],0.450838255830188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXTL1,Exostosin-like 1,42474,270,0.88 [0.68-1.15],0.3562686844199211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EZR,Ezrin,50968,342,1.15 [0.78-1.69],0.4712821788207273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F10,Coagulation factor X,43959,278,0.89 [0.58-1.35],0.5831065216014183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11,Coagulation factor XI,43347,272,1.22 [0.88-1.70],0.2331361616630346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11R,Junctional adhesion molecule A,50539,340,1.23 [1.04-1.45],0.0136541905004586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F12,Coagulation factor XII,43988,277,0.99 [0.75-1.30],0.9234799787631724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F13B,Coagulation factor XIII B chain,43744,275,0.94 [0.60-1.47],0.7716419363170414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2,Prothrombin,43988,277,0.68 [0.32-1.44],0.3105499560650555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2R,Proteinase-activated receptor 1,50654,338,1.29 [1.09-1.52],0.0026468473334409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F3,Tissue factor,50641,340,1.37 [0.97-1.93],0.069560592328345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F7,Coagulation factor VII,50639,343,1.16 [0.85-1.59],0.3507731649845442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F9,Coagulation factor IX,50641,343,0.89 [0.53-1.49],0.6483646158222648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",50485,337,1.29 [1.17-1.42],1.0994351162795177e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP2,"Fatty acid-binding protein, intestinal",50522,342,1.23 [1.10-1.38],0.0003759946668461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",43925,280,1.50 [1.24-1.82],4.005873169071025e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",51146,343,1.38 [1.16-1.65],0.0003394722843679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP5,Fatty acid-binding protein 5,50803,342,1.21 [1.06-1.39],0.0054149117032085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP6,Gastrotropin,49516,322,1.13 [0.95-1.33],0.1637380818000776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP9,Fatty acid-binding protein 9,50447,341,1.07 [0.90-1.26],0.4358818769558112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FADD,FAS-associated death domain protein,50522,342,1.04 [0.92-1.18],0.504237086210553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM13A,Protein FAM13A,43736,277,1.09 [0.92-1.28],0.3330590232812502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171A2,Protein FAM171A2,43847,277,1.03 [0.97-1.11],0.3325859045436502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171B,Protein FAM171B,43716,280,1.33 [0.93-1.89],0.1206287916136307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM172A,Cotranscriptional regulator FAM172A,42761,275,1.04 [0.87-1.26],0.6486799436608427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM20A,Pseudokinase FAM20A,43925,280,1.23 [0.83-1.83],0.3040933125578005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3B,Protein FAM3B,50286,339,1.70 [1.30-2.24],0.0001394694204906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,50447,342,2.11 [1.56-2.84],9.657235792771433e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3D,Protein FAM3D,43736,277,1.20 [1.05-1.37],0.0071204933749103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAP,Prolyl endopeptidase FAP,51146,343,0.79 [0.56-1.12],0.1813439637433958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FARSA,Phenylalanine--tRNA ligase alpha subunit,42721,269,1.00 [0.84-1.18],0.9774460274309716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAS,Tumor necrosis factor receptor superfamily member 6,50981,343,1.50 [1.23-1.83],6.232827551187677e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FASLG,Tumor necrosis factor ligand superfamily member 6,51074,342,1.03 [0.79-1.33],0.8491629310724382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBLN2,Fibulin-2,43926,275,1.27 [0.90-1.81],0.1775313000921548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBN2,Fibrillin-2,42721,269,1.02 [0.84-1.24],0.8433998571680108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBP1,"Fructose-1,6-bisphosphatase 1",50522,342,1.08 [0.95-1.22],0.2589359433797329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,43925,280,1.17 [1.00-1.36],0.0455480568158492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAR,Immunoglobulin alpha Fc receptor,50447,341,1.10 [0.90-1.34],0.3566552633694123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,43847,277,1.54 [0.98-2.43],0.0608882917564497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER2,Low affinity immunoglobulin epsilon Fc receptor,50539,340,1.05 [0.87-1.26],0.6390693949794324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,50311,342,1.06 [0.90-1.25],0.508890378718359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,49332,331,1.06 [0.90-1.25],0.498010610160932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,50560,343,1.10 [0.91-1.34],0.3396967301061458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN1,Ficolin-1,43874,278,1.01 [0.83-1.24],0.9189917653176524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN2,Ficolin-2,50317,341,1.04 [0.82-1.32],0.7359039991980489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL1,Fc receptor-like protein 1,50522,342,1.01 [0.82-1.25],0.9196921184612058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL2,Fc receptor-like protein 2,50833,339,1.25 [1.05-1.50],0.0122068571097916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL3,Fc receptor-like protein 3,49560,327,1.17 [0.99-1.40],0.0718924929180429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL5,Fc receptor-like protein 5,50539,340,1.05 [0.89-1.24],0.535394497125204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL6,Fc receptor-like protein 6,50447,341,1.12 [0.98-1.29],0.1077867953884885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRLB,Fc receptor-like B,49332,331,1.19 [1.03-1.36],0.0159618109527532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX1,"Adrenodoxin, mitochondrial",42474,270,1.13 [0.95-1.34],0.1581162034015322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX2,"Ferredoxin-2, mitochondrial",42474,270,1.06 [0.87-1.30],0.5523509006653025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FEN1,Flap endonuclease 1,49332,331,0.99 [0.85-1.15],0.8840825343765618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FES,Tyrosine-protein kinase Fes/Fps,49332,331,0.96 [0.77-1.18],0.6754646768239612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FETUB,Fetuin-B,50641,343,1.00 [0.75-1.34],0.9917822336445208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGA,Fibrinogen alpha chain,42947,271,0.67 [0.45-0.98],0.0400894354438153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",43847,277,1.07 [0.92-1.23],0.3770840479251132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF12,Fibroblast growth factor 12,42650,268,0.88 [0.65-1.18],0.391347042935336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF16,Fibroblast growth factor 16,42650,268,0.99 [0.77-1.27],0.9252106991793052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF19,Fibroblast growth factor 19,50737,340,1.05 [0.93-1.18],0.4638191256366955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF2,Fibroblast growth factor 2,50447,341,1.18 [1.03-1.35],0.0184731371738341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF20,Fibroblast growth factor 20,42650,268,0.94 [0.71-1.25],0.6805768070098573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF21,Fibroblast growth factor 21,50876,341,1.11 [1.03-1.20],0.0059570216063621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,50866,340,1.34 [1.16-1.53],3.388062783729086e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF3,Fibroblast growth factor 3,42650,268,0.62 [0.39-1.00],0.0494002885327768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,49560,327,1.63 [1.25-2.13],0.0003092003294656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF6,Fibroblast growth factor 6,42650,268,0.84 [0.61-1.16],0.2819956797341213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF7,Fibroblast growth factor 7,42355,265,1.01 [0.87-1.17],0.940509137972891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF9,Fibroblast growth factor 9,42279,265,0.71 [0.54-0.94],0.0148834933199781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP1,Fibroblast growth factor-binding protein 1,50678,342,0.61 [0.46-0.81],0.0006399451568216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP2,Fibroblast growth factor-binding protein 2,43926,275,0.90 [0.72-1.13],0.3666666817636679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP3,Fibroblast growth factor-binding protein 3,43820,278,1.08 [0.79-1.47],0.6464241691417708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR2,Fibroblast growth factor receptor 2,50678,342,2.20 [1.48-3.28],0.0001071351501338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR4,Fibroblast growth factor receptor 4,42966,266,1.01 [0.81-1.26],0.9109027409875736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,43959,278,1.38 [1.16-1.64],0.00032386593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGR,Tyrosine-protein kinase Fgr,49337,326,1.08 [0.93-1.26],0.318906738884785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FH,"Fumarate hydratase, mitochondrial",42497,265,0.99 [0.86-1.14],0.8816448123228294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIP2A,FHF complex subunit HOOK interacting protein 2A,42474,270,1.13 [0.91-1.39],0.279978679623848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIT,Bis(5'-adenosyl)-triphosphatase,49337,326,0.99 [0.87-1.13],0.901963285207105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FIS1,Mitochondrial fission 1 protein,50488,340,1.09 [0.96-1.23],0.176597801097067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,43847,277,1.05 [0.94-1.18],0.3969234878668282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,50669,333,1.04 [0.96-1.14],0.3136514039551999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,50135,340,1.31 [1.05-1.63],0.0187556648355464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,50135,340,1.12 [1.01-1.24],0.0317816639489535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,49254,326,1.10 [0.91-1.33],0.3334284620961134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBPL,FK506-binding protein-like,43736,277,1.15 [0.95-1.39],0.1564069720393215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLI1,Friend leukemia integration 1 transcription factor,49332,331,1.09 [1.00-1.19],0.0458932779917275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,50135,340,1.95 [1.42-2.68],4.027107632619652e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT1,Vascular endothelial growth factor receptor 1,50204,338,1.20 [0.79-1.83],0.3844983883036937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3,Receptor-type tyrosine-protein kinase FLT3,49332,331,0.95 [0.69-1.32],0.7747484882932455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3LG,Fms-related tyrosine kinase 3 ligand,51074,342,1.03 [0.78-1.36],0.8453202805437083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT4,Vascular endothelial growth factor receptor 3,50678,342,1.13 [0.85-1.51],0.3963868320784701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMNL1,Formin-like protein 1,49337,326,1.04 [0.90-1.20],0.5573819360326469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMR1,Synaptic functional regulator FMR1,49332,331,1.33 [1.02-1.74],0.0381314525306389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FN1,Fibronectin,43988,277,0.98 [0.64-1.50],0.9216117843726024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNDC1,Fibronectin type III domain-containing protein 1,43820,278,1.32 [1.03-1.69],0.0255806592439212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,43716,280,1.41 [1.08-1.85],0.0120428004285725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLH1,Glutamate carboxypeptidase 2,42650,268,1.04 [0.93-1.15],0.5061445570436047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR1,Folate receptor alpha,50446,340,1.69 [1.24-2.29],0.0008637617129594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,50968,342,1.71 [1.25-2.35],0.0008648485555235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR3,Folate receptor gamma,50516,342,1.00 [0.95-1.05],0.9399691363537748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOS,Proto-oncogene c-Fos,42279,265,1.00 [0.72-1.39],0.9829053214742548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOSB,Protein fosB,49337,326,0.99 [0.77-1.28],0.9451681674587188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXJ3,Forkhead box protein J3,42650,268,1.08 [0.83-1.39],0.5736468139548812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO1,Forkhead box protein O1,50447,341,1.05 [0.94-1.17],0.4101686534692252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO3,Forkhead box protein O3,49332,331,1.04 [0.94-1.15],0.4997612213374226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD4B,FERM domain-containing protein 4B,42474,270,0.97 [0.82-1.15],0.7345434310033814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD7,FERM domain-containing protein 7,42721,269,0.88 [0.62-1.25],0.4612130750732156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRZB,Secreted frizzled-related protein 3,49970,338,0.84 [0.58-1.22],0.3618601605098281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSHB,Follitropin subunit beta,42761,275,1.15 [0.96-1.39],0.1368294387046058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FST,Follistatin,50654,338,1.01 [0.83-1.23],0.9037783274171514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL1,Follistatin-related protein 1,42761,275,1.82 [1.12-2.96],0.0148596811611188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,50408,336,2.15 [1.64-2.80],1.84849565869914e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FTCD,Formimidoyltransferase-cyclodeaminase,43739,278,1.05 [0.93-1.20],0.4184079994319118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUCA1,Tissue alpha-L-fucosidase,50831,341,0.91 [0.81-1.02],0.0940887946670509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUOM,Fucose mutarotase,42966,266,1.18 [0.99-1.41],0.0710732284014424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FURIN,Furin,50678,342,1.01 [0.76-1.35],0.9343033056899434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUS,RNA-binding protein FUS,49249,330,1.19 [0.94-1.50],0.155302725290531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",43043,273,1.00 [0.83-1.20],0.967327971659083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,50968,342,1.22 [1.00-1.50],0.0518241261776952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT8,"Alpha-(1,6)-fucosyltransferase",50135,340,1.00 [0.85-1.18],0.9832578227229614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXN,"Frataxin, mitochondrial",50950,341,1.14 [1.00-1.29],0.051688290797136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXYD5,FXYD domain-containing ion transport regulator 5,49560,327,1.09 [0.94-1.26],0.2517483149488246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FYB1,FYN-binding protein 1,50455,340,1.07 [0.97-1.19],0.1810159919691908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD10,Frizzled-10,42721,269,1.04 [0.86-1.26],0.6923982276886038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD8,Frizzled-8,42497,265,1.13 [0.88-1.45],0.3503360243358593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAP,Gamma-aminobutyric acid receptor-associated protein,43716,280,1.17 [0.95-1.45],0.1427077792871043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,43124,274,1.04 [0.88-1.23],0.6558090873828035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,42497,265,0.94 [0.77-1.14],0.5036272304989188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD1,Glutamate decarboxylase 1,42355,265,1.02 [0.65-1.60],0.9347435559476724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD2,Glutamate decarboxylase 2,42650,268,0.94 [0.72-1.22],0.6411864956612465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,43124,274,0.96 [0.75-1.23],0.7499936549202328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,42761,275,1.12 [0.90-1.38],0.3076748026342389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAGE2A,G antigen 2A,42355,265,0.93 [0.76-1.14],0.4840725615215393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAL,Galanin peptides,50737,340,0.86 [0.74-0.99],0.0408492577486383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,50286,339,1.65 [1.18-2.31],0.0032515240693857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,50950,341,0.74 [0.52-1.06],0.1009195664413223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,49560,327,1.03 [0.82-1.30],0.7815828451531122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,43925,280,1.53 [1.04-2.24],0.0322640256392223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT7,N-acetylgalactosaminyltransferase 7,50286,339,1.09 [0.69-1.73],0.7005718498810719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAMT,Guanidinoacetate N-methyltransferase,42474,270,1.07 [0.80-1.45],0.6363607355411978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,42025,259,1.13 [0.77-1.66],0.5197399082609193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GART,Trifunctional purine biosynthetic protein adenosine-3,43847,277,0.97 [0.63-1.50],0.8974190360637464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS2,Growth arrest-specific protein 2,43124,274,1.10 [0.90-1.35],0.344024359057684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS6,Growth arrest-specific protein 6,50817,343,2.11 [1.45-3.06],8.381039447307652e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GASK1A,Golgi-associated kinase 1A,42474,270,0.97 [0.74-1.27],0.8337987372621578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAST,Gastrin,43820,278,1.14 [1.06-1.23],0.0005248359791185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,42355,265,0.71 [0.45-1.11],0.128962547721875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",42761,275,1.10 [0.95-1.28],0.1889332715031179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBA,Lysosomal acid glucosylceramidase,42721,269,1.06 [0.86-1.31],0.5875098148564664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP1,Guanylate-binding protein 1,43741,278,1.22 [1.03-1.45],0.0198603802665953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP2,Guanylate-binding protein 2,49560,327,1.04 [0.89-1.23],0.6021933196894771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,49337,326,1.35 [1.13-1.62],0.0008427576835019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP6,Guanylate-binding protein 6,42474,270,0.97 [0.74-1.27],0.8204872750489587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GC,Vitamin D-binding protein,43988,277,1.00 [0.64-1.56],0.99249987410284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCC1,GRIP and coiled-coil domain-containing protein 1,43820,278,1.03 [0.93-1.15],0.5682211289337952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCG,Pro-glucagon,49332,331,1.10 [1.02-1.19],0.0126226672647038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,41905,255,0.99 [0.78-1.27],0.9507644684517432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCLM,Glutamate--cysteine ligase regulatory subunit,42474,270,0.97 [0.75-1.25],0.7999394326492832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",50286,339,1.77 [1.35-2.30],2.68447290182666e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,51146,343,1.86 [1.61-2.14],7.82626955647703e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF2,Growth/differentiation factor 2,50522,342,1.03 [0.79-1.34],0.8323985895268512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDNF,Glial cell line-derived neurotrophic factor,49337,326,1.44 [1.14-1.82],0.0024881156590496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GET3,ATPase GET3,43925,280,1.00 [0.82-1.23],0.963709420380252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFAP,Glial fibrillary acidic protein,49252,331,1.36 [1.11-1.66],0.0025858894386579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFER,FAD-linked sulfhydryl oxidase ALR,49332,331,1.22 [1.05-1.41],0.0088204973205758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,49332,331,0.96 [0.88-1.04],0.323362092355666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,50876,341,2.59 [1.91-3.51],7.719471320307555e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA2,GDNF family receptor alpha-2,50286,339,1.51 [0.96-2.36],0.0738138085200453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA3,GDNF family receptor alpha-3,49979,340,1.48 [1.06-2.06],0.0210109644170215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRAL,GDNF family receptor alpha-like,42517,266,0.90 [0.74-1.09],0.2925266230338917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGA1,ADP-ribosylation factor-binding protein GGA1,49337,326,1.05 [0.91-1.20],0.5278009235383493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGACT,Gamma-glutamylaminecyclotransferase,43925,280,1.17 [1.00-1.37],0.0511126655121858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGCT,Gamma-glutamylcyclotransferase,43845,280,1.02 [0.81-1.30],0.8451397001341878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGH,Gamma-glutamyl hydrolase,49673,339,1.21 [0.92-1.59],0.1781623051230185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,50457,340,1.45 [1.23-1.72],1.2921114417073191e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT5,Glutathione hydrolase 5 proenzyme,50135,340,1.72 [1.17-2.53],0.0058120008641032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH1,Somatotropin,50447,342,1.02 [0.96-1.07],0.5362473565865997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH2,Growth hormone variant,49332,331,0.98 [0.92-1.04],0.551665298987029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,42966,266,0.46 [0.31-0.69],0.0001972148211461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRHR,Growth hormone-releasing hormone receptor,49337,326,0.99 [0.83-1.18],0.8989781691430556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRL,Appetite-regulating hormone,50522,342,0.93 [0.83-1.04],0.1995497378133575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GID8,Glucose-induced degradation protein 8 homolog,43847,277,1.06 [0.76-1.47],0.7324987491435951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIGYF2,GRB10-interacting GYF protein 2,43847,277,1.09 [0.94-1.27],0.2437746310574733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP7,GTPase IMAP family member 7,42966,266,0.99 [0.69-1.43],0.9770168677017712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP8,GTPase IMAP family member 8,42355,265,1.11 [0.89-1.38],0.3655092826129197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIP,Gastric inhibitory polypeptide,42761,275,0.98 [0.79-1.21],0.8268903895186654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC2,PDZ domain-containing protein GIPC2,43820,278,1.13 [0.78-1.64],0.5101571100447478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC3,PDZ domain-containing protein GIPC3,43736,277,1.06 [0.95-1.20],0.2974611988772327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPR,Gastric inhibitory polypeptide receptor,42650,268,0.86 [0.65-1.13],0.2867814300535192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIT1,ARF GTPase-activating protein GIT1,42650,268,1.01 [0.90-1.15],0.8257354329673051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GJA8,Gap junction alpha-8 protein,42355,265,0.95 [0.77-1.15],0.5804989929123539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GKN1,Gastrokine-1,48394,318,1.28 [0.90-1.83],0.1712101957544984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLA,Alpha-galactosidase A,42886,266,1.27 [0.94-1.73],0.1242056934038224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLB1,Beta-galactosidase,50135,340,1.17 [0.93-1.47],0.1780101941584071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLI2,Zinc finger protein GLI2,42650,268,1.00 [0.70-1.44],0.9886868934668744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLO1,Lactoylglutathione lyase,49594,325,1.01 [0.85-1.19],0.9430338902283864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLOD4,Glyoxalase domain-containing protein 4,50405,338,1.15 [0.88-1.52],0.3015439846517288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLP1R,Glucagon-like peptide 1 receptor,42497,265,1.07 [0.79-1.44],0.6597590999500779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX,Glutaredoxin-1,50198,339,0.88 [0.74-1.05],0.1487261934806391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",42966,266,1.04 [0.91-1.19],0.5283894729803432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,49337,326,0.92 [0.74-1.16],0.4927516024282755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLYR1,Putative oxidoreductase GLYR1,43716,280,1.07 [0.89-1.28],0.4948993183707855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GM2A,Ganglioside GM2 activator,42856,267,1.28 [1.00-1.65],0.0511059218378076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMFG,Glia maturation factor gamma,43925,280,1.06 [0.90-1.24],0.5065544577639274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR,GMP reductase 1,51074,342,0.95 [0.79-1.15],0.6300116363671892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR2,GMP reductase 2,42966,266,1.02 [0.85-1.21],0.8393605156389138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNAS,Neuroendocrine secretory protein 55,43847,277,0.99 [0.86-1.13],0.8477855427597153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,49332,331,1.16 [1.00-1.34],0.0461355001413878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,42721,269,1.04 [0.83-1.29],0.7490845583616057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNLY,Granulysin,50539,340,1.18 [0.99-1.41],0.07210454350206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA1,Glucosamine-6-phosphate isomerase 1,42761,275,0.91 [0.63-1.30],0.5918416820428192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA2,Glucosamine-6-phosphate isomerase 2,42966,266,1.18 [0.86-1.62],0.2938684901385743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLGA3,Golgin subfamily A member 3,43847,277,1.04 [0.89-1.20],0.6437790279998848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLM2,Protein GOLM2,50968,342,1.47 [0.99-2.18],0.0545765844006921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,50447,341,1.04 [0.95-1.15],0.3910669812966438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GORASP2,Golgi reassembly-stacking protein 2,43736,277,1.33 [1.06-1.67],0.0152863092834236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOT1,"Aspartate aminotransferase, cytoplasmic",43926,275,1.18 [0.90-1.53],0.2253525519293067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BA,Platelet glycoprotein Ib alpha chain,50312,341,1.26 [0.95-1.68],0.1098368112809947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BB,Platelet glycoprotein Ib beta chain,42474,270,1.11 [0.93-1.32],0.2421210813735677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,48960,320,1.02 [0.91-1.15],0.7287257601125999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP5,Platelet glycoprotein V,42966,266,1.06 [0.76-1.46],0.7462830350432914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP6,Platelet glycoprotein VI,50455,340,1.08 [0.97-1.21],0.1635481732966524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPA33,Cell surface A33 antigen,50286,339,0.98 [0.91-1.05],0.5464025575117053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC1,Glypican-1,50950,341,1.28 [0.93-1.77],0.1294391061770395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC5,Glypican-5,50135,340,0.98 [0.82-1.16],0.7851324174470444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPD1,Glycerol-3-phosphate dehydrogenase,43716,280,1.16 [0.95-1.43],0.1549195184222266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPHA2,Glycoprotein hormone alpha-2,43736,277,0.99 [0.78-1.28],0.9654576062456012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPI,Glucose-6-phosphate isomerase,43959,278,1.20 [0.95-1.51],0.126530366845449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,43736,277,0.93 [0.80-1.09],0.3565281649241814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPKOW,G-patch domain and KOW motifs-containing protein,49337,326,1.25 [0.94-1.66],0.1198678262030859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,49147,335,1.79 [1.28-2.51],0.0006829182198169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR101,Probable G-protein coupled receptor 101,42497,265,0.93 [0.75-1.15],0.4970060519377598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR158,Probable G-protein coupled receptor 158,43847,277,1.20 [0.90-1.60],0.2257484611881776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,43736,277,1.47 [1.24-1.75],1.0354226339806572e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,49594,325,1.47 [1.27-1.70],3.1419426409571546e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPRC5C,G-protein coupled receptor family C group 5 member C,43716,280,1.34 [1.14-1.58],0.0003598812191574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRAP2,GRB2-related adapter protein 2,50522,342,1.02 [0.95-1.10],0.5304664217611801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,43925,280,1.11 [0.93-1.32],0.2623653540890969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIK2,"Glutamate receptor ionotropic, kainate 2",43847,277,1.17 [0.92-1.50],0.2086285946604632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",42497,265,0.97 [0.78-1.21],0.8076018904915678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRK5,G protein-coupled receptor kinase 5,49594,325,1.04 [0.86-1.25],0.7126673176384606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRN,Progranulin,50291,336,1.89 [1.30-2.76],0.0008488010568148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRP,Gastrin-releasing peptide,42761,275,0.96 [0.77-1.18],0.6910505315275937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRPEL1,"GrpE protein homolog 1, mitochondrial",50286,339,1.32 [1.15-1.53],0.0001297059842025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRSF1,G-rich sequence factor 1,42124,265,1.03 [0.89-1.19],0.6845685990293708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSAP,Gamma-secretase-activating protein,49332,331,1.02 [0.92-1.14],0.6888667151040367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSN,Gelsolin,43794,276,0.87 [0.48-1.58],0.6558842889911072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSR,"Glutathione reductase, mitochondrial",43707,276,1.53 [0.92-2.54],0.0985417996167153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA1,Glutathione S-transferase A1,50444,341,1.01 [0.90-1.13],0.8886066487685835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA3,Glutathione S-transferase A3,49332,331,1.01 [0.89-1.15],0.8681370155226136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTM4,Glutathione S-transferase Mu 4,42474,270,1.00 [0.85-1.18],0.9871004999162626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTP1,Glutathione S-transferase P,49022,323,1.13 [0.98-1.29],0.0877272515111796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTT2B,Glutathione S-transferase theta-2B,43820,278,1.01 [0.96-1.06],0.7148810978584919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,43124,274,1.05 [0.90-1.23],0.5009566125347147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTPBP2,GTP-binding protein 2,42721,269,1.01 [0.87-1.17],0.8869412215591888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,50291,337,1.95 [1.50-2.52],4.4813947132991777e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCY2C,Heat-stable enterotoxin receptor,43124,274,1.01 [0.88-1.17],0.8472714548419075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUK1,Guanylate kinase,42474,270,1.00 [0.74-1.36],0.9852968261835529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUSB,Beta-glucuronidase,50747,341,1.15 [0.99-1.34],0.0712951772908002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GYS1,"Glycogen [starch] synthase, muscle",49594,325,1.09 [0.98-1.21],0.1114288433482195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMA,Granzyme A,51074,342,1.24 [0.95-1.62],0.1146507227170113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMB,Granzyme B,50447,341,1.00 [0.86-1.16],0.993893783107575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMH,Granzyme H,49594,325,1.06 [0.94-1.20],0.3400579855693069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),H2AP,Huntingtin-interacting protein M,42355,265,1.15 [0.94-1.40],0.1683628619087174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",42474,270,1.01 [0.85-1.20],0.8931292910003195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",50804,341,0.90 [0.79-1.03],0.1211204502034118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAO1,Hydroxyacid oxidase 1,50950,341,1.08 [1.00-1.16],0.0455882996795185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HARS1,"Histidine--tRNA ligase, cytoplasmic",50539,340,1.10 [0.97-1.24],0.1473646798790688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,50878,341,1.37 [1.19-1.57],1.1709548060427608e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,50539,340,2.08 [1.63-2.66],3.923649896818011e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBEGF,Proheparin-binding EGF-like growth factor,50804,341,1.10 [0.97-1.25],0.1514598210037208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBQ1,Hemoglobin subunit theta-1,50950,341,0.79 [0.67-0.93],0.0043570639604172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBZ,Hemoglobin subunit zeta,43925,280,0.94 [0.84-1.05],0.2577828553582618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCG22,Protein PBMUCL2,42474,270,0.80 [0.61-1.06],0.1193767987503532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCLS1,Hematopoietic lineage cell-specific protein,51074,342,1.10 [0.93-1.31],0.2735825865638114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC8,Histone deacetylase 8,42650,268,1.05 [0.87-1.27],0.5917922509474991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC9,Histone deacetylase 9,42497,265,0.97 [0.81-1.17],0.7789077278343796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDDC2,5'-deoxynucleotidase HDDC2,43736,277,0.99 [0.77-1.29],0.9549878280528432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGF,Hepatoma-derived growth factor,50876,341,1.09 [0.99-1.21],0.0953670354117664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGFL2,Hepatoma-derived growth factor-related protein 2,43820,278,1.02 [0.86-1.22],0.7983745761585865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEBP1,Heme-binding protein 1,49594,325,0.97 [0.80-1.17],0.7367043931032007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEG1,Protein HEG homolog 1,42966,266,1.23 [0.80-1.90],0.3381629857371535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPACAM2,HEPACAM family member 2,43820,278,0.68 [0.52-0.89],0.0057801219586635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPH,Hephaestin,43925,280,1.87 [1.19-2.93],0.0065752024750025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEXIM1,Protein HEXIM1,50447,341,1.05 [0.93-1.18],0.4155895234929537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGF,Hepatocyte growth factor,51074,342,1.50 [1.15-1.95],0.002481309731691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGFAC,Hepatocyte growth factor activator,43543,273,0.85 [0.57-1.26],0.4192664966614772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,49332,331,1.11 [0.98-1.26],0.0925416053999149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HHEX,Hematopoietically-expressed homeobox protein HHEX,43820,278,1.15 [0.99-1.33],0.0657410917252873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIF1A,Hypoxia-inducible factor 1-alpha,42650,268,1.03 [0.86-1.22],0.7680644638366809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1,Huntingtin-interacting protein 1,42474,270,0.93 [0.65-1.33],0.6909671246724739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1R,Huntingtin-interacting protein 1-related protein,43737,277,1.34 [1.10-1.62],0.0034248872102723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HJV,Hemojuvelin,43847,277,1.17 [0.92-1.49],0.201888132755896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HK2,Hexokinase-2,49594,325,1.03 [0.72-1.47],0.8737402334198165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-A,"HLA class I histocompatibility antigen, A alpha chain",43847,277,1.17 [0.82-1.66],0.3852576374059637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",50292,340,1.50 [1.17-1.93],0.0013367634517831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",50447,341,1.91 [1.42-2.56],1.6118790172579875e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMBS,Porphobilinogen deaminase,50950,341,0.86 [0.69-1.06],0.1618985155090978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMCN2,Hemicentin-2,42888,266,1.02 [0.83-1.25],0.837849311633112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",42761,275,1.12 [0.89-1.40],0.3434515158830681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",42474,270,1.06 [0.82-1.37],0.639889294751304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMMR,Hyaluronan mediated motility receptor,42275,265,1.02 [0.80-1.29],0.88643158563445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX1,Heme oxygenase 1,49954,340,1.15 [0.95-1.40],0.1584256736343262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX2,Heme oxygenase 2,49337,326,1.37 [1.15-1.63],0.0003911464025657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNF1A,Hepatocyte nuclear factor 1-alpha,42721,269,0.91 [0.76-1.10],0.3336325373770105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,49899,339,1.45 [1.19-1.76],0.0001856521508929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,49437,324,1.07 [0.94-1.21],0.2902800193777006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,43847,277,1.10 [0.88-1.37],0.3970836078266782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPCAL1,Hippocalcin-like protein 1,51074,342,1.04 [0.91-1.19],0.5484115505004705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPGDS,Hematopoietic prostaglandin D synthase,49332,331,0.72 [0.55-0.94],0.0172853768917013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPSE,Heparanase,43346,272,1.01 [0.89-1.14],0.8886892571475233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRAS,GTPase Hras,43044,274,0.95 [0.83-1.08],0.419084463522333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,42761,275,1.11 [0.81-1.52],0.504492193323336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRG,Histidine-rich glycoprotein,43744,275,1.04 [0.73-1.49],0.8294549878534273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS1BP3,HCLS1-binding protein 3,42761,275,1.08 [0.95-1.23],0.2253598934318723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,50286,339,1.19 [0.93-1.53],0.1753894464986354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,50950,341,1.16 [0.89-1.51],0.2774458669425458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,42650,268,1.52 [1.10-2.10],0.0107440542793631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSBP1,Heat shock factor-binding protein 1,42761,275,1.01 [0.89-1.14],0.916066019285621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,50447,341,1.18 [0.93-1.49],0.1814733763287339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,43820,278,1.22 [1.02-1.46],0.0319081621947643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B3,Testosterone 17-beta-dehydrogenase 3,42474,270,1.01 [0.79-1.28],0.9455929000958636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,42761,275,0.95 [0.74-1.21],0.6679567855455035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSP90B1,Endoplasmin,49095,326,1.02 [0.88-1.18],0.7763119156089633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA1A,Heat shock 70 kDa protein 1A,50652,340,1.06 [0.93-1.21],0.419856378628772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA2,Heat shock-related 70 kDa protein 2,43716,280,1.37 [1.03-1.81],0.0309990459542751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB1,Heat shock protein beta-1,49715,337,1.10 [0.95-1.27],0.2050448066818093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,50950,341,1.54 [1.22-1.94],0.0002277771003124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,50147,342,2.03 [1.48-2.77],9.000371698093505e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1A,5-hydroxytryptamine receptor 1A,42497,265,1.05 [0.91-1.22],0.4812311492936632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1B,5-hydroxytryptamine receptor 1B,42497,265,1.01 [0.77-1.32],0.9500459198012972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTRA2,"Serine protease HTRA2, mitochondrial",50678,342,1.18 [1.02-1.38],0.0300587409316397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYAL1,Hyaluronidase-1,50242,342,1.73 [1.17-2.55],0.0062743471175451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYOU1,Hypoxia up-regulated protein 1,51146,343,2.08 [1.38-3.14],0.0004664560337079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICA1,Islet cell autoantigen 1,49560,327,1.11 [0.99-1.26],0.081223674964534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM1,Intercellular adhesion molecule 1,50311,342,1.97 [1.45-2.67],1.2970366419729498e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM2,Intercellular adhesion molecule 2,51146,343,1.44 [1.07-1.95],0.0171379904615181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,51146,343,1.80 [1.28-2.54],0.0008058081004548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM4,Intercellular adhesion molecule 4,50447,341,0.96 [0.80-1.15],0.6359683274181032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM5,Intercellular adhesion molecule 5,50522,342,0.99 [0.81-1.23],0.957714410714082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICOSLG,ICOS ligand,50286,339,1.32 [0.80-2.17],0.2785432639644119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ID4,DNA-binding protein inhibitor ID-4,43124,274,1.13 [0.89-1.43],0.315760174778709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,49337,326,1.32 [1.10-1.58],0.0030199318842779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDO1,"Indoleamine 2,3-dioxygenase 1",42761,275,1.18 [1.00-1.40],0.0531365121170057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDS,Iduronate 2-sulfatase,51074,342,0.67 [0.24-1.90],0.4542257575542008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDUA,Alpha-L-iduronidase,50950,341,0.99 [0.81-1.21],0.9348390228165192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,42675,272,1.78 [1.37-2.32],1.5747030707032362e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,43124,274,1.12 [0.91-1.38],0.295670227850438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,43124,274,1.26 [0.95-1.66],0.1113573079078302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNAR1,Interferon alpha/beta receptor 1,43736,277,1.16 [0.75-1.79],0.5005793889183547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNG,Interferon gamma,49560,327,1.06 [0.98-1.16],0.1637588816886658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,50737,340,2.23 [1.52-3.28],4.15843598611281e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR2,Interferon gamma receptor 2,50135,340,1.22 [1.02-1.46],0.0259518454038172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL1,Interferon lambda-1,49337,326,1.39 [1.14-1.69],0.0011508265638006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL2,Interferon lambda-2,42497,265,0.89 [0.72-1.10],0.2815159385982305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNLR1,Interferon lambda receptor 1,50447,341,1.34 [1.06-1.67],0.0122388916731881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNW1,Interferon omega-1,42474,270,1.10 [0.82-1.49],0.5132109358856302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFT20,Intraflagellar transport protein 20 homolog,42721,269,1.14 [0.88-1.48],0.3171489817663749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGBP1,Immunoglobulin-binding protein 1,43847,277,1.03 [0.85-1.24],0.7924433935513113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,42497,265,0.89 [0.68-1.16],0.3981329361747752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,43926,275,0.71 [0.46-1.08],0.111791750925469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF1R,Insulin-like growth factor 1 receptor,50286,339,1.72 [1.21-2.45],0.0025069682672689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,42474,270,1.13 [0.90-1.43],0.2963514633779579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2R,Cation-independent mannose-6-phosphate receptor,50539,340,1.90 [1.26-2.84],0.001972244243048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP1,Insulin-like growth factor-binding protein 1,51063,343,1.06 [0.98-1.14],0.1690278946286925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,51066,343,1.31 [1.12-1.52],0.0005376380374115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP3,Insulin-like growth factor-binding protein 3,50722,343,0.64 [0.48-0.85],0.0017625600931865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,49893,335,1.64 [1.35-1.98],4.284872907935142e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP6,Insulin-like growth factor-binding protein 6,50313,340,1.60 [1.20-2.12],0.001332404897764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,51146,343,1.74 [1.36-2.22],8.677861854315657e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBPL1,Insulin-like growth factor-binding protein-like 1,50522,342,1.56 [1.20-2.02],0.000953343155464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFL4,Insulin growth factor-like family member 4,42650,268,1.02 [0.87-1.19],0.8198202636449685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGHMBP2,DNA-binding protein SMUBP-2,42474,270,1.04 [0.85-1.28],0.6807614803542497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLC2,Immunoglobulin lambda constant 2,43910,277,1.64 [1.24-2.16],0.0004804046508348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLON5,IgLON family member 5,42355,265,1.01 [0.89-1.15],0.8479090382426123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF21,Immunoglobulin superfamily member 21,42761,275,0.88 [0.65-1.20],0.4246308092260663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF3,Immunoglobulin superfamily member 3,50286,339,1.38 [1.09-1.75],0.0073880181167839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF8,Immunoglobulin superfamily member 8,50522,342,1.73 [1.29-2.30],0.0001970153087157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF9,Protein turtle homolog A,43925,280,1.07 [0.94-1.22],0.3002424959613327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKBKG,NF-kappa-B essential modulator,50447,341,1.04 [0.94-1.16],0.4414893988057887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKZF2,Zinc finger protein Helios,49332,331,1.00 [0.90-1.12],0.96471684703621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10,Interleukin-10,49560,327,1.02 [0.91-1.15],0.7433140148887458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RA,Interleukin-10 receptor subunit alpha,49560,327,1.16 [1.01-1.33],0.0320684595642089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,50737,340,1.87 [1.42-2.47],1.011481845627994e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL11,Interleukin-11,49560,327,0.91 [0.77-1.08],0.2766933108491394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12A_IL12B,Interleukin-12,50286,339,1.22 [1.08-1.37],0.0011125296004019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12B,Interleukin-12 subunit beta,51074,342,1.26 [1.06-1.50],0.0083313182772314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,49560,327,1.53 [1.20-1.96],0.0005935073571931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB2,Interleukin-12 receptor subunit beta-2,42650,268,1.28 [0.99-1.66],0.0611503969655074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13,Interleukin-13,49560,327,0.75 [0.58-0.98],0.0327109759197313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA1,Interleukin-13 receptor subunit alpha-1,49894,339,1.23 [0.80-1.90],0.3361740331574177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA2,Interleukin-13 receptor subunit alpha-2,42497,265,1.01 [0.67-1.51],0.976544364053999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15,Interleukin-15,50447,341,1.38 [1.04-1.82],0.0237800099374642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,49560,327,1.85 [1.40-2.43],1.2271698172917234e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL16,Pro-interleukin-16,51074,342,1.18 [0.96-1.46],0.1165660513242355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17A,Interleukin-17A,49485,324,1.08 [0.87-1.34],0.4681684877718999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,49560,327,1.32 [1.18-1.48],1.4894955504399869e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17D,Interleukin-17D,49560,327,1.05 [0.79-1.39],0.7500905103563029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17F,Interleukin-17F,49560,327,1.06 [0.94-1.20],0.3191428479318948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RA,Interleukin-17 receptor A,50539,340,1.12 [0.91-1.39],0.2933893062322835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RB,Interleukin-17 receptor B,49809,335,1.08 [0.90-1.30],0.3831334048113656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,50318,337,1.44 [1.19-1.75],0.0001745488075553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,50722,343,2.04 [1.55-2.68],2.7556359242323893e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18R1,Interleukin-18 receptor 1,51074,342,1.62 [1.23-2.14],0.0006098022464857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18RAP,Interleukin-18 receptor accessory protein,49817,339,1.00 [0.94-1.05],0.913528230246192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL19,Interleukin-19,49266,339,1.20 [1.06-1.36],0.0035775301202061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1A,Interleukin-1 alpha,49560,327,1.01 [0.85-1.19],0.9439980572689242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1B,Interleukin-1 beta,49323,327,1.05 [0.89-1.24],0.5559822776623339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R1,Interleukin-1 receptor type 1,50457,340,1.70 [1.13-2.54],0.0099715601414414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R2,Interleukin-1 receptor type 2,50402,337,1.76 [1.08-2.86],0.0222981572533549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RAP,Interleukin-1 receptor accessory protein,50539,340,1.02 [0.82-1.27],0.8465989023368639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL1,Interleukin-1 receptor-like 1,50981,343,1.52 [1.23-1.87],9.070595484449977e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL2,Interleukin-1 receptor-like 2,49560,327,0.92 [0.71-1.19],0.5197970566434691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RN,Interleukin-1 receptor antagonist protein,50403,340,1.28 [1.10-1.50],0.0013161771640485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2,Interleukin-2,49560,327,1.15 [0.85-1.57],0.3663484275230233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20,Interleukin-20,49560,327,1.07 [0.89-1.29],0.4557695753390679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RA,Interleukin-20 receptor subunit alpha,49560,327,0.92 [0.73-1.16],0.4973908410611823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RB,Interleukin-20 receptor subunit beta,42650,268,0.89 [0.67-1.18],0.4239281543354218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL21R,Interleukin-21 receptor,42650,268,1.02 [0.83-1.25],0.8689753014825303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,43716,280,1.28 [1.11-1.49],0.000940720484935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22RA1,Interleukin-22 receptor subunit alpha-1,49560,327,1.09 [0.88-1.35],0.4191119051127232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL24,Interleukin-24,49560,327,1.02 [0.84-1.24],0.8463520511217808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL25,Interleukin-25,42205,265,0.77 [0.55-1.09],0.1377774277123883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,50162,334,1.68 [1.36-2.07],1.1222883948806037e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RB,Interleukin-2 receptor subunit beta,49560,327,0.89 [0.68-1.17],0.4118836186407507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RG,Cytokine receptor common subunit gamma,43716,280,1.33 [1.07-1.66],0.01165947143181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3,Interleukin-3,42355,265,1.03 [0.85-1.26],0.7360486826576154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31,Interleukin-31,42650,268,0.98 [0.79-1.21],0.866561456417618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31RA,Interleukin-31 receptor subunit alpha,42489,268,1.02 [0.76-1.37],0.90466916215268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL32,Interleukin-32,50447,341,1.14 [0.92-1.41],0.2417096600465902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL33,Interleukin-33,49560,327,1.14 [0.88-1.46],0.3140474987407858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL34,Interleukin-34,49253,326,1.22 [0.92-1.61],0.1620320366201523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36A,Interleukin-36 alpha,42650,268,0.91 [0.73-1.13],0.3938354093369536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36G,Interleukin-36 gamma,42483,266,1.07 [0.90-1.26],0.4520620500017865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3RA,Interleukin-3 receptor subunit alpha,49560,327,1.71 [1.29-2.27],0.0001852518488288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4,Interleukin-4,49560,327,0.98 [0.88-1.08],0.6671762177550382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,50447,341,1.65 [1.30-2.09],3.776821580689813e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5,Interleukin-5,49560,327,1.00 [0.93-1.07],0.8900352788586632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5RA,Interleukin-5 receptor subunit alpha,50447,341,1.05 [0.89-1.24],0.566887838253937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6,Interleukin-6,50286,339,1.13 [1.01-1.27],0.0305105661255713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6R,Interleukin-6 receptor subunit alpha,50231,342,1.02 [0.77-1.35],0.8894441098095464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6ST,Interleukin-6 receptor subunit beta,50522,342,2.17 [1.30-3.62],0.0029700089009704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7,Interleukin-7,50447,341,1.06 [0.92-1.23],0.4109795413387089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7R,Interleukin-7 receptor subunit alpha,50539,340,1.04 [0.86-1.24],0.7128184768531074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL9,Interleukin-9,43124,274,1.16 [0.98-1.38],0.0820781082629258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,49259,326,1.02 [0.86-1.21],0.8186087323725659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMMT,MICOS complex subunit MIC60,43716,280,1.47 [1.20-1.81],0.0001827996021829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPA1,Inositol monophosphatase 1,50135,340,1.06 [0.90-1.24],0.4786717683487539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPACT,Protein IMPACT,43820,278,0.98 [0.80-1.20],0.8208121294009956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPG1,Interphotoreceptor matrix proteoglycan 1,42497,265,0.92 [0.62-1.39],0.704917495917099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ING1,Inhibitor of growth protein 1,49254,326,1.13 [0.93-1.37],0.2025384250617657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBB,Inhibin beta B chain,42966,266,1.37 [1.11-1.69],0.0039692198789327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBC,Inhibin beta C chain,50539,340,1.24 [0.98-1.58],0.0769120066330817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP1,Inositol polyphosphate 1-phosphatase,50286,339,1.12 [0.94-1.34],0.1898124948580846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",42761,275,0.95 [0.77-1.16],0.5902814612781953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",43847,277,1.04 [0.80-1.36],0.7606732012064058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",50286,339,1.03 [0.93-1.14],0.5798908180568467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL3,Insulin-like 3,43820,278,0.80 [0.69-0.92],0.0014402189048044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL4,Early placenta insulin-like peptide,43716,280,1.06 [0.85-1.31],0.6047364583575806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL5,Insulin-like peptide INSL5,43736,277,1.24 [1.11-1.38],0.0001122937662473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSR,Insulin receptor,42650,268,1.65 [0.84-3.25],0.1488463478554436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IPCEF1,Interactor protein for cytohesin exchange factors 1,50052,339,1.05 [0.94-1.17],0.3776017080550393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IQGAP2,Ras GTPase-activating-like protein IQGAP2,50286,339,1.17 [0.99-1.39],0.0704165152127154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",49594,325,1.06 [0.95-1.18],0.2740916451056764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK1,Interleukin-1 receptor-associated kinase 1,49560,327,1.11 [0.97-1.28],0.1336989641203164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK4,Interleukin-1 receptor-associated kinase 4,50447,341,1.04 [0.95-1.14],0.3924592425278757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,48638,320,0.99 [0.76-1.29],0.920092369657194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM1,Isthmin-1,50447,341,1.06 [0.83-1.35],0.6505257972915867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM2,Isthmin-2,43926,275,0.94 [0.72-1.23],0.6524834728959837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IST1,IST1 homolog,43415,276,1.07 [0.95-1.21],0.2473532487577818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA11,Integrin alpha-11,50447,341,0.74 [0.56-0.97],0.0302172642036976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA2,Integrin alpha-2,42966,266,0.91 [0.64-1.28],0.5707803787055759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,50539,340,2.13 [1.48-3.08],5.099980005675422e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA6,Integrin alpha-6,50447,341,1.06 [0.88-1.27],0.5379683628550078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAL,Integrin alpha-L,42650,268,1.31 [0.99-1.72],0.0601623479202845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAM,Integrin alpha-M,50539,340,1.11 [0.82-1.50],0.5067835412330324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAV,Integrin alpha-V,50950,341,0.47 [0.27-0.83],0.0088286812127374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAX,Integrin alpha-X,43124,274,1.00 [0.80-1.24],0.9942620082059084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1,Integrin beta-1,50473,343,1.43 [0.93-2.18],0.1002039495868076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP1,Integrin beta-1-binding protein 1,49332,331,0.96 [0.76-1.22],0.762553161601601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP2,Integrin beta-1-binding protein 2,49594,325,1.06 [0.97-1.16],0.2071875423168159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB2,Integrin beta-2,50239,341,1.39 [1.00-1.93],0.0510044423343786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB5,Integrin beta-5,50678,342,1.20 [0.94-1.53],0.1469497848848506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB6,Integrin beta-6,49560,327,1.03 [0.75-1.43],0.8378157708754951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB7,Integrin beta-7,50950,341,1.43 [1.17-1.73],0.0003346159172915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGBL1,Integrin beta-like protein 1,43926,275,1.36 [1.03-1.81],0.0327640279223367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,43988,277,0.88 [0.48-1.63],0.6902745193413724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,50722,343,1.51 [1.17-1.95],0.0014545804803644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,43988,277,1.32 [0.87-2.00],0.1962611641245278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,43716,280,1.02 [0.79-1.32],0.8670621603152068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITM2A,Integral membrane protein 2A,50447,341,1.09 [0.93-1.27],0.2942481697582402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPA,Inosine triphosphate pyrophosphatase,42474,270,1.01 [0.85-1.21],0.8754944313814859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",42761,275,1.14 [0.98-1.33],0.0781807867303514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",42497,265,0.95 [0.73-1.24],0.7075116357488004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",49337,326,1.09 [0.90-1.32],0.3828907609095285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IZUMO1,Izumo sperm-egg fusion protein 1,42355,265,1.12 [0.90-1.40],0.2956569806855273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM2,Junctional adhesion molecule B,50968,342,1.62 [1.16-2.28],0.0051837127486548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM3,Junctional adhesion molecule C,42966,266,1.26 [1.01-1.57],0.0378799183195975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JCHAIN,Immunoglobulin J chain,49560,327,1.13 [0.97-1.33],0.1155802053408812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,42355,265,0.86 [0.69-1.08],0.1961899648449527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JPT2,Jupiter microtubule associated homolog 2,43736,277,1.11 [0.97-1.26],0.1337807180767359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JUN,Transcription factor AP-1,49560,327,1.25 [1.06-1.46],0.0060628672195678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,50286,339,1.08 [0.87-1.34],0.4841827447794521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZN,Kazrin,43736,277,1.05 [0.94-1.17],0.3831946552984864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNC4,Potassium voltage-gated channel subfamily C member 4,42497,265,1.09 [0.89-1.32],0.4004728144715527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNH2,Potassium voltage-gated channel subfamily H member 2,42721,269,1.04 [0.89-1.20],0.6337342776357154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNIP4,Kv channel-interacting protein 4,49337,326,1.03 [0.85-1.25],0.7518768971721567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCTD5,BTB/POZ domain-containing protein KCTD5,42996,274,1.16 [0.91-1.47],0.2409947651901052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDM3A,Lysine-specific demethylase 3A,42650,268,1.03 [0.90-1.17],0.6844993408167157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDR,Vascular endothelial growth factor receptor 2,50678,342,1.10 [0.75-1.60],0.6321146481681265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KEL,Kell blood group glycoprotein,49337,326,0.98 [0.74-1.28],0.8644225420613625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHDC3L,KH domain-containing protein 3,42355,265,1.02 [0.86-1.21],0.8512692586307243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHK,Ketohexokinase,42761,275,1.12 [0.94-1.35],0.207022352274174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA0319,Dyslexia-associated protein KIAA0319,43820,278,0.96 [0.66-1.40],0.8474384787538127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549,UPF0606 protein KIAA1549,43124,274,0.95 [0.80-1.12],0.5076864657464298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549L,UPF0606 protein KIAA1549L,43124,274,1.26 [0.86-1.85],0.229892584048489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA2013,Uncharacterized protein KIAA2013,43716,280,1.07 [0.88-1.30],0.4842047171837592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF1C,Kinesin-like protein KIF1C,42474,270,1.30 [0.99-1.70],0.0588503696566315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF20B,Kinesin-like protein KIF20B,42497,265,0.95 [0.81-1.12],0.5383850427768193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF22,Kinesin-like protein KIF22,42474,270,1.02 [0.93-1.12],0.7065603417458587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIFBP,KIF-binding protein,50286,339,1.11 [0.99-1.25],0.0874816400864259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,43716,280,1.14 [1.00-1.30],0.0419453047639855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,49332,331,1.18 [1.04-1.33],0.0084951151545497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,43736,277,1.05 [0.99-1.12],0.1286975311274457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,49332,331,1.05 [0.97-1.13],0.2382445850131901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,42355,265,0.89 [0.76-1.05],0.1701276208632893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL1,Kin of IRRE-like protein 1,42497,265,1.16 [0.98-1.38],0.0789134947136252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL2,Kin of IRRE-like protein 2,49337,326,1.18 [0.93-1.50],0.1735074832570506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIT,Mast/stem cell growth factor receptor Kit,50641,343,0.67 [0.49-0.93],0.0147999829040565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KITLG,Kit ligand,50522,342,0.82 [0.64-1.06],0.1237438033039019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLB,Beta-klotho,49337,326,1.05 [0.92-1.20],0.4607638405355425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLF4,Krueppel-like factor 4,42497,265,1.35 [1.05-1.74],0.0201380351249371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLHL41,Kelch-like protein 41,43847,277,1.10 [0.88-1.37],0.3981036965500533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK1,Kallikrein-1,50034,338,1.03 [0.96-1.11],0.446235721587794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK10,Kallikrein-10,50523,342,1.32 [1.06-1.65],0.0119418634621539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,50197,342,1.81 [1.47-2.23],2.9003368797718897e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK12,Kallikrein-12,49332,331,1.00 [0.94-1.08],0.9166572064094743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK13,Kallikrein-13,49383,334,1.08 [0.87-1.33],0.4978946336237843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK14,Kallikrein-14,50950,341,1.10 [0.90-1.35],0.347277335190992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK15,Kallikrein-15,43637,279,1.17 [0.94-1.46],0.1709705714946084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK3,Prostate-specific antigen,43926,275,0.86 [0.76-0.98],0.0285781381914545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,50950,341,1.35 [1.18-1.55],1.0221509764704492e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK6,Kallikrein-6,50596,342,1.15 [0.85-1.57],0.3651230542457998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK7,Kallikrein-7,41862,259,0.98 [0.72-1.33],0.889450966615955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK8,Kallikrein-8,48828,334,1.38 [1.06-1.78],0.0157363094526823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLKB1,Plasma kallikrein,43097,270,0.94 [0.59-1.49],0.7977013258200785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,51074,342,1.80 [1.43-2.27],8.012231540335371e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,42497,265,1.05 [0.87-1.26],0.5908989949657674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRD1,Natural killer cells antigen CD94,51074,342,1.34 [1.09-1.64],0.0044563910444534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRF1,Killer cell lectin-like receptor subfamily F member 1,42650,268,1.27 [1.04-1.56],0.0209490033281848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRK1,NKG2-D type II integral membrane protein,43820,278,1.21 [0.95-1.55],0.1253858402141091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT14,"Keratin, type I cytoskeletal 14",47782,318,0.99 [0.70-1.40],0.9577493847090616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT17,"Keratin, type I cytoskeletal 17",42474,270,0.87 [0.64-1.20],0.4061744343588985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT18,"Keratin, type I cytoskeletal 18",50286,339,1.16 [1.04-1.29],0.0096765363664436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",50362,340,1.29 [1.13-1.47],0.0001794537971745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT5,"Keratin, type II cytoskeletal 5",49337,326,1.23 [1.02-1.48],0.0266420992070734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT6C,"Keratin, type II cytoskeletal 6C",42474,270,0.83 [0.59-1.16],0.2669460605449982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT8,"Keratin, type II cytoskeletal 8",42497,265,1.11 [0.97-1.26],0.1286088637996024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYAT1,Kynurenine--oxoglutarate transaminase 1,50440,342,0.99 [0.84-1.17],0.9079214221410132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYNU,Kynureninase,51074,342,1.23 [1.01-1.51],0.0413282608512276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L1CAM,Neural cell adhesion molecule L1,50678,342,1.06 [0.77-1.47],0.725938996985485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,43925,280,1.08 [0.96-1.23],0.2113569112985433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACRT,Extracellular glycoprotein lacritin,43633,278,0.84 [0.64-1.08],0.1732747031059576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACTB2,Endoribonuclease LACTB2,50522,342,1.06 [0.92-1.22],0.4267435834783155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAG3,Lymphocyte activation gene 3 protein,50286,339,1.23 [0.98-1.54],0.0709128718075589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,50485,337,1.88 [1.58-2.24],1.990083182427233e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,50135,340,1.04 [0.94-1.14],0.4591979993269424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA1,Laminin subunit alpha-1,42474,270,1.07 [0.87-1.32],0.5043663791451161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA4,Laminin subunit alpha-4,50737,340,1.59 [1.22-2.09],0.0007606127337028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMB1,Laminin subunit beta-1,42761,275,1.16 [0.79-1.70],0.4443950002788998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP1,Lysosome-associated membrane glycoprotein 1,42707,267,1.29 [0.96-1.74],0.0909285498102158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP2,Lysosome-associated membrane glycoprotein 2,48991,319,1.35 [0.81-2.24],0.2541121837871492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP3,Lysosome-associated membrane glycoprotein 3,50991,340,1.31 [1.09-1.56],0.0033983661063167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMTOR5,Ragulator complex protein LAMTOR5,43716,280,1.22 [0.95-1.57],0.1249899571704671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAP3,Cytosol aminopeptidase,49560,327,1.30 [1.09-1.56],0.0040828368549951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LARP1,La-related protein 1,43716,280,1.03 [0.87-1.24],0.7126006078162568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT,Linker for activation of T-cells family member 1,51074,342,1.12 [0.99-1.28],0.0731834120338833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT2,Linker for activation of T-cells family member 2,50286,339,1.08 [1.00-1.17],0.0462325402759634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LATS1,Serine/threonine-protein kinase LATS1,42650,268,1.08 [0.94-1.24],0.2837048861746032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,50052,340,2.05 [1.62-2.60],3.1605539094268317e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBP,Lipopolysaccharide-binding protein,50722,343,1.31 [1.11-1.53],0.001084161390522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBR,Delta(14)-sterol reductase LBR,50968,342,1.07 [0.93-1.22],0.3461103954164116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCAT,Phosphatidylcholine-sterol acyltransferase,43959,278,0.54 [0.36-0.81],0.0031593409828102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN15,Lipocalin-15,43847,277,1.24 [1.07-1.44],0.004813692230958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN2,Neutrophil gelatinase-associated lipocalin,48992,339,1.24 [0.98-1.56],0.078807590230532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCP1,Plastin-2,43926,275,1.15 [0.92-1.45],0.2236176437800317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLR,Low-density lipoprotein receptor,50660,336,0.88 [0.73-1.06],0.1707720217923365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLRAP1,Low density lipoprotein receptor adapter protein 1,43847,277,1.06 [0.94-1.19],0.3499123155521103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LECT2,Leukocyte cell-derived chemotaxin-2,43925,280,1.16 [0.98-1.37],0.083208796655314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEFTY2,Left-right determination factor 2,50876,341,1.07 [0.89-1.29],0.4608209743056535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEG1,Protein LEG1 homolog,41498,254,0.96 [0.80-1.14],0.6124643747502131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LELP1,Late cornified envelope-like proline-rich protein 1,42497,265,0.98 [0.83-1.16],0.823503378691121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEO1,RNA polymerase-associated protein LEO1,43847,277,1.32 [1.01-1.72],0.0433280556647579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEP,Leptin,50522,342,1.09 [0.94-1.26],0.2345616387167743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEPR,Leptin receptor,50522,342,1.14 [0.85-1.54],0.3780431222169733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LETM1,Mitochondrial proton/calcium exchanger protein,43847,277,1.32 [1.09-1.61],0.0047402209376346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS1,Galectin-1,50522,342,1.33 [1.02-1.74],0.0363236486645782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3,Galectin-3,50654,341,1.35 [0.99-1.85],0.061022311907227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3BP,Galectin-3-binding protein,43988,277,1.44 [1.04-1.99],0.0265917241679545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,50485,337,1.54 [1.32-1.81],9.221217150098741e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS7_LGALS7B,Galectin-7,50373,339,1.18 [0.95-1.46],0.1343601930184646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS8,Galectin-8,50968,342,1.11 [0.95-1.30],0.1786963785691151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,50490,338,2.28 [1.73-3.01],4.391350115684973e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGMN,Legumain,50737,340,1.40 [1.08-1.81],0.0116357820082081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHB,Lutropin subunit beta,49332,331,0.98 [0.87-1.10],0.6929130331880555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,50567,340,1.00 [0.86-1.18],0.971917186462168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIF,Leukemia inhibitory factor,49337,326,1.02 [0.85-1.24],0.8182262406706038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIFR,Leukemia inhibitory factor receptor,50447,341,1.64 [1.12-2.39],0.0105372038298202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,50539,340,1.48 [1.12-1.95],0.0051589897427521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,43926,275,1.03 [0.95-1.13],0.4634226515060434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,42474,270,1.11 [0.90-1.37],0.3439483799054346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,50447,342,1.81 [1.35-2.42],7.179017942485257e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,43925,280,1.14 [0.98-1.33],0.0953037944027397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,51146,343,1.56 [1.10-2.20],0.0115946700220186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,50901,343,1.52 [1.14-2.02],0.0038298376820305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,49560,327,1.81 [1.47-2.23],1.6275632552334113e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,51146,343,1.02 [0.89-1.17],0.7548538184125964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIPF,Gastric triacylglycerol lipase,42761,275,0.88 [0.73-1.06],0.1695262454721504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB1,Lamin-B1,43654,277,0.97 [0.81-1.18],0.7824494006901292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB2,Lamin-B2,43820,278,1.60 [1.10-2.33],0.0145177789549153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD1,Leiomodin-1,43847,277,1.49 [1.15-1.93],0.0021982819974755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD2,Leiomodin-2,42497,265,0.96 [0.79-1.17],0.6863084605960001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LONP1,"Lon protease homolog, mitochondrial",42761,275,1.07 [0.94-1.23],0.2841477520521248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPA,Apolipoprotein(a),42940,267,0.95 [0.89-1.01],0.0957781746520533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPCAT2,Lysophosphatidylcholine acyltransferase 2,50286,339,1.12 [0.92-1.36],0.2468671551471139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPL,Lipoprotein lipase,50522,342,0.93 [0.76-1.14],0.4832580794234498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPO,Lactoperoxidase,48862,329,1.14 [0.97-1.34],0.0993994269560592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPP,Lipoma-preferred partner,42474,270,1.03 [0.87-1.23],0.722292254927762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,42474,270,1.13 [0.95-1.33],0.163219771339778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,42721,269,1.04 [0.82-1.32],0.7619763151847072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRG1,Leucine-rich alpha-2-glycoprotein,43988,277,1.19 [0.77-1.83],0.4386656854064085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,50804,341,1.42 [1.08-1.86],0.0113587302107875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,42502,268,1.10 [0.73-1.65],0.6499660674333798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP1,Prolow-density lipoprotein receptor-related protein 1,50286,339,0.99 [0.69-1.42],0.9702444831163684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,50522,342,1.64 [1.27-2.11],0.0001236398409184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2,Low-density lipoprotein receptor-related protein 2,42721,269,1.12 [0.83-1.52],0.4420350953713367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2BP,LRP2-binding protein,42721,269,1.02 [0.89-1.16],0.8273252415248534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,50968,342,1.02 [0.87-1.20],0.7878726964061558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC25,Leucine-rich repeat-containing protein 25,50286,339,1.31 [1.04-1.65],0.0196408122026959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC37A2,Leucine-rich repeat-containing protein 37A2,43736,277,1.10 [0.84-1.43],0.4974116730401358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC38,Leucine-rich repeat-containing protein 38,42721,269,1.01 [0.79-1.29],0.9133015987161526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC59,Leucine-rich repeat-containing protein 59,43925,280,1.14 [0.91-1.43],0.2606848891776148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,43716,280,1.09 [0.87-1.37],0.4589681911438459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRN1,Leucine-rich repeat neuronal protein 1,49560,327,0.81 [0.63-1.04],0.0914009396162384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,42721,269,0.90 [0.67-1.21],0.4842986368436318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,43847,277,0.81 [0.52-1.28],0.3676353192852239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM1,U6 snRNA-associated Sm-like protein LSm1,49332,331,1.01 [0.85-1.20],0.9261284808838112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM8,U6 snRNA-associated Sm-like protein LSm8,43124,274,1.10 [0.98-1.24],0.1000258616909884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSP1,Lymphocyte-specific protein 1,50447,341,1.14 [0.90-1.44],0.2683134116481087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA,Lymphotoxin-alpha,50447,341,0.93 [0.73-1.18],0.5508376431731473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA4H,Leukotriene A-4 hydrolase,50950,341,1.25 [1.07-1.45],0.0049023319496454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTB,Lymphotoxin-beta,43716,280,0.98 [0.71-1.36],0.9174840614827258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,51146,343,1.80 [1.35-2.40],5.651900315129505e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP3,Latent-transforming growth factor beta-binding protein 3,49332,331,1.35 [1.16-1.56],6.079282959524526e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,50236,337,2.07 [1.54-2.79],1.6731897002441677e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTO1,Protein LTO1 homolog,49560,327,1.05 [0.83-1.32],0.7004625062541301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LUZP2,Leucine zipper protein 2,43716,280,1.14 [0.90-1.44],0.285917928125868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LXN,Latexin,49900,339,0.95 [0.82-1.09],0.4523366940571662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,50237,338,1.61 [1.30-2.00],1.573148498118228e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY75,Lymphocyte antigen 75,50447,341,1.21 [0.94-1.56],0.1351642130405677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY9,T-lymphocyte surface antigen Ly-9,49938,329,1.62 [1.17-2.22],0.0032084606054062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,50135,340,1.70 [1.35-2.14],5.654169618252671e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYAR,Cell growth-regulating nucleolar protein,49332,331,1.05 [0.88-1.24],0.6046159683112862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYN,Tyrosine-protein kinase Lyn,50286,339,1.12 [1.00-1.26],0.0458986347659669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD1,Ly6/PLAUR domain-containing protein 1,49337,326,0.94 [0.79-1.11],0.4383481308835141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD3,Ly6/PLAUR domain-containing protein 3,50278,342,1.16 [0.88-1.53],0.3043135899143873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD8,Ly6/PLAUR domain-containing protein 8,49332,331,1.14 [0.96-1.36],0.1430376390990982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPLA2,Acyl-protein thioesterase 2,42497,265,1.07 [0.96-1.18],0.2116622159344676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,42721,269,1.07 [0.96-1.18],0.238906098084223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,43988,277,1.27 [0.71-2.27],0.4235841476969378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYZL2,Lysozyme-like protein 2,42355,265,1.12 [0.81-1.53],0.4943440028323375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LZTFL1,Leucine zipper transcription factor-like protein 1,42966,266,1.06 [0.90-1.25],0.4688959812418487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),M6PR,Cation-dependent mannose-6-phosphate receptor,42761,275,1.01 [0.76-1.35],0.926978211353084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,49969,340,1.33 [1.15-1.53],0.0001081131026778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAEA,E3 ubiquitin-protein transferase MAEA,49332,331,1.05 [0.83-1.34],0.6756815177580543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAG,Myelin-associated glycoprotein,42721,269,0.78 [0.61-0.99],0.0440275739359156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGEA3,Melanoma-associated antigen 3,43124,274,0.98 [0.86-1.13],0.8237769415173368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGED1,Melanoma-associated antigen D1,49332,331,1.14 [0.94-1.38],0.190610949979298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC2,MAM domain-containing protein 2,43925,280,1.52 [1.11-2.07],0.0089016394935968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC4,Apical endosomal glycoprotein,43716,280,1.13 [0.92-1.38],0.2312075069249686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",42761,275,1.08 [0.69-1.69],0.746203314359603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN2B2,Epididymis-specific alpha-mannosidase,43925,280,1.08 [0.89-1.30],0.4568059487208299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",42355,265,0.99 [0.78-1.25],0.9109139251747148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANF,Mesencephalic astrocyte-derived neurotrophic factor,50737,340,1.05 [0.97-1.14],0.2311077472096727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC1,MANSC domain-containing protein 1,50678,342,1.50 [1.07-2.10],0.0186375268880741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC4,MANSC domain-containing protein 4,42474,270,1.03 [0.87-1.22],0.7441577424369017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,42497,265,1.00 [0.69-1.45],0.9972391958996792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,42474,270,1.06 [0.90-1.24],0.5206468054995943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2,Microtubule-associated protein 2,43820,278,1.22 [0.97-1.53],0.0910950605486693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,43736,277,1.14 [0.96-1.36],0.1432516600601617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,50447,341,1.04 [0.94-1.14],0.426586618907887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,49332,331,1.07 [0.97-1.18],0.1793000593323659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,50052,340,1.06 [0.98-1.16],0.1554277263303495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK13,Mitogen-activated protein kinase 13,42355,265,1.30 [1.04-1.63],0.021830437999765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK9,Mitogen-activated protein kinase 9,50447,341,0.97 [0.78-1.21],0.7963202368026007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPKAPK2,MAP kinase-activated protein kinase 2,43124,274,1.11 [0.95-1.29],0.2003354695471299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPRE3,Microtubule-associated protein RP/EB family member 3,42355,265,1.03 [0.96-1.12],0.4004241558552724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPT,Microtubule-associated protein tau,49337,326,1.25 [1.03-1.52],0.0269091153891397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARCO,Macrophage receptor MARCO,50522,342,1.27 [0.88-1.82],0.2025418215529786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARS1,"Methionine--tRNA ligase, cytoplasmic",42886,266,1.05 [0.92-1.21],0.4663756866894929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MASP1,Mannan-binding lectin serine protease 1,50052,340,1.07 [0.71-1.60],0.7508970847427993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,50569,337,1.89 [1.38-2.60],8.503655676218538e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN3,Matrilin-3,50052,339,0.96 [0.71-1.29],0.7921849249197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAVS,Mitochondrial antiviral-signaling protein,49332,331,1.09 [0.98-1.21],0.1119176772797126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAX,Protein max,49337,326,1.10 [1.00-1.21],0.0436619103204385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MB,Myoglobin,51146,343,1.23 [1.04-1.45],0.016504196051892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MBL2,Mannose-binding protein C,43353,273,1.07 [0.96-1.19],0.2221152996977282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCAM,Cell surface glycoprotein MUC18,50722,343,1.22 [0.92-1.61],0.1609011501996577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",43847,277,1.18 [0.93-1.50],0.1754171416702425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEMP1,Mast cell-expressed membrane protein 1,42650,268,1.03 [0.91-1.18],0.6072805075677605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCFD2,Multiple coagulation factor deficiency protein 2,50286,341,1.37 [1.11-1.69],0.0035376638999899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCTS1,Malignant T-cell-amplified sequence 1,43736,277,0.80 [0.50-1.28],0.3600621363777002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,50135,340,1.05 [0.92-1.21],0.4657849928442037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDH1,"Malate dehydrogenase, cytoplasmic",43712,276,1.01 [0.76-1.34],0.9598062829010112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDK,Midkine,50523,341,1.36 [1.17-1.59],8.690668960326101e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDM1,Nuclear protein MDM1,42721,269,1.18 [0.82-1.70],0.3825696625308903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",42761,275,1.09 [0.96-1.23],0.2000822063343988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED18,Mediator of RNA polymerase II transcription subunit 18,49332,331,1.10 [0.97-1.25],0.147490494185994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED21,Mediator of RNA polymerase II transcription subunit 21,42474,270,0.92 [0.71-1.18],0.5055581969988654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF10,Multiple epidermal growth factor-like domains protein 10,50485,337,0.98 [0.76-1.25],0.846922561268946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF11,Multiple epidermal growth factor-like domains protein 11,42474,270,1.01 [0.71-1.45],0.9444341337941122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF9,Multiple epidermal growth factor-like domains protein 9,50981,343,1.11 [0.69-1.77],0.671596132897458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MELTF,Melanotransferrin,43925,280,1.20 [0.82-1.75],0.339829283795952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MENT,Protein MENT,42966,266,0.59 [0.36-0.98],0.0396478421052115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1A,Meprin A subunit alpha,43736,277,1.08 [0.93-1.26],0.3160936816505991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1B,Meprin A subunit beta,50522,342,0.90 [0.83-0.97],0.0054178420409749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEPE,Matrix extracellular phosphoglycoprotein,50485,337,0.90 [0.62-1.30],0.5806828401057853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MERTK,Tyrosine-protein kinase Mer,51074,342,1.76 [1.22-2.53],0.0023953779554027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MESD,LRP chaperone MESD,50539,340,1.08 [1.00-1.17],0.056682348553703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MET,Hepatocyte growth factor receptor,50663,336,1.24 [0.77-2.00],0.3821086947919185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1,Methionine aminopeptidase 1,49337,326,0.97 [0.69-1.35],0.8494732810693104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",50447,341,1.10 [0.98-1.24],0.0978054157173188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP2,Methionine aminopeptidase 2,50876,341,1.10 [0.93-1.31],0.2628320729869849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3,Microfibril-associated glycoprotein 3,49594,325,0.94 [0.76-1.16],0.5442280036750833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3L,Microfibrillar-associated protein 3-like,42721,269,1.06 [0.90-1.25],0.5037231580421717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP4,Microfibril-associated glycoprotein 4,42966,266,1.35 [0.94-1.94],0.1091856944243685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP5,Microfibrillar-associated protein 5,51146,343,1.21 [0.95-1.53],0.1152954561759721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFGE8,Lactadherin,50539,340,1.22 [0.99-1.50],0.0682725919138172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGLL,Monoglyceride lipase,50654,338,1.05 [0.94-1.17],0.3904055671498355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGMT,Methylated-DNA--protein-cysteine methyltransferase,50447,341,1.04 [0.96-1.13],0.3325024313592054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIA,Melanoma-derived growth regulatory protein,50678,342,1.30 [1.01-1.66],0.040731427674361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICALL2,MICAL-like protein 2,42721,269,1.01 [0.85-1.19],0.9408084062122944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,50447,341,1.03 [0.97-1.11],0.3120364451787619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIF,Macrophage migration inhibitory factor,50455,340,1.04 [0.90-1.20],0.5821819905997458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,49560,327,1.44 [1.20-1.73],9.088363104389074e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,43716,280,1.05 [0.94-1.17],0.3757627068695264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINK1,Misshapen-like kinase 1,43820,278,1.06 [0.94-1.20],0.3662514485804754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MITD1,MIT domain-containing protein 1,50135,340,1.04 [0.95-1.15],0.3915355994706893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MKI67,Proliferation marker protein Ki-67,42650,268,1.17 [0.90-1.53],0.2325988270015313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLLT1,Protein ENL,42355,265,0.95 [0.79-1.14],0.585769142207651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLN,Promotilin,50447,341,1.10 [0.99-1.22],0.0875264617145482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MME,Neprilysin,50286,339,1.19 [1.07-1.34],0.0020301033973171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP1,Interstitial collagenase,48695,325,1.18 [1.05-1.32],0.0041523048045359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP10,Stromelysin-2,50401,337,1.20 [1.02-1.40],0.023907761916724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,50560,339,1.40 [1.18-1.66],0.000129000573403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP13,Collagenase 3,49337,326,1.42 [1.05-1.92],0.023084735401482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP15,Matrix metalloproteinase-15,43925,280,1.15 [0.95-1.39],0.1650260102817234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP3,Stromelysin-1,50539,340,1.16 [0.96-1.40],0.1217374361600874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP7,Matrilysin,49517,325,1.29 [1.04-1.58],0.0175240468449421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP8,Neutrophil collagenase,50884,342,1.04 [0.92-1.19],0.5267463520059676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP9,Matrix metalloproteinase-9,50455,340,1.10 [0.94-1.28],0.2587623973776066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",42474,270,1.11 [0.88-1.39],0.3888866324329042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MN1,Transcriptional activator MN1,42721,269,1.03 [0.84-1.25],0.7860132598751469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNAT1,CDK-activating kinase assembly factor MAT1,43124,274,1.08 [0.84-1.38],0.5699840475651213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNDA,Myeloid cell nuclear differentiation antigen,50444,341,0.99 [0.90-1.09],0.8470866191546021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOCS2,Molybdopterin synthase catalytic subunit,42966,266,1.11 [0.94-1.33],0.2206683976818229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOG,Myelin-oligodendrocyte glycoprotein,50950,341,1.25 [0.94-1.67],0.1197628152135492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORC3,MORC family CW-type zinc finger protein 3,43820,278,1.04 [0.70-1.56],0.8341363035335567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L1,Mortality factor 4-like protein 1,43124,274,1.16 [0.90-1.50],0.2443341567129994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L2,Mortality factor 4-like protein 2,42355,265,1.27 [0.96-1.68],0.0990542496910528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORN4,MORN repeat-containing protein 4,42355,265,0.87 [0.73-1.03],0.1027325993324399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPHOSPH8,M-phase phosphoprotein 8,49594,325,1.12 [0.99-1.27],0.0709623355753202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPI,Mannose-6-phosphate isomerase,50286,339,1.09 [0.98-1.22],0.1158508149364923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,50654,338,1.11 [0.97-1.26],0.1236071974093133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPO,Myeloperoxidase,50539,340,1.20 [0.99-1.45],0.0653711964664998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPRIP,Myosin phosphatase Rho-interacting protein,43635,279,0.98 [0.75-1.27],0.8583865068159711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,43959,278,2.09 [1.44-3.04],0.0001208446197965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRI1,Methylthioribose-1-phosphate isomerase,42721,269,0.95 [0.80-1.13],0.5764721062697536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL24,"39S ribosomal protein L24, mitochondrial",42474,270,1.20 [0.93-1.56],0.1677592634207655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL28,"39S ribosomal protein L28, mitochondrial",43847,277,0.84 [0.58-1.21],0.3426960113606383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL46,"39S ribosomal protein L46, mitochondrial",49337,326,1.24 [0.89-1.72],0.2013825009466393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL52,"39S ribosomal protein L52, mitochondrial",42275,265,1.10 [0.71-1.69],0.6805934853487053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",43847,277,0.97 [0.82-1.14],0.7211747942186266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPS16,"28S ribosomal protein S16, mitochondrial",42650,268,0.97 [0.64-1.47],0.8850434860856023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLN,Mesothelin,50203,338,1.24 [1.06-1.46],0.0069537939298444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLNL,Mesothelin-like protein,42721,269,0.91 [0.66-1.25],0.5589837744099045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSMB,Beta-microseminoprotein,50402,339,1.03 [0.90-1.18],0.6886690116898238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,50968,342,1.70 [1.39-2.09],3.038578270363898e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSRA,Mitochondrial peptide methionine sulfoxide reductase,50678,342,1.10 [0.97-1.26],0.1527906307162821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MST1,Hepatocyte growth factor-like protein,43300,273,1.04 [0.86-1.25],0.7038595543320432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSTN,Growth/differentiation factor 8,49594,325,0.94 [0.78-1.13],0.489661113605501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTDH,Protein LYRIC,42650,268,1.13 [1.00-1.28],0.0491775922989767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",43820,278,1.40 [0.99-1.98],0.0585943927032654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,43124,274,1.02 [0.92-1.13],0.681128015457013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTIF3,"Translation initiation factor IF-3, mitochondrial",43736,277,1.11 [0.98-1.27],0.103789024814716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTPN,Myotrophin,49594,325,0.88 [0.64-1.20],0.4200976678254999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTR,Methionine synthase,42474,270,1.00 [0.83-1.19],0.9742476761933508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS1,Protein MTSS 1,43736,277,0.99 [0.90-1.10],0.9185192279459704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS2,Protein MTSS 2,43716,280,1.02 [0.91-1.15],0.6740629501483741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTUS1,Microtubule-associated tumor suppressor 1,43124,274,1.15 [0.95-1.40],0.1531398281535819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC13,Mucin-13,49337,326,1.17 [0.97-1.41],0.0962965963841325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC16,Mucin-16,50286,339,1.00 [0.95-1.05],0.9854636447772837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC2,Mucin-2,43926,275,0.95 [0.84-1.08],0.4445250122703196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUCL3,Mucin-like protein 3,42355,265,1.01 [0.77-1.32],0.9405238904458628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MVK,Mevalonate kinase,49560,327,1.18 [1.05-1.33],0.0048691758259088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MXRA8,Matrix remodeling-associated protein 8,42966,266,0.81 [0.55-1.18],0.276878985160554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC1,"Myosin-binding protein C, slow-type",43925,280,1.29 [1.11-1.49],0.0006621906280849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC2,"Myosin-binding protein C, fast-type",42761,275,1.16 [1.03-1.30],0.0117255646361408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,43847,277,1.15 [0.99-1.35],0.0753456219609323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYDGF,Myeloid-derived growth factor,43925,280,1.12 [1.00-1.25],0.0598976914710011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH4,Myosin-4,42474,270,0.94 [0.72-1.22],0.6416494367830852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH7B,Myosin-7B,42355,265,1.37 [1.10-1.69],0.0040124793299556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH9,Myosin-9,43926,275,1.03 [0.93-1.14],0.5365014924381115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",42474,270,1.01 [0.77-1.34],0.9214930710085254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL3,Myosin light chain 3,42761,275,1.20 [1.03-1.39],0.0220450997371544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL4,Myosin light chain 4,42761,275,0.88 [0.70-1.11],0.2818653847735956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL6B,Myosin light chain 6B,42721,269,1.05 [0.93-1.19],0.4057219391813436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",42721,269,1.23 [1.00-1.50],0.0446649778022352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO6,Unconventional myosin-VI,43847,277,1.20 [0.91-1.58],0.187038201430575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO9B,Unconventional myosin-IXb,49560,327,1.08 [0.94-1.24],0.2899869987938992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOC,Myocilin,50539,340,1.05 [0.85-1.29],0.6795568195623324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM1,Myomesin-1,42497,265,1.22 [0.99-1.50],0.0594739720084165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM2,Myomesin-2,42474,270,1.37 [1.13-1.66],0.0012577756658272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM3,Myomesin-3,42966,266,1.12 [0.99-1.27],0.0660687027938436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZB1,Marginal zone B- and B1-cell-specific protein,50652,339,1.34 [1.13-1.60],0.0010765988909813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZT1,Mitotic-spindle organizing protein 1,49332,331,1.07 [0.89-1.29],0.448349040161734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA10,N-alpha-acetyltransferase 10,42474,270,1.02 [0.81-1.28],0.8927237548752384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA80,N-alpha-acetyltransferase 80,42721,269,1.03 [0.93-1.13],0.5555376190431622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAAA,N-acylethanolamine-hydrolyzing acid amidase,49902,339,0.89 [0.75-1.05],0.1536277802895572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NACC1,Nucleus accumbens-associated protein 1,43716,280,1.06 [0.87-1.30],0.5521642588445871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NADK,NAD kinase,50522,342,1.06 [0.90-1.25],0.5115402237623283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGA,Alpha-N-acetylgalactosaminidase,42571,268,0.99 [0.81-1.22],0.9565739843732974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGK,N-acetyl-D-glucosamine kinase,42682,275,1.10 [0.90-1.34],0.369145330473311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,42966,266,1.47 [0.86-2.53],0.1615385732547067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAMPT,Nicotinamide phosphoribosyltransferase,49332,331,1.12 [0.95-1.31],0.1750362719420007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAP1L4,Nucleosome assembly protein 1-like 4,43655,277,1.06 [0.80-1.40],0.7021190829933095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAPRT,Nicotinate phosphoribosyltransferase,43820,278,1.09 [0.78-1.53],0.6125456886539035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NARS1,"Asparagine--tRNA ligase, cytoplasmic",43847,277,1.05 [0.82-1.34],0.7072731436726747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,50678,342,2.16 [1.55-3.02],6.209064511211735e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBN,Nibrin,49560,327,1.00 [0.84-1.20],0.9677561996221656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM1,Neural cell adhesion molecule 1,50722,343,1.06 [0.77-1.44],0.7302671759865853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM2,Neural cell adhesion molecule 2,50539,340,0.70 [0.49-1.01],0.0550847066725123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAN,Neurocan core protein,50968,342,0.68 [0.53-0.86],0.0018417817135754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCF2,Neutrophil cytosol factor 2,50362,340,1.01 [0.90-1.12],0.9221656768790976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCK2,Cytoplasmic protein NCK2,50737,340,1.05 [0.96-1.15],0.2613362613127857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCLN,Nicalin,49560,327,1.04 [0.87-1.25],0.6626237207920329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR1,Natural cytotoxicity triggering receptor 1,50373,337,1.48 [1.15-1.91],0.0021176162850575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,43736,277,1.75 [1.27-2.41],0.0006003745709255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCS1,Neuronal calcium sensor 1,50950,341,1.71 [1.23-2.38],0.0013288552787663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDRG1,Protein NDRG1,49337,326,0.98 [0.85-1.14],0.8285292146788795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,43716,280,1.11 [0.95-1.30],0.1985357752108438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,42578,268,1.04 [0.75-1.45],0.8031123001998118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,43736,277,1.07 [0.94-1.21],0.3122605061474371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",49332,331,1.14 [1.03-1.27],0.0151378786115225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEB,Nebulin,42474,270,1.19 [0.90-1.56],0.2293014946575244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECAP2,Adaptin ear-binding coat-associated protein 2,42474,270,1.09 [0.92-1.28],0.3225779335547629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN1,Nectin-1,42650,268,1.09 [0.77-1.54],0.6438183849671442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,50447,342,2.20 [1.65-2.93],7.698632543794998e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN4,Nectin-4,50678,342,1.78 [1.38-2.29],8.951800603609518e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,42650,268,0.92 [0.73-1.17],0.5003678077817095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD9,Enhancer of filamentation 1,42650,268,1.22 [0.89-1.66],0.2195735311130117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,49181,325,1.75 [1.47-2.09],5.53533930222471e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEK7,Serine/threonine-protein kinase Nek7,43124,274,1.08 [0.93-1.25],0.2983195446117461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL1,Protein kinase C-binding protein NELL1,50678,342,0.67 [0.53-0.83],0.0003664490812928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL2,Protein kinase C-binding protein NELL2,50737,340,1.01 [0.72-1.40],0.972154155154774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NENF,Neudesin,43716,280,1.07 [0.97-1.17],0.1606204929830067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEO1,Neogenin,43847,277,1.03 [0.62-1.71],0.8996332980228439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEXN,Nexilin,43959,278,1.10 [0.94-1.29],0.2450625472335321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,51074,342,1.82 [1.32-2.50],0.0002311926567502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFAT5,Nuclear factor of activated T-cells 5,42650,268,1.04 [0.91-1.19],0.520536007401263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",50447,341,1.03 [0.94-1.14],0.4932820674943908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",49560,327,1.10 [0.94-1.29],0.2532902779963866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFE2,Transcription factor NF-E2 45 kDa subunit,42761,275,1.04 [0.89-1.22],0.6052646334489279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFIC,Nuclear factor 1 C-type,43847,277,0.95 [0.72-1.25],0.6878666370025086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB1,Nuclear factor NF-kappa-B p105 subunit,42474,270,1.02 [0.87-1.19],0.8266495019497211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB2,Nuclear factor NF-kappa-B p100 subunit,43124,274,1.06 [0.88-1.29],0.5267632266632032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKBIE,NF-kappa-B inhibitor epsilon,49332,331,1.19 [0.98-1.44],0.0790461364370784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",43736,277,1.09 [0.98-1.22],0.1296181334897738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFX1,Transcriptional repressor NF-X1,42474,270,0.99 [0.83-1.18],0.9039964270752602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFYA,Nuclear transcription factor Y subunit alpha,42474,270,1.14 [0.87-1.49],0.3545133517813407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGF,Beta-nerve growth factor,50135,340,1.42 [0.66-3.06],0.375368993980635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGFR,Tumor necrosis factor receptor superfamily member 16,43925,280,1.45 [1.07-1.95],0.0153943477694599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGRN,Neugrin,43820,278,1.11 [0.68-1.84],0.6730673121730143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NHLRC3,NHL repeat-containing protein 3,41925,259,1.44 [0.98-2.11],0.0603294594672342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID1,Nidogen-1,50559,342,1.21 [0.95-1.55],0.1232640740299902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID2,Nidogen-2,50539,340,1.14 [1.01-1.30],0.0343905169078183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NINJ1,Ninjurin-1,49332,331,1.13 [0.96-1.32],0.1447947546287918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT1,Deaminated glutathione amidase,42761,275,0.97 [0.76-1.24],0.7928095513184131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT2,Omega-amidase NIT2,43757,277,1.04 [0.89-1.22],0.5896473847324505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN1,Neuroligin-1,42721,269,0.95 [0.79-1.14],0.5600228208142701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN2,Neuroligin-2,42497,265,0.98 [0.76-1.27],0.8903320885894151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME1,Nucleoside diphosphate kinase A,42650,268,1.31 [0.77-2.21],0.3223306860992102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME3,Nucleoside diphosphate kinase 3,50569,337,1.42 [0.99-2.05],0.0568821214702693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMI,N-myc-interactor,43549,279,1.11 [0.95-1.30],0.1694881428175294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,50135,340,0.99 [0.87-1.13],0.8782719310672662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMRK2,Nicotinamide riboside kinase 2,42355,265,1.14 [0.88-1.47],0.3105659950035625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,43847,277,1.10 [0.94-1.29],0.2168585888216938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOMO1,Nodal modulator 1,50539,340,1.55 [1.04-2.31],0.0302827520988966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOP56,Nucleolar protein 56,42474,270,1.08 [0.98-1.19],0.116376191138294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",49337,326,1.47 [1.25-1.73],3.4091221644475367e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS2,"Nitric oxide synthase, inducible",42474,270,1.13 [0.85-1.50],0.4091731782758769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS3,"Nitric oxide synthase, endothelial",49337,326,1.18 [1.00-1.39],0.0489689913403787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH1,Neurogenic locus notch homolog protein 1,51146,343,1.34 [0.74-2.43],0.3334333255525223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH2,Neurogenic locus notch homolog protein 2,43926,275,1.38 [0.84-2.27],0.2032346427312451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH3,Neurogenic locus notch homolog protein 3,51146,343,1.22 [0.92-1.60],0.1648280358081263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPC2,NPC intracellular cholesterol transporter 2,43183,270,1.71 [1.27-2.31],0.0004514477527841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,50522,342,1.69 [1.30-2.19],8.129503775977611e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS1,Nephrin,42650,268,0.96 [0.68-1.36],0.8249594057491753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS2,Podocin,42650,268,1.12 [1.01-1.24],0.0283396100446891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPL,N-acetylneuraminate lyase,43925,280,1.24 [0.97-1.58],0.0865782612090433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPB,Natriuretic peptides B,49594,325,1.03 [0.95-1.10],0.4891859387280485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPC,C-type natriuretic peptide,50447,341,1.33 [1.11-1.59],0.0019740594232058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPR1,Atrial natriuretic peptide receptor 1,42474,270,0.93 [0.68-1.26],0.6277263589461022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTN,Neuroplastin,49332,331,1.01 [0.90-1.14],0.835118110391145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX1,Neuronal pentraxin-1,50539,340,1.10 [0.87-1.39],0.4138299738351441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX2,Neuronal pentraxin-2,43926,275,1.35 [0.95-1.91],0.0938746079732866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTXR,Neuronal pentraxin receptor,50522,342,1.05 [0.80-1.38],0.7007761141881653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPY,Pro-neuropeptide Y,50950,341,1.01 [0.87-1.17],0.8857115713209676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRCAM,Neuronal cell adhesion molecule,50522,342,1.32 [0.95-1.83],0.0934727874307368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRGN,Neurogranin,43959,278,1.04 [0.91-1.18],0.5706231356987644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRN1,Neuritin,43847,277,1.27 [0.99-1.62],0.0567335036547383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP1,Neuropilin-1,50807,343,1.58 [1.13-2.21],0.0077147766872745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP2,Neuropilin-2,50539,340,1.39 [1.01-1.92],0.0425904845898002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRTN,Neurturin,49560,327,1.12 [0.94-1.35],0.2102862337080942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRXN3,Neurexin-3,42721,269,0.91 [0.64-1.29],0.5962531344484456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NSFL1C,NSFL1 cofactor p47,50968,342,1.02 [0.88-1.18],0.7878175842793779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",43925,280,1.07 [0.92-1.25],0.3790668935070894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C1A,Cytosolic 5'-nucleotidase 1A,43820,278,1.70 [1.33-2.17],2.260271941284956e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C3A,Cytosolic 5'-nucleotidase 3A,50369,341,1.06 [0.95-1.18],0.334129836658539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5E,5'-nucleotidase,50678,342,1.15 [0.98-1.36],0.090644098099018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF3,Neurotrophin-3,50447,341,1.03 [0.79-1.34],0.8406452291141018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF4,Neurotrophin-4,49332,331,1.06 [0.83-1.34],0.6368644993659023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK2,BDNF/NT-3 growth factors receptor,50522,342,0.96 [0.66-1.40],0.8314943445630998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK3,NT-3 growth factor receptor,50968,342,0.70 [0.45-1.08],0.1110725723670647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTproBNP,N-terminal prohormone of brain natriuretic peptide,50522,342,1.15 [1.06-1.25],0.0008749873210345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUB1,NEDD8 ultimate buster 1,50447,341,1.07 [0.96-1.20],0.2226542081952544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,43716,280,1.03 [0.92-1.15],0.6346370826633095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUCB2,Nucleobindin-2,50868,341,1.55 [1.21-1.98],0.00049084578983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDC,Nuclear migration protein nudC,51074,342,1.11 [0.95-1.29],0.1983409600666488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,42761,275,0.76 [0.45-1.27],0.2938357816598518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,42474,270,0.89 [0.70-1.15],0.3814975563910792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT16,U8 snoRNA-decapping enzyme,43661,277,1.09 [0.96-1.24],0.1856123815772387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],50286,339,0.94 [0.79-1.11],0.4554180463252647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT5,ADP-sugar pyrophosphatase,50539,340,1.16 [0.97-1.39],0.112662662022957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUMB,Protein numb homolog,42650,268,1.05 [0.91-1.21],0.5214425164167035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUP50,Nuclear pore complex protein Nup50,42474,270,0.86 [0.58-1.26],0.4336732214450821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPE4,NXPE family member 4,42474,270,0.93 [0.65-1.33],0.690772035649477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH1,Neurexophilin-1,49337,326,1.11 [0.87-1.42],0.399937775719247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH3,Neurexophilin-3,42650,268,1.25 [0.85-1.85],0.2578048200588816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OBP2B,Odorant-binding protein 2b,49969,339,1.08 [0.93-1.27],0.3074902760513883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,43847,277,1.80 [1.44-2.25],2.658557833131103e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ODAM,Odontogenic ameloblast-associated protein,49253,326,0.91 [0.76-1.10],0.3418490667745945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OFD1,Oral-facial-digital syndrome 1 protein,43124,274,1.04 [0.88-1.23],0.6602004996817515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGA,Protein O-GlcNAcase,43736,277,1.14 [0.97-1.34],0.1103021171128633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGFR,Opioid growth factor receptor,50286,339,1.30 [0.97-1.73],0.075126362658595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,50539,340,1.70 [1.38-2.11],8.221356235129242e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,43124,274,1.08 [0.91-1.28],0.3667592913846386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLFM4,Olfactomedin-4,41363,252,1.04 [0.94-1.15],0.4463747353882469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLR1,Oxidized low-density lipoprotein receptor 1,50033,341,1.07 [0.91-1.25],0.4148547306766744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMD,Osteomodulin,50737,340,0.96 [0.77-1.19],0.6804651563400519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMG,Oligodendrocyte-myelin glycoprotein,50286,339,0.85 [0.74-0.98],0.02902187756999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMP,Olfactory marker protein,42497,265,0.93 [0.72-1.20],0.5816107359291732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPHN1,Oligophrenin-1,43820,278,1.02 [0.92-1.14],0.6933014486490372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPLAH,5-oxoprolinase,42761,275,1.04 [0.88-1.23],0.6718556480418184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPTC,Opticin,50286,339,0.92 [0.74-1.15],0.4736979782574659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ORM1,Alpha-1-acid glycoprotein 1,43832,276,0.83 [0.47-1.49],0.5389774382086379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSBPL2,Oxysterol-binding protein-related protein 2,43820,278,1.10 [0.84-1.44],0.4837340482384962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,50569,337,1.85 [1.39-2.45],2.0212325997768326e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSM,Oncostatin-M,50208,341,1.09 [0.95-1.25],0.21252155777514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSMR,Oncostatin-M-specific receptor subunit beta,50807,343,1.65 [1.04-2.63],0.0344254481861703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSTN,Osteocrin,42721,269,0.79 [0.58-1.10],0.1610497693036551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTOA,Otoancorin,42497,265,1.13 [0.93-1.38],0.2044778697998371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD6B,Deubiquitinase OTUD6B,43736,277,1.11 [0.91-1.35],0.2916586927953118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD7B,OTU domain-containing protein 7B,43847,277,1.15 [0.96-1.37],0.1319886795281921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",42761,275,1.06 [0.90-1.25],0.481682169570729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXT,Oxytocin-neurophysin 1,50968,342,1.00 [0.94-1.07],0.984572491494118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),P4HB,Protein disulfide-isomerase,50271,341,1.42 [1.12-1.81],0.0044608383207537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PACS2,Phosphofurin acidic cluster sorting protein 2,42474,270,1.11 [0.92-1.34],0.2834952790894422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI2,Protein-arginine deiminase type-2,49560,327,1.09 [0.94-1.28],0.2578299502621504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI4,Protein-arginine deiminase type-4,49253,326,1.01 [0.89-1.15],0.9050028987133908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAEP,Glycodelin,50135,340,1.02 [0.94-1.11],0.6236634365044034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,43847,277,1.10 [1.00-1.20],0.0407181859268603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",43124,274,1.28 [1.03-1.58],0.0262077840970873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,49594,325,1.16 [0.98-1.37],0.0813165414632322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAGR1,PAXIP1-associated glutamate-rich protein 1,42761,275,0.80 [0.60-1.07],0.1271699122333834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,42279,265,1.21 [0.99-1.49],0.067493247756945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAK4,Serine/threonine-protein kinase PAK 4,49337,326,1.14 [0.98-1.33],0.0881204804745731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALLD,Palladin,42650,268,0.85 [0.61-1.18],0.3195389867913393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM,Paralemmin-1,43498,277,1.53 [1.08-2.16],0.0159635261697866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,43820,278,1.66 [1.28-2.16],0.0001663204245762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM3,Paralemmin-3,42474,270,1.09 [0.95-1.25],0.2320961924391741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAM,Peptidyl-glycine alpha-amidating monooxygenase,50899,343,1.21 [0.86-1.72],0.2781431034475219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAMR1,Inactive serine protease PAMR1,50539,340,0.84 [0.60-1.19],0.3357892184102319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAPPA,Pappalysin-1,49560,327,1.09 [0.88-1.34],0.4288718860405146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARD3,Partitioning defective 3 homolog,43124,274,1.01 [0.86-1.18],0.916227540991284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARK7,Parkinson disease protein 7,50539,340,1.03 [0.86-1.23],0.7643494398274034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARP1,Poly [ADP-ribose] polymerase 1,50447,341,1.01 [0.86-1.19],0.9027185396370944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAXX,Protein PAXX,42966,266,1.07 [0.83-1.38],0.5845832605530381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBK,Lymphokine-activated killer T-cell-originated protein kinase,42355,265,1.08 [0.74-1.58],0.6975214947972008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBLD,Phenazine biosynthesis-like domain-containing protein,49337,326,1.14 [0.95-1.37],0.16332861802047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,43736,277,1.04 [0.72-1.51],0.8324296993930657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCARE,Photoreceptor cilium actin regulator,42497,265,0.90 [0.77-1.06],0.2093052887763989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,42883,264,1.12 [0.88-1.42],0.3682940013475676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBP2,Poly(rC)-binding protein 2,43847,277,1.07 [0.91-1.25],0.4254815552918167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH1,Protocadherin-1,50910,339,1.23 [0.80-1.87],0.3464739895644186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH12,Protocadherin-12,43847,277,1.48 [0.96-2.28],0.0781838773954961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH17,Protocadherin-17,50522,342,1.22 [0.94-1.58],0.127789410688983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH7,Protocadherin-7,43736,277,0.93 [0.67-1.31],0.6868890242597245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH9,Protocadherin-9,43736,277,1.11 [0.79-1.56],0.5383125394375905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDHB15,Protocadherin beta-15,43716,280,1.09 [0.82-1.44],0.5445512387453127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCNA,Proliferating cell nuclear antigen,42355,265,1.06 [0.89-1.26],0.5100644396540698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK7,Proprotein convertase subtilisin/kexin type 7,43716,280,1.16 [0.92-1.45],0.2068139185389157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK9,Proprotein convertase subtilisin/kexin type 9,51146,343,1.26 [0.99-1.59],0.0606281286234284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCYT2,Ethanolamine-phosphate cytidylyltransferase,43736,277,1.09 [0.93-1.26],0.284643393551186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDAP1,28 kDa heat- and acid-stable phosphoprotein,43925,280,1.07 [0.95-1.20],0.2838161877640003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1,Programmed cell death protein 1,50866,341,1.38 [1.12-1.69],0.0021821377552964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,50286,339,1.78 [1.34-2.35],6.030154900827679e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD5,Programmed cell death protein 5,50968,342,1.04 [0.88-1.22],0.6615023482247515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD6,Programmed cell death protein 6,50522,342,1.10 [0.95-1.27],0.220493656071115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCL2,Phosducin-like protein 2,42355,265,0.95 [0.76-1.20],0.6931012789580104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",42355,265,1.02 [0.82-1.26],0.8837439038904232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",42474,270,0.81 [0.64-1.03],0.0840535175516796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",42966,266,0.99 [0.89-1.11],0.8896864435100879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFA,Platelet-derived growth factor subunit A,51146,343,1.08 [0.94-1.23],0.2695105731765409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFB,Platelet-derived growth factor subunit B,50737,340,1.08 [0.96-1.20],0.1976684848851375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFC,Platelet-derived growth factor C,49332,331,1.44 [1.05-1.96],0.0219652161202159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRA,Platelet-derived growth factor receptor alpha,50522,342,1.37 [0.98-1.90],0.0628295488099363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRB,Platelet-derived growth factor receptor beta,51146,343,1.20 [0.91-1.57],0.2025580353820279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA2,Protein disulfide-isomerase A2,42355,265,1.08 [0.81-1.42],0.6010464003135881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA3,Protein disulfide-isomerase A3,42966,266,1.53 [1.06-2.21],0.0235259287226868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA4,Protein disulfide-isomerase A4,43926,275,1.13 [0.94-1.36],0.1914229199291484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA5,Protein disulfide-isomerase A5,42355,265,0.87 [0.70-1.07],0.1867773633325664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM5,PDZ and LIM domain protein 5,43847,277,1.05 [0.95-1.16],0.3492908427775952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM7,PDZ and LIM domain protein 7,50737,340,1.06 [0.98-1.14],0.1193079431557336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",49332,331,1.26 [1.08-1.47],0.003016968500622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDRG1,p53 and DNA damage-regulated protein 1,42721,269,0.98 [0.78-1.23],0.8753321809472253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,42355,265,1.06 [0.89-1.27],0.4939926882019495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZD2,PDZ domain-containing protein 2,42474,270,1.17 [0.98-1.40],0.0821764649976781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,42650,268,1.53 [1.23-1.90],0.0001159498173113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEAR1,Platelet endothelial aggregation receptor 1,51146,343,1.63 [1.07-2.48],0.0232406945808254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEBP1,Phosphatidylethanolamine-binding protein 1,50539,340,1.00 [0.85-1.18],0.9790228398308276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECAM1,Platelet endothelial cell adhesion molecule,50539,340,1.36 [1.00-1.85],0.0515526971459455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECR,Peroxisomal trans-2-enoyl-CoA reductase,42761,275,0.95 [0.63-1.43],0.7922361816945864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PENK,Proenkephalin-A,42966,266,1.36 [0.97-1.91],0.076887642476163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEPD,Xaa-Pro dipeptidase,43959,278,1.03 [0.66-1.59],0.9086551843596912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PER3,Period circadian protein homolog 3,42650,268,1.07 [0.98-1.18],0.1457570487816332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PF4,Platelet factor 4,43662,274,1.02 [0.90-1.14],0.7811195059071068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN2,Prefoldin subunit 2,49337,326,1.05 [0.88-1.26],0.5835983182239609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN4,Prefoldin subunit 4,42355,265,0.96 [0.76-1.21],0.7208115324746132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN6,Prefoldin subunit 6,42721,269,0.84 [0.68-1.04],0.1135305306948346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",50204,339,1.08 [0.96-1.23],0.2119340161482616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGA4,Pepsin A-4,43959,278,1.04 [0.90-1.22],0.5823361816908095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",43925,280,1.12 [0.91-1.38],0.3028509415873535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,51074,342,2.05 [1.58-2.68],9.73258440300692e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP1,Peptidoglycan recognition protein 1,50901,343,1.37 [1.11-1.68],0.00287030851055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,43425,271,0.67 [0.46-0.98],0.0389218644520156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP4,Peptidoglycan recognition protein 4,42474,270,1.10 [0.92-1.31],0.2827492496337904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGM2,Phosphoglucomutase-2,42721,269,0.99 [0.81-1.21],0.9334339463615728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGR,Progesterone receptor,42650,268,0.99 [0.88-1.12],0.9127945723267868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHACTR2,Phosphatase and actin regulator 2,43847,277,1.04 [0.94-1.15],0.4345414893633136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB1,Pleckstrin homology-like domain family B member 1,43736,277,1.18 [0.95-1.46],0.1284040053373885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB2,Pleckstrin homology-like domain family B member 2,42355,265,0.94 [0.83-1.08],0.4054773898125682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,50135,340,1.76 [1.29-2.38],0.0003140580827389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,42966,266,1.20 [0.90-1.59],0.2096919921169164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI16,Peptidase inhibitor 16,43959,278,1.20 [0.76-1.90],0.4378388587179808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,49856,334,1.24 [1.06-1.46],0.0077992309936585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",43847,277,1.02 [0.88-1.18],0.7869307809551582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,49879,337,1.83 [1.42-2.34],1.957204333248963e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,50447,341,1.02 [0.88-1.19],0.7898751349583678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,50539,340,2.13 [1.58-2.88],7.515465008830416e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,42650,268,0.97 [0.78-1.20],0.783698697569756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,50539,340,1.77 [1.41-2.23],9.616797241853138e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,50522,342,1.48 [1.24-1.77],1.6260953759354673e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,42966,266,1.13 [0.95-1.34],0.1724863163951906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PITHD1,PITH domain-containing protein 1,42279,265,1.03 [0.89-1.19],0.6915009225495059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD1,Polycystin-1,43925,280,1.82 [1.19-2.80],0.0062704493896586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD2,Polycystin-2,42474,270,1.09 [0.90-1.32],0.3949966618473028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKLR,Pyruvate kinase PKLR,50569,338,0.91 [0.78-1.05],0.1942027744536286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKN3,Serine/threonine-protein kinase N3,43124,274,1.01 [0.86-1.18],0.9192717220794774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G10,Group 10 secretory phospholipase A2,50135,340,1.23 [1.05-1.45],0.0109704025046528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,50678,342,1.87 [1.33-2.62],0.0003286394790345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G1B,Phospholipase A2,51064,341,0.88 [0.71-1.09],0.2316324768562255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G2A,"Phospholipase A2, membrane associated",50421,333,1.14 [0.97-1.33],0.1091134337744876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G4A,Cytosolic phospholipase A2,50737,340,1.07 [0.96-1.20],0.2092807325050901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G7,Platelet-activating factor acetylhydrolase,50539,340,0.67 [0.50-0.88],0.0038336511775946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAT,Tissue-type plasminogen activator,50981,343,1.05 [0.87-1.27],0.5862742479248766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAU,Urokinase-type plasminogen activator,50539,340,1.08 [0.79-1.48],0.63439017137222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,50154,337,3.02 [2.21-4.14],4.34646940624504e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLB1,"Phospholipase B1, membrane-associated",43820,278,0.84 [0.70-1.01],0.0702960888928896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",42650,268,1.02 [0.78-1.33],0.9084348472010384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",43820,278,1.07 [0.96-1.21],0.2299820376473278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLEKHO1,Pleckstrin homology domain-containing family O member 1,43820,278,1.03 [0.87-1.21],0.748382722415865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLG,Plasminogen,42863,269,0.94 [0.55-1.61],0.823625546213165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN1,Perilipin-1,49337,326,1.12 [0.86-1.47],0.3913811462817336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN3,Perilipin-3,50522,342,1.22 [0.98-1.51],0.0729428171628025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLPBP,Pyridoxal phosphate homeostasis protein,50522,342,1.03 [0.89-1.18],0.7226082200731384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLSCR3,Phospholipid scramblase 3,43737,275,1.16 [0.96-1.41],0.1262041548097512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLTP,Phospholipid transfer protein,50983,343,0.87 [0.67-1.13],0.3010799987763848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC1,Plexin domain-containing protein 1,49332,331,1.12 [0.85-1.47],0.4260738960048398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC2,Plexin domain-containing protein 2,43820,278,1.63 [1.16-2.28],0.0044654545881197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNA4,Plexin-A4,50447,341,1.07 [0.95-1.20],0.257379480149232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,50899,343,2.13 [1.47-3.08],6.330683168476737e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB3,Plexin-B3,50359,342,1.09 [0.89-1.33],0.3837606584857647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,50281,342,1.00 [0.95-1.05],0.987165883134145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMCH,Pro-MCH,42474,270,0.96 [0.83-1.12],0.6229118470833218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMM2,Phosphomannomutase 2,42474,270,1.07 [0.88-1.30],0.4896051095745571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMS1,PMS1 protein homolog 1,42721,269,0.83 [0.65-1.07],0.1444088579040569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMVK,Phosphomevalonate kinase,49257,324,1.03 [0.94-1.12],0.5823361132224321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIP,Pancreatic triacylglycerol lipase,43959,278,0.87 [0.72-1.04],0.1196520430483178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP1,Inactive pancreatic lipase-related protein 1,43820,278,1.04 [0.90-1.20],0.5710423474094168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP2,Pancreatic lipase-related protein 2,50485,337,0.98 [0.95-1.01],0.2493244556300329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA1,Paraneoplastic antigen Ma1,42761,275,0.94 [0.76-1.16],0.5538599025832629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA2,Paraneoplastic antigen Ma2,42497,265,0.91 [0.69-1.20],0.510219278465881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",49560,327,1.00 [0.92-1.09],0.9791311586589864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL,Podocalyxin,50286,339,0.72 [0.39-1.35],0.3055732779995058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL2,Podocalyxin-like protein 2,50678,342,1.14 [0.81-1.60],0.4471629869756311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POF1B,Protein POF1B,42650,268,1.43 [1.16-1.75],0.0007749300826955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2A,DNA-directed RNA polymerase II subunit RPB1,42650,268,0.94 [0.63-1.40],0.7587685473459214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",50286,339,1.33 [1.06-1.67],0.0136674991296702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POMC,Pro-opiomelanocortin,42761,275,0.85 [0.72-1.01],0.0573002080490561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON1,Serum paraoxonase/arylesterase 1,43959,278,0.61 [0.43-0.88],0.0081905624310974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON2,Serum paraoxonase/arylesterase 2,49594,325,1.09 [0.83-1.44],0.5446170484837443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON3,Serum paraoxonase/lactonase 3,50737,340,0.84 [0.64-1.10],0.2114900158602183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POSTN,Periostin,43926,275,1.04 [0.77-1.41],0.7862145732546663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPBP,Platelet basic protein,43662,273,1.06 [0.93-1.22],0.3920658000589331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPCDC,Phosphopantothenoylcysteine decarboxylase,50968,342,1.00 [0.81-1.22],0.9617577351619698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIB,Peptidyl-prolyl cis-trans isomerase B,50568,341,1.09 [0.99-1.21],0.0867943469047828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIE,Peptidyl-prolyl cis-trans isomerase E,43124,274,0.94 [0.78-1.15],0.563106029358736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",43926,275,1.11 [0.94-1.32],0.2222280268146758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPL,Periplakin,42650,268,1.20 [0.86-1.69],0.2875735549291823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1A,Protein phosphatase 1A,49332,331,1.10 [0.82-1.47],0.5255591360521831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1B,Protein phosphatase 1B,42650,268,0.95 [0.77-1.16],0.6063033204188406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1F,Protein phosphatase 1F,43925,280,1.08 [0.87-1.34],0.464623808070103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPME1,Protein phosphatase methylesterase 1,50286,339,1.02 [0.87-1.20],0.7666831861602037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,43716,280,1.07 [0.94-1.23],0.3044658374141645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,50678,342,1.10 [1.00-1.21],0.0584829730788466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,43124,274,1.18 [1.03-1.35],0.0144650594535414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,43847,277,1.03 [0.89-1.19],0.7074435688866242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,43847,277,1.20 [0.92-1.58],0.1843461479950596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R2,Protein phosphatase inhibitor 2,50522,342,1.08 [0.96-1.22],0.1928265515339933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R9B,Neurabin-2,51074,342,1.07 [0.97-1.18],0.1918473471092454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,43736,277,1.10 [1.00-1.21],0.0511504171500537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP3R1,Calcineurin subunit B type 1,50135,340,1.43 [1.14-1.80],0.0020670667907462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPT1,Palmitoyl-protein thioesterase 1,42721,269,1.06 [0.92-1.22],0.4497268863334142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPY,Pancreatic prohormone,50444,339,0.94 [0.86-1.04],0.2283364502213641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PQBP1,Polyglutamine-binding protein 1,49332,331,1.08 [0.92-1.26],0.3575893815722977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAME,Melanoma antigen preferentially expressed in tumors,42355,265,1.03 [0.65-1.63],0.889380665843211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAP1,Proline-rich acidic protein 1,43926,275,1.42 [1.07-1.90],0.016695276399968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRC1,Protein regulator of cytokinesis 1,43716,280,1.16 [0.95-1.42],0.1542747608602785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRCP,Lysosomal Pro-X carboxypeptidase,50830,339,1.20 [0.90-1.61],0.214269683904494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX1,Peroxiredoxin-1,49095,338,1.06 [0.95-1.18],0.2831405118835789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX2,Peroxiredoxin-2,43224,273,0.80 [0.66-0.96],0.018908514271079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",49560,327,1.23 [1.08-1.41],0.0016930170626764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX5,"Peroxiredoxin-5, mitochondrial",51074,342,1.07 [0.92-1.23],0.3890187576651239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX6,Peroxiredoxin-6,50950,341,1.01 [0.86-1.18],0.938981135309626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,49560,327,1.40 [1.05-1.86],0.0214733256352771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRELP,Prolargin,50485,337,1.67 [1.09-2.55],0.0183506781480246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG2,Bone marrow proteoglycan,43926,275,1.12 [0.90-1.39],0.3069873608368273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG3,Proteoglycan 3,43926,275,1.03 [0.83-1.30],0.7665228612431165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,49560,327,1.23 [1.04-1.45],0.0182723406580189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,42721,269,1.16 [0.82-1.65],0.3993626195897478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,50522,342,1.04 [0.93-1.17],0.5071317959793362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,43736,278,1.04 [0.90-1.20],0.5633573780539902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKCQ,Protein kinase C theta type,49560,327,1.20 [0.98-1.46],0.0783357900593523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKD2,Serine/threonine-protein kinase D2,42474,270,1.08 [0.85-1.38],0.5288453896464873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKG1,cGMP-dependent protein kinase 1,42966,266,1.04 [0.95-1.15],0.3575338373770259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,49332,331,1.02 [0.88-1.18],0.7688149081179748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRL,Prolactin,50968,342,1.23 [1.09-1.38],0.0005153824792289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRND,Prion-like protein doppel,43820,278,1.09 [0.88-1.35],0.444403607523567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROC,Vitamin K-dependent protein C,50641,343,0.88 [0.60-1.27],0.4851062929386859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROCR,Endothelial protein C receptor,42474,270,0.94 [0.67-1.33],0.7331723900188554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROK1,Prokineticin-1,50447,341,1.09 [0.93-1.28],0.2771335443590206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROS1,Vitamin K-dependent protein S,43988,277,0.53 [0.34-0.83],0.00550131527277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR4,Proline-rich protein 4,42648,263,1.09 [0.92-1.28],0.3107879672386892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR5,Proline-rich protein 5,42650,268,1.17 [0.93-1.47],0.1830179560033858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRRT3,Proline-rich transmembrane protein 3,42761,275,1.08 [0.80-1.46],0.5960235377880239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS2,Trypsin-2,50722,343,1.18 [0.99-1.39],0.0578400571141367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS22,Brain-specific serine protease 4,42650,268,1.06 [0.77-1.45],0.7358980826050536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS27,Serine protease 27,50359,342,1.21 [0.96-1.53],0.1057871593963718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS53,Serine protease 53,43820,278,1.19 [0.89-1.59],0.2378331432271409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,50318,340,1.67 [1.34-2.08],4.507846133570422e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,49337,326,1.03 [0.94-1.12],0.5544658329571777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTG,Protogenin,50950,341,1.26 [0.86-1.84],0.2380765810286775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTN3,Myeloblastin,49257,330,1.14 [0.95-1.38],0.166037752140327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRUNE2,Protein prune homolog 2,43124,274,1.22 [0.85-1.75],0.2857455422152244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAP,Prosaposin,43511,273,1.69 [1.21-2.36],0.0019451767471345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAPL1,Proactivator polypeptide-like 1,43736,277,1.10 [0.88-1.37],0.4128236753902167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSCA,Prostate stem cell antigen,43736,277,1.04 [0.99-1.08],0.1338283126430826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSG1,Pregnancy-specific beta-1-glycoprotein 1,50135,340,1.17 [1.07-1.29],0.0007171740562834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSIP1,PC4 and SFRS1-interacting protein,50447,341,1.09 [0.95-1.25],0.2255769818281184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMA1,Proteasome subunit alpha type-1,49332,331,0.90 [0.72-1.12],0.3405019546683996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMC3,26S proteasome regulatory subunit 6A,42355,265,1.12 [0.77-1.64],0.5572830390005468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD1,26S proteasome non-ATPase regulatory subunit 1,43847,277,1.02 [0.81-1.28],0.8872492856023978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD5,26S proteasome non-ATPase regulatory subunit 5,42721,269,0.93 [0.74-1.16],0.5120467473680663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD9,26S proteasome non-ATPase regulatory subunit 9,50286,339,0.82 [0.68-0.98],0.0301438329948107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME1,Proteasome activator complex subunit 1,50052,340,0.98 [0.75-1.26],0.8534541049914331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME2,Proteasome activator complex subunit 2,49902,339,1.00 [0.77-1.31],0.9786099612491012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG3,Proteasome assembly chaperone 3,50447,341,0.88 [0.73-1.07],0.1964423699751774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG4,Proteasome assembly chaperone 4,42650,268,0.84 [0.68-1.04],0.1082948347744205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSPN,Persephin,50447,341,1.05 [0.95-1.16],0.383071859036181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSRC1,Proline/serine-rich coiled-coil protein 1,49332,331,1.18 [1.02-1.38],0.0296764234867485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,41431,256,1.02 [0.91-1.14],0.7663624184198655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",49337,326,1.18 [0.85-1.63],0.3166201605549732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,50147,342,1.94 [1.49-2.52],8.2548492808424e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGES2,Prostaglandin E synthase 2,42326,267,1.34 [1.09-1.65],0.0048749110841764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGR1,Prostaglandin reductase 1,43925,280,1.07 [0.93-1.22],0.3313428550734667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH,Parathyroid hormone,42721,269,1.06 [0.92-1.22],0.4350868503676338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,50447,341,1.18 [0.95-1.46],0.1311719293964708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTK7,Inactive tyrosine-protein kinase 7,49337,326,1.39 [1.08-1.79],0.0114858299696952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTN,Pleiotrophin,49594,325,1.37 [1.14-1.66],0.0009090068858778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTP4A3,Protein tyrosine phosphatase type IVA 3,42650,268,1.00 [0.80-1.25],0.9787308233919094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,50135,340,1.10 [0.98-1.24],0.1121624179161093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,50654,338,1.05 [0.94-1.17],0.3763629838727499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,42572,268,0.95 [0.69-1.30],0.747834653021167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRB,Receptor-type tyrosine-protein phosphatase beta,43925,280,0.79 [0.54-1.16],0.2337397690703918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRC,Receptor-type tyrosine-protein phosphatase C,43926,275,1.97 [1.26-3.11],0.0032364979002247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRF,Receptor-type tyrosine-protein phosphatase F,51146,343,1.33 [0.96-1.85],0.086219173221296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRH,Receptor-type tyrosine-protein phosphatase H,43736,277,1.16 [0.92-1.46],0.221213596562989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,43736,277,1.95 [1.35-2.82],0.0003605926060029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRM,Receptor-type tyrosine-protein phosphatase mu,50365,340,1.24 [0.84-1.83],0.278573673754599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,49970,340,1.58 [1.19-2.09],0.0014100748182376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRR,Receptor-type tyrosine-protein phosphatase R,43820,278,1.03 [0.75-1.40],0.8748886052554086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRS,Receptor-type tyrosine-protein phosphatase S,51146,343,1.43 [0.98-2.09],0.062971711558031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,43925,280,1.32 [0.93-1.87],0.1164901026977371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,42966,266,1.00 [0.82-1.21],0.9643791444264914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTS,6-pyruvoyl tetrahydrobiopterin synthase,49104,326,1.15 [0.97-1.36],0.1088400881215385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTTG1,Securin,43124,274,0.96 [0.72-1.27],0.771371064100907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTX3,Pentraxin-related protein PTX3,50447,341,1.00 [0.82-1.21],0.972412635213675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVALB,Parvalbumin alpha,50721,341,1.00 [0.92-1.09],0.9802363213185789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVR,Poliovirus receptor,50968,342,1.22 [0.95-1.56],0.1219811512787458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXDNL,Peroxidasin-like protein,43716,280,1.03 [0.85-1.25],0.7419571437848961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXN,Paxillin,49337,326,1.14 [0.96-1.36],0.1339401475248827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYDC1,Pyrin domain-containing protein 1,42761,275,0.87 [0.65-1.17],0.3576842698692573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYY,Peptide YY,42474,270,1.12 [1.00-1.25],0.0562700548648665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PZP,Pregnancy zone protein,43988,277,0.86 [0.68-1.07],0.1725398140003322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QDPR,Dihydropteridine reductase,50278,341,1.07 [0.86-1.33],0.5633355538309386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QPCT,Glutaminyl-peptide cyclotransferase,50581,337,1.50 [1.06-2.13],0.0234891109345313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QSOX1,Sulfhydryl oxidase 1,43093,272,1.04 [0.78-1.37],0.8059118535841485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB10,Ras-related protein Rab-10,43925,280,1.07 [0.87-1.32],0.5255607581960202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB11FIP3,Rab11 family-interacting protein 3,43925,280,1.04 [0.93-1.15],0.4792817347710838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB27B,Ras-related protein Rab-27B,43925,280,1.03 [0.90-1.19],0.6736258258593049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB2B,Ras-related protein Rab-2B,43716,280,1.20 [1.00-1.44],0.0495972189949137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB33A,Ras-related protein Rab-33A,42474,270,1.08 [0.90-1.28],0.4122230226108309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB37,Ras-related protein Rab-37,49560,327,1.03 [0.92-1.16],0.6189873992690951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB39B,Ras-related protein Rab-39B,42474,270,1.08 [0.97-1.21],0.176901353305855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,42497,265,1.06 [0.87-1.29],0.547361735700395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB44,Ras-related protein Rab-44,43716,280,1.16 [0.94-1.43],0.1689985450203982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6A,Ras-related protein Rab-6A,50447,341,0.93 [0.76-1.14],0.4767509326080946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6B,Ras-related protein Rab-6B,49337,326,1.26 [1.06-1.50],0.0088787324087172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEP1,Rab GTPase-binding effector protein 1,42966,266,1.04 [0.90-1.21],0.5853022795499266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEPK,Rab9 effector protein with kelch motifs,49332,331,1.19 [1.03-1.38],0.0217692583703743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABGAP1L,Rab GTPase-activating protein 1-like,49560,327,1.04 [0.88-1.22],0.6446651803585511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAC3,Ras-related C3 botulinum toxin substrate 3,42721,269,1.03 [0.87-1.22],0.7096937037158426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD23B,UV excision repair protein RAD23 homolog B,49332,331,1.13 [0.92-1.39],0.2389604272072137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD51,DNA repair protein RAD51 homolog 1,43124,274,1.09 [0.90-1.33],0.3548214963870981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALB,Ras-related protein Ral-B,42650,268,1.16 [0.79-1.72],0.4460704742459854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALY,RNA-binding protein Raly,43716,280,1.08 [0.87-1.34],0.5027008602145017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP1,Ran-specific GTPase-activating protein,42761,275,0.91 [0.73-1.13],0.3927663311239662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP2,E3 SUMO-protein ligase RanBP2,42497,265,1.23 [0.88-1.73],0.2253556447667235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANGAP1,Ran GTPase-activating protein 1,49332,331,1.10 [0.90-1.33],0.3441978522940336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAP1A,Ras-related protein Rap-1A,42650,268,1.12 [0.97-1.29],0.1365311328872119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAPGEF2,Rap guanine nucleotide exchange factor 2,43124,274,1.17 [0.95-1.44],0.1412430534290889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES1,Retinoic acid receptor responder protein 1,49332,331,1.34 [1.06-1.68],0.0124540336422549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,50807,343,1.37 [1.14-1.64],0.0006753029407867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASA1,Ras GTPase-activating protein 1,49337,326,1.31 [1.00-1.71],0.0491899383685845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,42355,265,0.78 [0.59-1.03],0.0794272930189982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASSF2,Ras association domain-containing protein 2,49332,331,1.09 [0.93-1.27],0.2969023802738042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,43847,277,1.69 [1.38-2.08],5.710976513696764e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBKS,Ribokinase,49345,334,0.86 [0.72-1.04],0.1239363421980836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM17,Splicing factor 45,43847,277,1.05 [0.90-1.21],0.551865591442999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM19,Probable RNA-binding protein 19,42474,270,0.91 [0.70-1.19],0.4972718032522681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM25,RNA-binding protein 25,42355,265,0.95 [0.74-1.24],0.7243160968700812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP1,Retinol-binding protein 1,42721,269,1.09 [0.93-1.27],0.2908987375966922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP2,Retinol-binding protein 2,50286,339,1.28 [1.14-1.44],4.651434221950283e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP5,Retinol-binding protein 5,50286,339,1.28 [1.09-1.50],0.0022067847911317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP7,Retinoid-binding protein 7,43736,277,1.18 [1.00-1.40],0.0516542585084843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS,RNA-binding protein with multiple splicing,42650,268,1.05 [0.88-1.24],0.6017584497246887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS2,RNA-binding protein with multiple splicing 2,42761,275,1.03 [0.92-1.15],0.5845270024119236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCC1,Regulator of chromosome condensation,43716,280,1.14 [0.94-1.39],0.1913270684098256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCOR1,REST corepressor 1,49594,325,0.98 [0.78-1.23],0.8598052909282898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,42761,275,0.95 [0.55-1.67],0.8682630664632258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REEP4,Receptor expression-enhancing protein 4,43847,277,1.05 [0.88-1.26],0.5733281563720956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,50232,340,1.53 [1.30-1.79],2.477012753707835e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,51146,343,1.39 [1.21-1.61],5.153021696016794e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,51146,343,1.35 [1.18-1.55],1.6483699471382844e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3G,Regenerating islet-derived protein 3-gamma,43716,280,1.04 [0.78-1.37],0.8024965910046241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,50569,337,1.45 [1.22-1.74],4.249450773581493e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELB,Transcription factor RelB,42650,268,1.17 [0.95-1.44],0.1372574838575894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,50539,340,1.99 [1.47-2.69],9.510775692756208e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,50522,342,1.29 [1.16-1.44],1.556035482664118e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REPS1,RalBP1-associated Eps domain-containing protein 1,42650,268,1.05 [0.78-1.42],0.7255825738033916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REST,RE1-silencing transcription factor,42355,265,1.09 [0.78-1.50],0.6211789251885886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,50286,339,0.98 [0.77-1.25],0.8828267127042708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RETN,Resistin,50413,341,1.30 [1.05-1.60],0.016631870062522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REXO2,"Oligoribonuclease, mitochondrial",42474,270,1.08 [0.87-1.35],0.4844295983110006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RFC4,Replication factor C subunit 4,43716,280,1.16 [0.69-1.95],0.5646481727528486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGCC,Regulator of cell cycle RGCC,43847,277,1.02 [0.88-1.19],0.7547855233555778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,43124,274,1.08 [0.91-1.27],0.3929829087544523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMA,Repulsive guidance molecule A,50968,342,1.08 [0.80-1.46],0.5983362321245591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMB,RGM domain family member B,50968,342,1.34 [0.95-1.89],0.0980031955235962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS10,Regulator of G-protein signaling 10,43847,277,1.15 [0.96-1.38],0.1399246310239473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS8,Regulator of G-protein signaling 8,49560,327,0.97 [0.83-1.13],0.7031478535462109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RHOC,Rho-related GTP-binding protein RhoC,49837,335,1.06 [0.97-1.15],0.182996755522602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RICTOR,Rapamycin-insensitive companion of mTOR,42650,268,0.95 [0.73-1.22],0.670560742160345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,42966,266,1.05 [0.84-1.33],0.6495119402592997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILP,Rab-interacting lysosomal protein,50804,341,1.06 [0.90-1.24],0.4980778296213953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILPL2,RILP-like protein 2,43925,280,1.07 [0.95-1.20],0.2465670393586476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,42474,270,1.21 [1.05-1.38],0.0069858999853756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN1,Prorelaxin H1,43847,277,1.05 [0.87-1.25],0.626466324819565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN2,Prorelaxin H2,42887,264,1.06 [0.94-1.19],0.3628932500824187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE1,Ribonuclease pancreatic,43959,278,1.99 [1.43-2.77],4.4657863102123215e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE10,Inactive ribonuclease-like protein 10,42761,275,1.09 [0.86-1.37],0.4856071713394246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE3,Eosinophil cationic protein,50281,341,1.01 [0.93-1.10],0.8526924509069482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE4,Ribonuclease 4,42500,270,1.55 [1.06-2.28],0.0255400370041419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,43642,275,1.74 [1.39-2.17],1.423999171933174e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASEH2A,Ribonuclease H2 subunit A,43847,277,1.03 [0.82-1.30],0.7969307497367117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,50907,339,1.92 [1.41-2.61],3.750526929309226e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF149,E3 ubiquitin-protein ligase RNF149,42761,275,1.58 [1.12-2.21],0.0082558040258567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF168,E3 ubiquitin-protein ligase RNF168,42650,268,1.00 [0.75-1.34],0.9897588695825597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF31,E3 ubiquitin-protein ligase RNF31,42650,268,1.02 [0.74-1.40],0.919161207095288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF4,E3 ubiquitin-protein ligase RNF4,43124,274,0.95 [0.79-1.14],0.5466225235582473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF41,E3 ubiquitin-protein ligase NRDP1,49332,331,1.11 [0.96-1.28],0.1562495660497619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF43,E3 ubiquitin-protein ligase RNF43,43124,274,1.10 [0.92-1.32],0.2787357332500876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF5,E3 ubiquitin-protein ligase RNF5,42761,275,0.95 [0.81-1.12],0.5629215317751237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO1,Roundabout homolog 1,50569,337,2.07 [1.44-2.97],8.544715259209652e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO2,Roundabout homolog 2,50968,342,1.20 [0.80-1.81],0.3867721033496389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO4,Roundabout homolog 4,42761,275,0.76 [0.39-1.45],0.4009942475426471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,50522,342,1.38 [1.03-1.86],0.0311432270284629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RP2,Protein XRP2,50286,339,1.19 [0.95-1.47],0.124037252559984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPA2,Replication protein A 32 kDa subunit,42650,268,1.04 [0.71-1.50],0.851265777523644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPE,Ribulose-phosphate 3-epimerase,43124,274,1.05 [0.89-1.23],0.5781482925206194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPGR,X-linked retinitis pigmentosa GTPase regulator,42721,269,1.01 [0.77-1.34],0.9230085368146448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPL14,60S ribosomal protein L14,42761,275,0.99 [0.74-1.32],0.9299658746907528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPS10,40S ribosomal protein S10,42474,270,1.19 [0.93-1.52],0.1780075794529401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRAS,Ras-related protein R-Ras,42721,269,1.06 [0.97-1.16],0.214105304291464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2,Ribonucleoside-diphosphate reductase subunit M2,49332,331,1.16 [0.99-1.37],0.0727337175465377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,49332,331,1.00 [0.87-1.16],0.9735295461977213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRP15,RRP15-like protein,42497,265,0.98 [0.86-1.12],0.7899079469643064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO1,R-spondin-1,50135,340,1.40 [1.07-1.82],0.0136879921720158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,50950,341,1.75 [1.28-2.40],0.0004451310378256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTBDN,Retbindin,50286,339,1.11 [0.81-1.53],0.5178099776242155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTKN2,Rhotekin-2,42474,270,1.06 [0.86-1.31],0.6054689466933746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",43847,277,1.06 [0.94-1.20],0.335033662408554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4R,Reticulon-4 receptor,50950,341,1.23 [0.94-1.61],0.1356847662235418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RUVBL1,RuvB-like 1,49332,331,1.07 [0.98-1.17],0.1102492892542058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RWDD1,RWD domain-containing protein 1,50968,342,1.09 [0.94-1.26],0.2767763030626182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RYR1,Ryanodine receptor 1,42474,270,1.23 [0.92-1.64],0.1621975119177667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A11,Protein S100-A11,50121,339,1.08 [0.89-1.30],0.4573291334431743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A12,Protein S100-A12,49805,338,1.00 [0.88-1.14],0.9950245357768134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A13,Protein S100-A13,42650,268,1.29 [0.95-1.75],0.105514521436469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A14,Protein S100-A14,43847,277,1.19 [0.97-1.45],0.1009059621475449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A16,Protein S100-A16,49253,326,1.16 [1.00-1.35],0.0496255691820196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A3,Protein S100-A3,43716,280,1.00 [0.78-1.29],0.995859225108882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A4,Protein S100-A4,50678,342,0.94 [0.79-1.11],0.4432669250825148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100G,Protein S100-G,43847,277,1.11 [0.88-1.40],0.388570895614015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100P,Protein S100-P,49594,325,1.09 [0.92-1.29],0.310724163204936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAA4,Serum amyloid A-4 protein,43988,277,0.79 [0.48-1.30],0.3509488839470934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAFB2,Scaffold attachment factor B2,43847,277,1.33 [0.93-1.91],0.1239011340479298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAG,S-arrestin,42497,265,1.06 [0.85-1.33],0.5834759541920838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAMD9L,Sterile alpha motif domain-containing protein 9-like,50447,341,1.07 [0.93-1.21],0.3449505364815205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAP18,Histone deacetylase complex subunit SAP18,43124,274,1.06 [0.91-1.22],0.462896693691822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SARG,Specifically androgen-regulated gene protein,43755,279,1.04 [0.94-1.16],0.4212678935861941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SART1,U4/U6.U5 tri-snRNP-associated protein 1,42474,270,1.01 [0.75-1.38],0.929020965927244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT1,Diamine acetyltransferase 1,42474,270,1.06 [0.85-1.33],0.6086862439742126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT2,Thialysine N-epsilon-acetyltransferase,43124,274,1.25 [1.09-1.44],0.001191107759095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SATB1,DNA-binding protein SATB1,43847,277,1.60 [1.20-2.13],0.0015194403781673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SBSN,Suprabasin,43844,275,0.94 [0.67-1.31],0.7137109570303136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCAMP3,Secretory carrier-associated membrane protein 3,50286,339,1.11 [1.00-1.24],0.0596941793512495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,50968,342,1.72 [1.26-2.34],0.0005761304749323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB1,Scavenger receptor class B member 1,49337,326,1.21 [1.06-1.39],0.0064448160371866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,49178,336,1.99 [1.54-2.57],1.817495556113213e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF1,Scavenger receptor class F member 1,51146,343,1.35 [1.08-1.67],0.0078099452629296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,50968,342,1.80 [1.30-2.48],0.0003707227915187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG2,Secretogranin-2,50722,341,1.50 [1.13-1.99],0.0054910469939656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG3,Secretogranin-3,50569,337,1.53 [1.15-2.03],0.0036603884513294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB1A1,Uteroglobin,50569,340,1.10 [0.93-1.31],0.2690274877241447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB2A2,Mammaglobin-A,42474,270,0.97 [0.66-1.43],0.8844788218744055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A1,Secretoglobin family 3A member 1,42966,266,1.37 [0.87-2.18],0.1762050099156537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A2,Secretoglobin family 3A member 2,50654,338,1.04 [0.94-1.16],0.455095772403473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGN,Secretagogin,49560,327,1.30 [1.06-1.61],0.01251224785108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCIN,Adseverin,42497,265,1.00 [0.85-1.18],0.9771033509753084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCLY,Selenocysteine lyase,50804,341,1.14 [0.94-1.38],0.1879545322667775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2A,Sodium channel protein type 2 subunit alpha,42497,265,0.80 [0.60-1.06],0.1158487931541325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2B,Sodium channel subunit beta-2,42721,269,0.95 [0.62-1.43],0.7910778415282382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3A,Sodium channel protein type 3 subunit alpha,42721,269,1.09 [0.80-1.47],0.587616396315622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3B,Sodium channel subunit beta-3,42497,265,1.06 [0.84-1.34],0.6428694934377686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN4B,Sodium channel subunit beta-4,42761,275,0.96 [0.74-1.26],0.7945290523617692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCP2,Non-specific lipid-transfer protein,49332,331,0.99 [0.87-1.13],0.9085778018622216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCPEP1,Retinoid-inducible serine carboxypeptidase,42602,274,1.32 [1.06-1.65],0.0145748758653122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRG1,Scrapie-responsive protein 1,43925,280,1.39 [0.95-2.04],0.0887696144074711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRIB,Protein scribble homolog,42761,275,0.97 [0.85-1.11],0.6618192750303971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRN1,Secernin-1,50447,341,1.14 [0.96-1.34],0.1336470742107394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCT,Secretin,42721,269,0.91 [0.70-1.17],0.4431436940774996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,50522,342,1.50 [1.21-1.87],0.0002606056454651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC4,Syndecan-4,50522,342,1.07 [0.87-1.31],0.5348200348773111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDCCAG8,Serologically defined colon cancer antigen 8,43716,280,1.02 [0.93-1.13],0.6525789945686337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDHB,Succinate dehydrogenase,43736,277,1.21 [1.04-1.41],0.0132190931705938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDK2,Protein sidekick-2,42966,266,1.03 [0.76-1.40],0.8633038131792397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEC31A,Protein transport protein Sec31A,42761,275,1.00 [0.86-1.16],0.9983672290258075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEL1L,Protein sel-1 homolog 1,42761,275,1.30 [0.98-1.73],0.0705415250899194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELE,E-selectin,51146,343,1.10 [0.92-1.33],0.3012670653977188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELENOP,Selenoprotein P,43988,277,0.48 [0.29-0.81],0.0058530252737564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELL,L-selectin,43988,277,0.86 [0.52-1.41],0.5428634947083376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELP,P-selectin,50722,343,1.11 [0.94-1.31],0.2120433818161545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELPLG,P-selectin glycoprotein ligand 1,50447,341,1.02 [0.73-1.42],0.904752749916296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3F,Semaphorin-3F,50522,342,1.39 [0.97-1.98],0.0710170887954025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3G,Semaphorin-3G,42966,266,1.08 [0.83-1.40],0.5891223613656849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4C,Semaphorin-4C,50286,339,1.10 [0.79-1.52],0.585884152444836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4D,Semaphorin-4D,50968,342,1.21 [0.88-1.67],0.2366667934976827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA6C,Semaphorin-6C,42650,268,1.34 [0.90-1.98],0.1461520646624675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA7A,Semaphorin-7A,50981,343,1.37 [1.00-1.88],0.0519650992895403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN3,Neuronal-specific septin-3,43847,277,1.06 [0.91-1.23],0.45340147044274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN7,Septin-7,43124,274,0.91 [0.72-1.15],0.4301087714482594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN8,Septin-8,43735,276,1.40 [1.02-1.94],0.0381225979331761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN9,Septin-9,50286,339,1.10 [0.79-1.52],0.5753607918354389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA1,Alpha-1-antitrypsin,43162,270,1.65 [0.41-6.62],0.4779046957701069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA11,Serpin A11,51146,343,1.25 [0.99-1.58],0.0576970025609818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA12,Serpin A12,49068,334,1.07 [0.99-1.16],0.104481355357287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA3,Alpha-1-antichymotrypsin,43825,277,1.23 [0.58-2.61],0.5812000986398822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA4,Kallistatin,43177,272,0.91 [0.56-1.49],0.7208471878889867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA5,Plasma serine protease inhibitor,43342,270,0.92 [0.63-1.33],0.6533399192510294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA6,Corticosteroid-binding globulin,43988,277,2.09 [1.07-4.07],0.0308752177596079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA7,Thyroxine-binding globulin,43988,277,0.72 [0.39-1.34],0.3001293300861293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA9,Serpin A9,50047,338,1.08 [0.95-1.23],0.2399345922310559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB1,Leukocyte elastase inhibitor,50371,340,1.06 [0.96-1.18],0.2473645034539504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB5,Serpin B5,49594,325,1.14 [0.93-1.40],0.1990560380321676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB6,Serpin B6,50801,342,1.17 [1.00-1.37],0.0562211743852724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB8,Serpin B8,51074,342,1.10 [0.95-1.28],0.1985211409301909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB9,Serpin B9,50135,340,1.12 [0.84-1.50],0.4473234459820271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINC1,Antithrombin-III,43904,275,0.98 [0.45-2.11],0.949375716985314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPIND1,Heparin cofactor 2,43904,275,1.29 [0.86-1.94],0.2192241670738852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE1,Plasminogen activator inhibitor 1,51146,343,1.09 [0.95-1.26],0.2365834637112738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE2,Glia-derived nexin,43925,280,1.23 [1.04-1.46],0.0157822865462223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF1,Pigment epithelium-derived factor,43329,271,1.32 [0.86-2.03],0.2101707833669933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF2,Alpha-2-antiplasmin,43168,269,0.54 [0.23-1.27],0.1576657921170816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPING1,Plasma protease C1 inhibitor,43904,275,1.76 [0.95-3.24],0.0718100044183972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINH1,Serpin H1,43124,274,1.06 [0.97-1.16],0.21720266925641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI1,Neuroserpin,42886,266,1.13 [0.78-1.65],0.5194007896886046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI2,Serpin I2,43736,277,0.92 [0.75-1.13],0.4461677870516878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,49337,326,1.15 [0.99-1.33],0.0663632349365185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SETMAR,Histone-lysine N-methyltransferase SETMAR,49970,339,1.12 [0.82-1.54],0.4707023586909248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6,Seizure protein 6 homolog,42721,269,1.17 [0.81-1.68],0.4016206947017164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L,Seizure 6-like protein,50678,342,1.16 [0.82-1.63],0.4099036422404398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L2,Seizure 6-like protein 2,50286,339,1.19 [0.80-1.78],0.3904960614382082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SF3B4,Splicing factor 3B subunit 4,50286,339,1.07 [0.94-1.22],0.2939098598937759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,49970,339,1.39 [1.14-1.70],0.0011072216914509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP4,Secreted frizzled-related protein 4,42966,266,1.02 [0.76-1.36],0.9005968414197029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA1,Pulmonary surfactant-associated protein A1,49332,331,1.03 [0.87-1.22],0.6972500583091972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA2,Pulmonary surfactant-associated protein A2,49332,331,1.08 [0.90-1.30],0.427599548409444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPD,Pulmonary surfactant-associated protein D,50522,342,1.07 [0.93-1.24],0.3230897015542951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SGSH,N-sulphoglucosamine sulphohydrolase,43188,278,0.99 [0.80-1.21],0.8967914174321729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2B3,SH2B adapter protein 3,49332,331,1.06 [0.96-1.18],0.2280686639944895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2D1A,SH2 domain-containing protein 1A,50447,341,1.09 [0.94-1.27],0.2668611755994314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,42497,265,1.29 [1.12-1.49],0.0003995412681528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BP1,SH3 domain-binding protein 1,43736,277,1.07 [0.85-1.33],0.5791250438676285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GL3,Endophilin-A3,42878,273,1.02 [0.89-1.17],0.801785932592318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GLB2,Endophilin-B2,43820,278,0.99 [0.83-1.17],0.8874331367212066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHBG,Sex hormone-binding globulin,43959,278,1.02 [0.82-1.28],0.8465684425995488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHC1,SHC-transforming protein 1,42355,265,0.92 [0.83-1.03],0.1484221284510305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHD,SH2 domain-containing adapter protein D,42394,270,1.07 [0.94-1.21],0.2907815309174434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHH,Sonic hedgehog protein,42650,268,1.16 [0.90-1.50],0.2437516804191996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHISA5,Protein shisa-5,43926,275,1.65 [1.14-2.38],0.0079778967222072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHMT1,"Serine hydroxymethyltransferase, cytosolic",50654,338,1.01 [0.91-1.13],0.8049436647818309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHPK,Sedoheptulokinase,43124,274,1.08 [0.82-1.41],0.5755929941906877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIAE,Sialate O-acetylesterase,50593,341,1.33 [1.09-1.62],0.005457286841737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,50737,340,1.74 [1.41-2.15],2.774453891840388e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC10,Sialic acid-binding Ig-like lectin 10,50447,341,1.52 [1.17-1.97],0.0016436226963239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC15,Sialic acid-binding Ig-like lectin 15,49337,326,1.02 [0.90-1.15],0.8028953771313583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC5,Sialic acid-binding Ig-like lectin 5,50539,340,1.10 [1.00-1.20],0.0448901440452281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC6,Sialic acid-binding Ig-like lectin 6,50950,341,1.25 [0.94-1.66],0.1215058095774374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC7,Sialic acid-binding Ig-like lectin 7,50522,342,1.65 [1.18-2.30],0.0032749733537883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC8,Sialic acid-binding Ig-like lectin 8,42761,275,1.57 [1.22-2.00],0.0003481923617136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC9,Sialic acid-binding Ig-like lectin 9,50878,341,1.35 [0.98-1.85],0.0656078102707086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIL1,Nucleotide exchange factor SIL1,42761,275,0.90 [0.61-1.33],0.6015008401302417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,50655,342,1.20 [1.01-1.43],0.0389159587382939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPB1,Signal-regulatory protein beta-1,50400,337,1.43 [1.17-1.75],0.0005213351200217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT1,NAD-dependent protein deacetylase sirtuin-1,42650,268,1.01 [0.88-1.16],0.8367051944597158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT2,NAD-dependent protein deacetylase sirtuin-2,50286,339,1.09 [0.98-1.21],0.1302026674372748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",49337,326,1.06 [0.89-1.26],0.532413089724168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIT1,Signaling threshold-regulating transmembrane adapter 1,49560,327,1.20 [1.01-1.43],0.0385286256410583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP1,Src kinase-associated phosphoprotein 1,50052,340,0.99 [0.86-1.12],0.823789872575778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP2,Src kinase-associated phosphoprotein 2,50737,340,1.05 [0.96-1.15],0.2554049691559393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKIV2L,Helicase SKI2W,42474,270,1.06 [0.80-1.41],0.6685259771176076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLA2,Src-like-adapter 2,43847,277,1.01 [0.90-1.13],0.878299403271126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,49560,327,1.44 [1.22-1.70],1.555703721012711e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF6,SLAM family member 6,49332,331,1.37 [1.07-1.74],0.0116702507994432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF7,SLAM family member 7,50447,341,1.28 [1.09-1.49],0.0023143057590869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF8,SLAM family member 8,49332,331,1.36 [1.13-1.64],0.0010741479181699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC12A2,Solute carrier family 12 member 2,42474,270,1.09 [0.73-1.63],0.6670921792401729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC13A1,Solute carrier family 13 member 1,43716,280,1.11 [0.95-1.31],0.1943579701314786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC16A1,Monocarboxylate transporter 1,49337,326,1.22 [1.05-1.41],0.0075386951096276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC1A4,Neutral amino acid transporter A,42721,269,1.15 [0.94-1.42],0.1775733666358261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC27A4,Long-chain fatty acid transport protein 4,49337,326,1.20 [1.05-1.36],0.0054344483488839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC28A1,Sodium/nucleoside cotransporter 1,42355,265,1.15 [0.97-1.37],0.1055901243764938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC34A3,Sodium-dependent phosphate transport protein 2C,42355,265,0.80 [0.60-1.06],0.1181135591554272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A14,Zinc transporter ZIP14,49337,326,1.51 [1.19-1.92],0.0007011867670474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A5,Zinc transporter ZIP5,50447,341,1.05 [0.88-1.26],0.5622725966759324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC44A4,Choline transporter-like protein 4,42721,269,1.05 [0.90-1.24],0.5271723878131791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC4A1,Band 3 anion transport protein,43926,275,0.83 [0.65-1.07],0.1459172856292586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC51B,Organic solute transporter subunit beta,42474,270,1.08 [0.94-1.25],0.2878080557550684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,42966,266,1.08 [0.94-1.24],0.2502411094074547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,43736,277,1.18 [0.98-1.42],0.0785558977097895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",42355,265,1.20 [1.01-1.43],0.0414797887886555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIT2,Slit homolog 2 protein,49337,326,1.06 [0.88-1.27],0.5216202162001762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK1,SLIT and NTRK-like protein 1,42650,268,0.74 [0.51-1.06],0.0996714659065984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK2,SLIT and NTRK-like protein 2,50950,341,1.22 [0.95-1.55],0.1128794353641107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK6,SLIT and NTRK-like protein 6,49594,325,1.24 [0.94-1.63],0.133097446896624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLK,STE20-like serine/threonine-protein kinase,43124,274,1.04 [0.90-1.19],0.6267066503884476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLMAP,Sarcolemmal membrane-associated protein,43736,277,1.12 [0.98-1.28],0.0929872853549551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLURP1,Secreted Ly-6/uPAR-related protein 1,43606,273,1.19 [0.90-1.56],0.2253262531142681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD1,Mothers against decapentaplegic homolog 1,49332,331,1.11 [0.99-1.25],0.0744004956626675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD2,Mothers against decapentaplegic homolog 2,43716,280,1.11 [0.95-1.31],0.1881896790156462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD3,Mothers against decapentaplegic homolog 3,43716,280,1.06 [0.85-1.32],0.6075080629033732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD5,Mothers against decapentaplegic homolog 5,50286,339,1.18 [0.72-1.91],0.5101347351142469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMARCA2,Probable global transcription activator SNF2L2,49337,326,1.04 [0.91-1.19],0.5685919124440995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMC3,Structural maintenance of chromosomes protein 3,42355,265,0.85 [0.67-1.08],0.1789760141259968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMNDC1,Survival of motor neuron-related-splicing factor 30,43736,277,1.11 [0.94-1.31],0.2193927910321974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC1,SPARC-related modular calcium-binding protein 1,50950,341,1.40 [1.05-1.85],0.0201008400682702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC2,SPARC-related modular calcium-binding protein 2,50737,340,1.28 [1.00-1.62],0.0482832694975955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD1,Sphingomyelin phosphodiesterase,50720,342,1.11 [0.92-1.34],0.2861429137306316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD3,Sphingomyelin phosphodiesterase 3,42650,268,1.02 [0.83-1.25],0.8675991201714615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,50652,340,0.96 [0.83-1.11],0.5587657453161867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,43716,280,0.96 [0.82-1.13],0.6467596500689745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMS,Spermine synthase,42497,265,1.00 [0.84-1.21],0.9629542744745094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMTN,Smoothelin,43735,278,1.01 [0.90-1.14],0.81153494806669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP23,Synaptosomal-associated protein 23,50522,342,1.03 [0.92-1.15],0.5970259626590267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP25,Synaptosomal-associated protein 25,42497,265,1.23 [0.96-1.57],0.0965859262542414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP29,Synaptosomal-associated protein 29,50678,342,1.10 [0.99-1.22],0.0692677565399847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAPIN,SNARE-associated protein Snapin,43847,277,1.05 [0.86-1.28],0.6188976161247395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCA,Alpha-synuclein,42966,266,0.97 [0.87-1.07],0.5289226948748078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCG,Gamma-synuclein,50135,340,1.13 [0.98-1.30],0.1028477420544074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",42761,275,1.09 [0.77-1.53],0.628958475449992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNRPB2,U2 small nuclear ribonucleoprotein B'',43820,278,1.16 [0.94-1.42],0.1607151719516152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNU13,NHP2-like protein 1,42474,270,1.02 [0.85-1.22],0.8140204416325688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX15,Sorting nexin-15,42966,266,0.98 [0.79-1.22],0.8795622018919619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX18,Sorting nexin-18,43736,277,1.21 [0.96-1.53],0.1078622872677593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX2,Sorting nexin-2,43716,280,1.09 [0.95-1.24],0.2165636780338902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX5,Sorting nexin-5,42761,275,1.04 [0.70-1.52],0.8609608395405695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX9,Sorting nexin-9,50522,342,1.11 [0.97-1.28],0.1283727118073657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD1,Superoxide dismutase [Cu-Zn],49512,340,0.97 [0.79-1.18],0.7548563070735429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD2,"Superoxide dismutase [Mn], mitochondrial",50539,340,1.48 [1.18-1.85],0.0005832122508653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD3,Extracellular superoxide dismutase,43959,278,0.96 [0.79-1.18],0.7221941763316171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORBS1,Sorbin and SH3 domain-containing protein 1,43847,277,1.29 [1.02-1.61],0.0297897304303515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,49332,331,1.82 [1.41-2.34],3.0585028315924617e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORD,Sorbitol dehydrogenase,50721,340,1.00 [0.87-1.15],0.955151865004195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORT1,Sortilin,50447,342,1.27 [0.99-1.63],0.0616775968138483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOST,Sclerostin,50447,342,0.92 [0.72-1.17],0.4995255905323351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,42721,269,1.11 [0.90-1.38],0.3122172276347741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX2,Transcription factor SOX-2,43767,277,0.81 [0.49-1.33],0.3967938489896081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX9,Transcription factor SOX-9,42721,269,1.38 [0.90-2.13],0.1422287158223988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,43847,277,1.32 [0.95-1.84],0.095216495348402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPAG1,Sperm-associated antigen 1,43847,277,0.99 [0.82-1.21],0.9540903824123168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARC,SPARC,50678,342,1.03 [0.90-1.18],0.6960011624749185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARCL1,SPARC-like protein 1,50552,343,1.13 [0.81-1.57],0.48803666590412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPART,Spartin,42966,266,1.06 [0.91-1.24],0.419291116276379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPESP1,Sperm equatorial segment protein 1,43925,280,1.07 [0.75-1.54],0.704849111968384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,50539,340,1.64 [1.36-1.99],3.227310640350087e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK2,Serine protease inhibitor Kazal-type 2,42966,266,1.17 [0.87-1.57],0.3138021037726937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK4,Serine protease inhibitor Kazal-type 4,50447,341,1.13 [0.98-1.30],0.0843107590373781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK5,Serine protease inhibitor Kazal-type 5,50539,340,1.29 [0.98-1.70],0.0741940629650108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK6,Serine protease inhibitor Kazal-type 6,50950,341,1.35 [1.12-1.62],0.0012237187562639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK8,Serine protease inhibitor Kazal-type 8,42474,270,1.03 [0.76-1.41],0.8378422147594684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,50373,340,2.01 [1.45-2.78],2.61030589767852e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT2,Kunitz-type protease inhibitor 2,50737,340,1.62 [1.28-2.05],5.188110758317064e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT3,Kunitz-type protease inhibitor 3,43736,277,0.96 [0.89-1.04],0.2939979572861291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPOCK1,Testican-1,50135,340,0.85 [0.59-1.23],0.3882110116345812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,50569,337,1.81 [1.42-2.31],2.248577247307502e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,50281,341,2.26 [1.75-2.92],5.212708673396632e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,51066,343,1.49 [1.22-1.82],9.603902905057485e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",42650,268,0.98 [0.75-1.29],0.9059404751758514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRING1,SREBP regulating gene protein,42355,265,1.02 [0.83-1.24],0.8757292701621613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR1B,Cornifin-B,43124,274,1.00 [0.87-1.15],0.9805798756932942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR3,Small proline-rich protein 3,43820,278,1.02 [0.87-1.21],0.7755837205639764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRY2,Protein sprouty homolog 2,49560,327,1.06 [0.95-1.18],0.2751824853979968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",42497,265,0.95 [0.66-1.38],0.7904903440152246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTLC1,Serine palmitoyltransferase 1,43820,278,1.29 [1.01-1.65],0.0452218958520422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRC,Proto-oncogene tyrosine-protein kinase Src,50593,342,1.06 [0.98-1.15],0.1600345110023157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRP14,Signal recognition particle 14 kDa protein,50286,339,1.12 [0.96-1.31],0.148189781038026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPK2,SRSF protein kinase 2,50447,341,1.07 [0.95-1.19],0.2594987001474493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,43925,280,1.69 [1.23-2.34],0.0013144466969794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSB,Lupus La protein,49337,326,0.93 [0.77-1.11],0.401374229958321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",42650,268,1.16 [0.85-1.58],0.3444842290038618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,50447,342,0.96 [0.88-1.04],0.2723799037362094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,50722,343,1.08 [0.86-1.35],0.5210986514668876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSH3,Protein phosphatase Slingshot homolog 3,42355,265,0.82 [0.53-1.25],0.3492474379038746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSNA1,Sjoegren syndrome nuclear autoantigen 1,43736,277,1.24 [1.01-1.54],0.041078451456493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST13,Hsc70-interacting protein,42966,266,0.91 [0.74-1.13],0.4057972148848859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",50286,339,1.10 [0.89-1.37],0.3769679794972768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",51146,343,1.63 [1.22-2.17],0.0009638384388782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",42650,268,1.00 [0.79-1.28],0.9695945457643204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAB2,Stabilin-2,43926,275,1.22 [0.81-1.83],0.33700378321851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAM,Signal transducing adapter molecule 1,43716,280,1.00 [0.74-1.36],0.9994227466236252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAMBP,STAM-binding protein,50052,340,1.10 [0.95-1.28],0.2096202094365016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT2,Signal transducer and activator of transcription 2,42650,268,1.08 [0.93-1.26],0.3202051231456679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT5B,Signal transducer and activator of transcription 5B,50286,339,1.01 [0.95-1.09],0.6820293576020721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,42355,265,1.17 [1.00-1.37],0.0551402807045364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC1,Stanniocalcin-1,50968,342,1.29 [1.05-1.58],0.0157339778230104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC2,Stanniocalcin-2,50470,339,1.43 [0.97-2.11],0.0691902316718308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STEAP4,Metalloreductase STEAP4,42497,265,0.90 [0.75-1.08],0.2510587924238119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STIP1,Stress-induced-phosphoprotein 1,50455,340,1.09 [0.94-1.26],0.2556466939875154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK11,Serine/threonine-protein kinase STK11,49594,325,1.07 [0.94-1.22],0.3199307493951922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK24,Serine/threonine-protein kinase 24,49337,326,1.08 [0.93-1.27],0.3147490527293133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK4,Serine/threonine-protein kinase 4,50522,342,1.09 [0.97-1.21],0.1434973092564969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STOML2,"Stomatin-like protein 2, mitochondrial",42355,265,1.00 [0.88-1.14],0.9763766532510376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX16,Syntaxin-16,49332,331,1.12 [0.95-1.31],0.1799561385068166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX1B,Syntaxin-1B,42721,269,1.01 [0.76-1.33],0.9454758841274998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX3,Syntaxin-3,43820,278,0.91 [0.67-1.25],0.5678926724954689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX4,Syntaxin-4,50286,339,1.20 [1.05-1.38],0.0083917694272971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX5,Syntaxin-5,42650,268,1.12 [0.86-1.46],0.3946882074715008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX6,Syntaxin-6,49332,331,1.15 [1.00-1.31],0.0476837142382671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX7,Syntaxin-7,42650,268,0.86 [0.68-1.10],0.230211311503539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX8,Syntaxin-8,50447,341,1.14 [0.94-1.38],0.1876450528195967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP1,Syntaxin-binding protein 1,43847,277,1.00 [0.86-1.16],0.9869733964193432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP3,Syntaxin-binding protein 3,49332,331,1.17 [0.95-1.44],0.1479346345915226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGP1,SURP and G-patch domain-containing protein 1,43736,277,1.16 [0.88-1.52],0.2985627196887521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGT1,Protein SGT1 homolog,49332,331,1.09 [0.97-1.24],0.1542225134226944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT1A1,Sulfotransferase 1A1,50968,342,1.05 [0.98-1.14],0.1739608517763377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT2A1,Bile salt sulfotransferase,50447,341,1.14 [0.98-1.33],0.0850880105025338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF1,Formylglycine-generating enzyme,42650,268,1.07 [0.91-1.26],0.3944216209106196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,50968,342,1.20 [0.99-1.44],0.0588162823056583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUOX,"Sulfite oxidase, mitochondrial",43847,277,1.19 [1.00-1.41],0.045991399631419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD1,Sushi domain-containing protein 1,49594,325,1.12 [0.91-1.38],0.2713435030137848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD2,Sushi domain-containing protein 2,50539,340,1.21 [0.88-1.67],0.2449554971883995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD4,Sushi domain-containing protein 4,43716,280,1.18 [0.91-1.52],0.214925198109852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD5,Sushi domain-containing protein 5,42726,266,1.00 [0.71-1.40],0.990911442652132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SV2A,Synaptic vesicle glycoprotein 2A,42721,269,1.23 [1.04-1.45],0.014347978810455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SWAP70,Switch-associated protein 70,43736,277,1.42 [1.08-1.86],0.0109730529234724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYAP1,Synapse-associated protein 1,42966,266,1.04 [0.85-1.28],0.6769293527559128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,42497,265,1.02 [0.83-1.24],0.8814935076597618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYT1,Synaptotagmin-1,43820,278,1.06 [0.80-1.40],0.673245869442924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYTL4,Synaptotagmin-like protein 4,43925,280,1.09 [0.94-1.27],0.2658757853408896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,43124,274,1.04 [0.93-1.16],0.4731877896559009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACC3,Transforming acidic coiled-coil-containing protein 3,50286,339,1.03 [0.95-1.11],0.5405408060760017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACSTD2,Tumor-associated calcium signal transducer 2,44748,307,0.98 [0.69-1.38],0.8902677602830856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TADA3,Transcriptional adapter 3,43716,280,1.15 [0.86-1.52],0.3463231916159692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,50286,339,1.58 [1.23-2.02],0.0002943566863485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAGLN3,Transgelin-3,42355,265,1.02 [0.84-1.23],0.8804912868817062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TALDO1,Transaldolase,43762,275,1.08 [0.84-1.39],0.5628691356065971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TANK,TRAF family member-associated NF-kappa-B activator,49560,327,1.12 [0.97-1.28],0.1227457543332021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAP1,Antigen peptide transporter 1,43124,274,1.00 [0.83-1.22],0.9644439126339132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARBP2,RISC-loading complex subunit TARBP2,49337,326,1.10 [0.98-1.25],0.1155669846336192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",42721,269,0.87 [0.73-1.04],0.1170215957997591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",43716,280,1.22 [0.91-1.64],0.1757819993224313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAX1BP1,Tax1-binding protein 1,43820,278,1.02 [0.85-1.22],0.8355398163249053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D17,TBC1 domain family member 17,49337,326,1.10 [0.89-1.36],0.3639562784752833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D23,TBC1 domain family member 23,50286,339,1.06 [0.95-1.18],0.270604769970611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D5,TBC1 domain family member 5,50447,341,1.02 [0.90-1.15],0.7833206854366849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCA,Tubulin-specific chaperone A,42966,266,1.03 [0.89-1.18],0.7240409641488983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCB,Tubulin-folding cofactor B,50135,340,1.07 [0.97-1.18],0.1471379001999234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCC,Tubulin-specific chaperone C,50135,340,1.09 [0.97-1.23],0.1647894972139932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBL1X,F-box-like/WD repeat-containing protein TBL1X,49332,331,1.14 [1.02-1.28],0.0258257612984626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBR1,T-box brain protein 1,42721,269,1.04 [0.82-1.31],0.7354204172646753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1A,T-cell leukemia/lymphoma protein 1A,50061,340,0.97 [0.88-1.06],0.4661468288174811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1B,T-cell leukemia/lymphoma protein 1B,49594,325,1.01 [0.89-1.14],0.917695000490896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN1,Transcobalamin-1,43066,271,1.22 [0.89-1.69],0.218551914432895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,51066,343,1.68 [1.28-2.20],0.0002109925173116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCOF1,Treacle protein,43925,280,1.29 [0.93-1.78],0.1208902693887254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCP11,T-complex protein 11 homolog,43124,274,1.01 [0.83-1.23],0.94066994163693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCTN3,Tectonic-3,43925,280,1.26 [0.86-1.84],0.2345242838351743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDGF1,Teratocarcinoma-derived growth factor 1,49337,326,1.02 [0.95-1.09],0.5966817995407165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDO2,"Tryptophan 2,3-dioxygenase",42721,269,1.06 [0.79-1.41],0.7146764976787107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDP1,Tyrosyl-DNA phosphodiesterase 1,43716,280,1.04 [0.89-1.22],0.6404304986755467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDRKH,Tudor and KH domain-containing protein,49337,326,1.14 [1.02-1.28],0.0196393249635174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEF,Thyrotroph embryonic factor,42474,270,1.10 [0.85-1.42],0.4880670343177012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEK,Angiopoietin-1 receptor,50678,342,1.18 [0.76-1.82],0.4598802705538162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TERF1,Telomeric repeat-binding factor 1,42650,268,1.12 [0.76-1.64],0.5810013616690374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TET2,Methylcytosine dioxygenase TET2,43044,274,1.09 [0.98-1.20],0.1058993525348314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX101,Testis-expressed protein 101,42721,269,1.03 [0.82-1.29],0.8237493938095868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX33,Testis-expressed protein 33,43124,274,1.22 [0.96-1.55],0.0955573792174058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TF,Serotransferrin,43988,277,1.22 [0.72-2.06],0.4599710612378654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFAP2A,Transcription factor AP-2-alpha,42497,265,1.03 [0.85-1.26],0.7287811469729972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,50288,339,1.25 [1.12-1.39],4.786704206393547e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,50654,338,1.40 [1.20-1.63],1.6833609923657678e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,50471,341,1.34 [1.12-1.59],0.0012111608774286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI,Tissue factor pathway inhibitor,50394,342,1.00 [0.74-1.36],0.9878881376219152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI2,Tissue factor pathway inhibitor 2,50526,342,1.28 [1.06-1.55],0.0088676170690237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFRC,Transferrin receptor protein 1,50724,343,0.96 [0.75-1.24],0.771419200262731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TG,Thyroglobulin,43716,280,0.99 [0.90-1.10],0.8734834963682967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,50447,341,1.53 [1.27-1.84],6.5886920213396e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB1,Transforming growth factor beta-1 proprotein,50991,340,1.43 [1.13-1.81],0.0027500793604201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB2,Transforming growth factor beta-2 proprotein,43716,280,1.01 [0.81-1.25],0.931910865162504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBI,Transforming growth factor-beta-induced protein ig-h3,50231,342,1.14 [0.80-1.61],0.4726189179800016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR1,TGF-beta receptor type-1,42650,268,1.08 [0.64-1.82],0.7821565669624893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,50678,342,1.72 [1.34-2.21],1.9209383226778977e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR3,Transforming growth factor beta receptor type 3,51146,343,1.77 [1.30-2.40],0.0002534396748383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGM2,Protein-glutamine gamma-glutamyltransferase 2,50441,342,0.90 [0.79-1.02],0.0892555667169359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGOLN2,Trans-Golgi network integral membrane protein 2,43959,278,1.98 [1.31-3.00],0.0011724691669119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THAP12,52 kDa repressor of the inhibitor of the protein kinase,42279,265,0.97 [0.84-1.11],0.6579043176873598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBD,Thrombomodulin,50522,342,1.56 [1.14-2.14],0.0059320464090976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,50539,340,1.60 [1.29-2.00],2.89933614424192e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS4,Thrombospondin-4,50559,342,1.13 [0.92-1.39],0.249594793952337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THOP1,Thimet oligopeptidase,50282,341,0.91 [0.67-1.23],0.5374339424880653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THPO,Thrombopoietin,49594,325,1.27 [0.99-1.63],0.0589225434836042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THRAP3,Thyroid hormone receptor-associated protein 3,42474,270,1.08 [0.98-1.18],0.1285949065082167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THSD1,Thrombospondin type-1 domain-containing protein 1,42329,268,1.23 [0.89-1.71],0.2184363984597797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THTPA,Thiamine-triphosphatase,43632,279,1.04 [0.91-1.19],0.5454732419199158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THY1,Thy-1 membrane glycoprotein,50968,342,1.63 [1.18-2.25],0.0030955919262964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIA1,Nucleolysin TIA-1 isoform p40,49040,320,1.04 [0.96-1.13],0.3574523976763578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIE1,Tyrosine-protein kinase receptor Tie-1,51146,343,1.13 [0.89-1.43],0.3258027116281102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",49254,326,1.20 [0.99-1.47],0.0681041259123423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,43124,274,1.18 [0.89-1.58],0.2464550208496386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,50722,343,1.16 [0.93-1.44],0.1814676635952183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,43925,280,1.23 [0.94-1.62],0.1298019960679899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,43820,278,1.07 [0.93-1.22],0.3471148776980624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,49975,340,2.11 [1.58-2.82],4.07480645307861e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP2,Metalloproteinase inhibitor 2,43925,280,1.24 [0.88-1.75],0.2153812345199656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP3,Metalloproteinase inhibitor 3,50737,340,1.10 [1.03-1.18],0.0075937376148522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,50539,340,1.53 [1.23-1.90],0.0001094522935221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TINAGL1,Tubulointerstitial nephritis antigen-like,50365,342,1.36 [0.88-2.09],0.1606346065384167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJAP1,Tight junction-associated protein 1,50678,342,1.06 [0.95-1.19],0.2971961384842113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJP3,Tight junction protein ZO-3,42497,265,1.13 [0.87-1.46],0.3643774664438803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TK1,"Thymidine kinase, cytosolic",43124,274,1.08 [0.84-1.38],0.5418600803146925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR1,Toll-like receptor 1,42650,268,1.61 [1.08-2.41],0.0199727923101651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR2,Toll-like receptor 2,43124,274,1.81 [1.13-2.90],0.0142023614095956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR3,Toll-like receptor 3,51074,342,1.12 [0.95-1.31],0.1721734761784426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR4,Toll-like receptor 4,42650,268,0.98 [0.65-1.49],0.9215130769471592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,42721,269,1.17 [0.96-1.43],0.124770949139929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED1,Transmembrane emp24 domain-containing protein 1,43124,274,0.79 [0.63-1.01],0.055029953506494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED10,Transmembrane emp24 domain-containing protein 10,42474,270,0.98 [0.76-1.26],0.8738190532290173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED4,Transmembrane emp24 domain-containing protein 4,42474,270,0.81 [0.63-1.03],0.0840580358460964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED8,Protein TMED8,43736,277,1.08 [0.96-1.20],0.2036434228088693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM106A,Transmembrane protein 106A,43716,280,1.14 [0.98-1.33],0.0948036550046206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM132A,Transmembrane protein 132A,42761,275,1.07 [0.89-1.28],0.4659863257081578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM25,Transmembrane protein 25,43847,277,1.02 [0.80-1.31],0.8542120535757043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMOD4,Tropomodulin-4,42355,265,1.03 [0.77-1.38],0.8581289113439303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11B,Transmembrane protease serine 11B,42497,265,0.90 [0.76-1.07],0.2424411169872603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11D,Transmembrane protease serine 11D,43735,276,1.57 [1.23-2.01],0.0003381360555253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS15,Enteropeptidase,50286,339,1.07 [0.97-1.19],0.1847066296566791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS5,Transmembrane protease serine 5,49893,338,1.37 [1.06-1.77],0.0158964444627563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMSB10,Thymosin beta-10,50539,340,1.20 [1.06-1.36],0.005171719532819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNC,Tenascin,50722,343,1.24 [1.02-1.50],0.0301791173296263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNF,Tumor necrosis factor,49516,324,1.33 [1.09-1.63],0.004456190844781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,43736,277,1.28 [1.03-1.58],0.0236147518728103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,49560,327,1.04 [0.80-1.35],0.7842884254801887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,42966,266,1.04 [0.87-1.25],0.6454353464802624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,50135,340,2.01 [1.62-2.48],9.673140538500256e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,50135,340,1.33 [1.18-1.51],6.219402416591327e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,50652,342,1.09 [0.89-1.32],0.4112043832382753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,51074,342,1.90 [1.53-2.36],5.617633336698939e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,50485,337,1.68 [1.24-2.29],0.0008898555154859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,50678,342,1.93 [1.52-2.45],7.749628199935862e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,50569,337,1.60 [1.29-1.99],2.458123051232661e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,49560,327,1.14 [0.91-1.44],0.24141156704222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,50569,337,2.27 [1.72-2.98],5.3723431393966234e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,42966,266,1.17 [0.88-1.55],0.2781178563665675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,50950,341,1.86 [1.44-2.41],2.0018723406280524e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,50539,340,2.48 [1.89-3.24],3.795343559711576e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,50539,340,1.64 [1.41-1.91],1.119810288610828e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,50968,342,1.64 [1.18-2.29],0.0032213209294076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,50991,340,1.78 [1.43-2.23],2.7652325102774364e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,50135,340,1.45 [1.25-1.67],6.623689104374647e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,50968,342,1.31 [1.07-1.59],0.0076215096714565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,50135,340,1.59 [1.33-1.91],5.82352034327e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF10,Tumor necrosis factor ligand superfamily member 10,51074,342,0.99 [0.69-1.43],0.9630178217129522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF11,Tumor necrosis factor ligand superfamily member 11,50447,341,1.02 [0.87-1.19],0.8037927972054714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF12,Tumor necrosis factor ligand superfamily member 12,51074,342,0.70 [0.50-0.98],0.0373022916932669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,50737,340,2.17 [1.55-3.04],7.51472979709897e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,51064,343,2.03 [1.53-2.68],7.618505630789492e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF14,Tumor necrosis factor ligand superfamily member 14,50135,340,1.08 [0.92-1.28],0.3503852998506357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF8,Tumor necrosis factor ligand superfamily member 8,43926,275,1.56 [1.15-2.10],0.0039436632120619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNIP1,TNFAIP3-interacting protein 1,43820,278,0.99 [0.87-1.12],0.8239964115245653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNN,Tenascin-N,43926,275,1.08 [0.83-1.40],0.5617452050223114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNNI3,"Troponin I, cardiac muscle",49594,325,1.03 [0.91-1.16],0.6149981230127568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNPO1,Transportin-1,43124,274,0.85 [0.61-1.19],0.341798869352612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNR,Tenascin-R,50135,340,0.84 [0.67-1.05],0.1268195823708516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNXB,Tenascin-X,50539,340,1.11 [0.77-1.61],0.5716356203702411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,43925,280,1.11 [0.96-1.28],0.1427384860014383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1,DNA topoisomerase 1,43736,277,0.98 [0.89-1.09],0.7508658508040765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1MT,"DNA topoisomerase I, mitochondrial",42355,265,0.93 [0.72-1.19],0.5624463099764688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP2B,DNA topoisomerase 2-beta,42650,268,0.99 [0.86-1.15],0.9301106206761378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOR1AIP1,Torsin-1A-interacting protein 1,42761,275,1.14 [0.94-1.40],0.1825404585274118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53,Cellular tumor antigen p53,49332,331,1.25 [1.00-1.55],0.0472344552182453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53BP1,TP53-binding protein 1,42650,268,1.10 [0.96-1.25],0.1689337515888996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53I3,Quinone oxidoreductase PIG3,42028,259,0.99 [0.79-1.24],0.922181182916709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53INP1,Tumor protein p53-inducible nuclear protein 1,49594,325,0.99 [0.72-1.36],0.943611344711108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP73,Tumor protein p73,42721,269,0.95 [0.68-1.34],0.7748300009118774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPBGL,Trophoblast glycoprotein-like,42721,269,0.94 [0.70-1.26],0.6910786348287954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPD52L2,Tumor protein D54,42966,266,1.02 [0.92-1.14],0.7040141799790014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPK1,Thiamin pyrophosphokinase 1,43925,280,1.45 [0.96-2.18],0.0747696414373177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPM3,Tropomyosin alpha-3 chain,42474,270,1.07 [0.82-1.38],0.6300376017576058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPMT,Thiopurine S-methyltransferase,49332,331,0.90 [0.78-1.03],0.1180593079647273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPP1,Tripeptidyl-peptidase 1,50149,335,1.30 [1.08-1.57],0.0067311102424271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP2,Tubulin polymerization-promoting protein family member 2,43124,274,0.96 [0.83-1.12],0.6348030185581872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP3,Tubulin polymerization-promoting protein family member 3,49337,326,0.90 [0.69-1.17],0.4290621045434126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPR,Nucleoprotein TPR,42474,270,1.15 [0.94-1.41],0.1638288113538556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPRKB,EKC/KEOPS complex subunit TPRKB,42355,265,1.01 [0.84-1.21],0.9478502953064736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSAB1,Tryptase alpha/beta-1,50991,342,1.41 [1.17-1.70],0.0002527839874164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSD1,Tryptase delta,43847,277,1.29 [1.01-1.66],0.0435489486134254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSG1,Tryptase gamma,42650,268,1.08 [0.71-1.65],0.7253003535087743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPT1,Translationally-controlled tumor protein,49560,327,0.99 [0.85-1.15],0.9131121999172572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF2,TNF receptor-associated factor 2,50447,341,1.01 [0.88-1.15],0.9141983412047446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3,"TNF receptor-associated factor 3, Isoform 2",42650,268,1.08 [0.80-1.46],0.6249552049778591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,42474,270,0.91 [0.70-1.18],0.4738399436383415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,43124,274,1.01 [0.89-1.16],0.8440675715692278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREH,Trehalase,43926,275,1.04 [0.89-1.22],0.5927509084124012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,50485,337,1.51 [1.27-1.79],2.362412094663252e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML1,Trem-like transcript 1 protein,43959,278,1.18 [0.96-1.46],0.1206910958761228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,50539,340,1.62 [1.24-2.11],0.000399189099304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIAP1,TP53-regulated inhibitor of apoptosis 1,50950,341,1.18 [1.01-1.37],0.0322709889351365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM21,E3 ubiquitin-protein ligase TRIM21,50447,341,0.99 [0.87-1.12],0.8141172036588811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM24,Transcription intermediary factor 1-alpha,43042,274,1.20 [1.01-1.41],0.0334358688134222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,43736,277,1.09 [0.98-1.21],0.1284981002199455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM26,Tripartite motif-containing protein 26,42355,265,0.88 [0.70-1.10],0.2651646023170328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM40,E3 ubiquitin ligase TRIM40,42721,269,1.00 [0.85-1.18],0.984892097820908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM5,Tripartite motif-containing protein 5,50447,341,1.08 [0.96-1.20],0.1994020476312361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM58,E3 ubiquitin-protein ligase TRIM58,43716,280,1.07 [0.94-1.22],0.2913552785041884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRPV3,Transient receptor potential cation channel subfamily V member 3,42474,270,0.82 [0.63-1.07],0.1477018728472096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC1,Hamartin,42650,268,0.83 [0.68-1.01],0.0621763806394315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC22D1,TSC22 domain family protein 1,43847,277,1.05 [0.89-1.25],0.5554268824375057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSHB,Thyrotropin subunit beta,50522,342,0.87 [0.77-0.98],0.0272283899144677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSLP,Thymic stromal lymphopoietin,49594,325,1.02 [0.87-1.20],0.7802735235040816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSNAX,Translin-associated protein X,42474,270,0.89 [0.66-1.20],0.4451890153039441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN1,Tetraspanin-1,49594,325,0.95 [0.81-1.12],0.5431799184383053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN15,Tetraspanin-15,42474,270,0.99 [0.78-1.24],0.9128012985391144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN7,Tetraspanin-7,42497,265,0.98 [0.86-1.12],0.8160369678484776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN8,Tetraspanin-8,43736,277,1.12 [1.00-1.25],0.0563205468697128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPYL1,Testis-specific Y-encoded-like protein 1,42650,268,1.07 [0.80-1.42],0.6448922880963202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TST,Thiosulfate sulfurtransferase,49256,326,1.07 [0.94-1.22],0.2927682606978686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTF2,Transcription termination factor 2,42721,269,1.08 [0.85-1.36],0.5399175844222543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTN,Titin,42474,270,1.17 [1.00-1.36],0.0452462609585272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTR,Transthyretin,43506,274,0.65 [0.42-1.02],0.0620662601361059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TUBB3,Tubulin beta-3 chain,42497,265,1.43 [0.97-2.12],0.0694403017243671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TWF2,Twinfilin-2,43926,275,1.07 [0.93-1.22],0.3615199187546483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXK,Tyrosine-protein kinase TXK,43124,274,1.02 [0.88-1.18],0.8175453093239666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXLNA,Alpha-taxilin,50135,340,1.07 [0.96-1.19],0.2284194297078523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXN,Thioredoxin,43233,273,1.03 [0.80-1.33],0.8163098068335226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC15,Thioredoxin domain-containing protein 15,50678,342,1.63 [1.17-2.27],0.0042350322584307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC5,Thioredoxin domain-containing protein 5,50968,342,1.22 [1.07-1.40],0.0038364980615547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC9,Thioredoxin domain-containing protein 9,43820,278,1.09 [0.89-1.35],0.3968831931997922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNL1,Thioredoxin-like protein 1,42416,265,1.05 [0.94-1.18],0.3837847390640763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",50539,340,1.13 [0.93-1.39],0.2261105943651626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYMP,Thymidine phosphorylase,50195,341,1.17 [1.01-1.35],0.0368006284119874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRO3,Tyrosine-protein kinase receptor TYRO3,50522,342,1.11 [0.79-1.55],0.5418333968037284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",42650,268,0.91 [0.75-1.09],0.2879332442127229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBAC1,Ubiquitin-associated domain-containing protein 1,50286,339,0.81 [0.61-1.06],0.129566067540328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2B,Ubiquitin-conjugating enzyme E2 B,43716,280,1.35 [0.94-1.95],0.1053601456882815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,43925,280,1.26 [1.05-1.51],0.0132915578342198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,42650,268,1.04 [0.86-1.27],0.6696558980084131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBQLN3,Ubiquilin-3,42474,270,1.15 [0.94-1.40],0.1832636750604938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBXN1,UBX domain-containing protein 1,42966,266,1.03 [0.87-1.22],0.7405965867177319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,43736,277,1.05 [0.97-1.14],0.2334142339011901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UGDH,UDP-glucose 6-dehydrogenase,42474,270,1.10 [0.99-1.22],0.0768359696936727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UHRF2,E3 ubiquitin-protein ligase UHRF2,42474,270,0.97 [0.69-1.36],0.8572712687965425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,50135,340,1.70 [1.35-2.14],6.060362323949058e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UMOD,Uromodulin,50985,343,0.79 [0.66-0.93],0.0043849140491477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC5D,Netrin receptor UNC5D,42650,268,1.04 [0.67-1.62],0.8681173743161827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC79,Protein unc-79 homolog,42355,265,1.04 [0.84-1.28],0.7471961436353571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNG,Uracil-DNA glycosylase,43716,280,1.11 [0.81-1.53],0.5243107341148716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPB1,Beta-ureidopropionase,43925,280,1.04 [0.92-1.17],0.5521814572445412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3A,Uroplakin-3a,42497,265,1.10 [0.87-1.38],0.4274110616066451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3BL1,Uroplakin-3b-like protein 1,43043,274,1.00 [0.80-1.24],0.9837848426233194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROD,Uroporphyrinogen decarboxylase,42966,266,0.95 [0.80-1.12],0.5388862484645665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROS,Uroporphyrinogen-III synthase,42721,269,0.84 [0.70-1.02],0.0722181204849486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USO1,General vesicular transport factor p115,50286,339,1.09 [0.98-1.22],0.1080490290206609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP25,Ubiquitin carboxyl-terminal hydrolase 25,43716,280,1.10 [0.94-1.29],0.2484697159917224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP28,Ubiquitin carboxyl-terminal hydrolase 28,43820,278,1.27 [0.97-1.65],0.0771460473747637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP47,Ubiquitin carboxyl-terminal hydrolase 47,42474,270,0.95 [0.82-1.10],0.4724222850572788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP8,Ubiquitin carboxyl-terminal hydrolase 8,49594,325,1.06 [0.96-1.18],0.2265808336133281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UXS1,UDP-glucuronic acid decarboxylase 1,49332,331,1.19 [1.01-1.41],0.0402458603325562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP5,Vesicle-associated membrane protein 5,49594,325,1.26 [1.08-1.46],0.0024663108683845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP8,Vesicle-associated membrane protein 8,42650,268,1.17 [1.03-1.33],0.0185200076556487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASH1,Tubulinyl-Tyr carboxypeptidase 1,50447,341,1.07 [0.95-1.20],0.2683739177798239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASN,Vasorin,49738,339,1.38 [0.98-1.95],0.0646403773636234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASP,Vasodilator-stimulated phosphoprotein,43959,278,1.02 [0.88-1.20],0.7580848754611713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,50286,339,0.97 [0.60-1.58],0.9023241633549526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAV3,Guanine nucleotide exchange factor VAV3,42497,265,1.08 [0.96-1.22],0.205958096220652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,50641,343,1.98 [1.43-2.73],3.856405253233482e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAN,Versican core protein,50968,342,1.63 [1.20-2.23],0.0018232828610222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCPKMT,Protein-lysine methyltransferase METTL21D,42355,265,1.12 [1.00-1.26],0.0548516096657209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFA,Vascular endothelial growth factor A,50907,342,1.14 [0.97-1.33],0.1161575168542808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFB,Vascular endothelial growth factor B,42650,268,1.39 [0.93-2.08],0.1034934274286884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFC,Vascular endothelial growth factor C,50678,342,1.11 [0.93-1.31],0.2459660174126702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFD,Vascular endothelial growth factor D,50989,342,1.29 [0.99-1.68],0.055010737731159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VGF,Neurosecretory protein VGF,43847,277,1.34 [0.93-1.93],0.1128330164345976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIM,Vimentin,49594,325,1.05 [0.96-1.15],0.2565158653592664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIPR1,Vasoactive intestinal polypeptide receptor 1,42761,275,0.68 [0.41-1.14],0.1450735748314438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIT,Vitrin,43925,280,1.40 [1.04-1.88],0.0267511865856734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VMO1,Vitelline membrane outer layer protein 1 homolog,50286,339,1.05 [0.91-1.21],0.4801061480363391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN1,Pantetheinase,43959,278,1.04 [0.89-1.21],0.6533843931379536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN2,Vascular non-inflammatory molecule 2,50286,339,1.09 [0.89-1.35],0.4121458311651435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS28,Vacuolar protein sorting-associated protein 28 homolog,43124,274,1.22 [1.04-1.44],0.0147930166195668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS37A,Vacuolar protein sorting-associated protein 37A,50286,339,1.06 [0.94-1.19],0.3608360012921445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS4B,Vacuolar protein sorting-associated protein 4B,43716,280,1.09 [0.97-1.23],0.1577009707884565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS53,Vacuolar protein sorting-associated protein 53 homolog,50286,339,1.10 [0.98-1.24],0.1166290935739113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10,V-set and immunoglobulin domain-containing protein 10,43716,280,1.42 [1.11-1.83],0.0057365734306849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,42474,270,1.59 [1.18-2.13],0.0020522270502913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG2,V-set and immunoglobulin domain-containing protein 2,43716,280,1.44 [1.22-1.68],8.498212278947788e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,50470,339,2.29 [1.87-2.79],3.1411057614140367e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,50444,341,1.23 [1.06-1.42],0.0052567252139029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSNL1,Visinin-like protein 1,43820,278,1.10 [0.82-1.47],0.516874681363128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM1,V-set and transmembrane domain-containing protein 1,49337,326,1.21 [1.00-1.46],0.0515675386758235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2B,V-set and transmembrane domain-containing protein 2B,43124,274,1.03 [0.78-1.35],0.8593262967466846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,49594,325,1.15 [0.99-1.34],0.0652460491819132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,50968,342,1.02 [0.89-1.16],0.7710185360234297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTCN1,V-set domain-containing T-cell activation inhibitor 1,49332,331,1.42 [1.06-1.90],0.0180336803728405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,42966,266,1.06 [0.87-1.30],0.5635158473668205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA1,von Willebrand factor A domain-containing protein 1,50876,341,1.40 [1.12-1.75],0.0029580463509562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA5A,von Willebrand factor A domain-containing protein 5A,42355,265,1.07 [0.93-1.22],0.351344844147019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,49969,339,1.64 [1.30-2.08],3.918265235045874e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2L,von Willebrand factor C domain-containing protein 2-like,43847,277,1.20 [0.97-1.47],0.0876968729994649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWF,von Willebrand factor,51146,343,1.02 [0.89-1.16],0.8158136301539416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WARS,"Tryptophan--tRNA ligase, cytoplasmic",50539,340,1.26 [0.98-1.62],0.0738938322292288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WAS,Wiskott-Aldrich syndrome protein,49560,327,1.04 [0.90-1.21],0.5529426290623274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF1,Wiskott-Aldrich syndrome protein family member 1,49594,325,1.08 [0.98-1.20],0.1345554742062006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF3,Wiskott-Aldrich syndrome protein family member 3,49337,326,1.00 [0.89-1.12],0.9983576053790512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASHC3,WASH complex subunit 3,43820,278,1.04 [0.90-1.21],0.5695297753783699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASL,Neural Wiskott-Aldrich syndrome protein,42650,268,1.08 [0.90-1.29],0.4100041295037001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WDR46,WD repeat-containing protein 46,43716,280,1.20 [0.90-1.59],0.2148176303126982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC1,WAP four-disulfide core domain protein 1,42832,276,1.15 [0.96-1.38],0.1192000314970438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC12,WAP four-disulfide core domain protein 12,50866,341,1.12 [0.97-1.30],0.119881085164905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,47955,325,2.12 [1.75-2.57],1.7456688837593115e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",49970,339,0.69 [0.55-0.88],0.0022039964223807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",50569,337,1.09 [0.82-1.44],0.5634361850649559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WIF1,Wnt inhibitory factor 1,50950,341,1.09 [0.82-1.43],0.5609473864120655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,49560,327,1.86 [1.41-2.46],1.1255825845083457e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,50135,340,1.04 [0.87-1.24],0.6897454562702736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XCL1,Lymphotactin,50950,341,1.21 [1.04-1.41],0.0160335501323007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XG,Glycoprotein Xg,50901,339,1.59 [1.20-2.10],0.0011227017794455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XIAP,E3 ubiquitin-protein ligase XIAP,42650,268,1.08 [0.89-1.33],0.427868656192652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XPNPEP2,Xaa-Pro aminopeptidase 2,50678,342,0.92 [0.84-1.01],0.0909876263571753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XRCC4,DNA repair protein XRCC4,49337,326,1.21 [0.95-1.55],0.1257191382393872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YAP1,Transcriptional coactivator YAP1,43820,278,1.76 [1.21-2.56],0.0031176334848157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",43736,277,1.06 [0.98-1.15],0.1454220737906001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YES1,Tyrosine-protein kinase Yes,50286,339,1.05 [0.97-1.15],0.2139720753072569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YJU2,Splicing factor YJU2,43716,280,1.37 [1.00-1.89],0.0525980668055224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YOD1,Ubiquitin thioesterase OTU1,42474,270,0.80 [0.67-0.97],0.0213049003527928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YTHDF3,YTH domain-containing family protein 3,49560,327,1.11 [0.99-1.25],0.0684737720431683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YWHAQ,14-3-3 protein theta,42966,266,1.08 [0.92-1.26],0.3512134592108041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YY1,Transcriptional repressor protein YY1,42650,268,1.15 [0.77-1.72],0.5000181236623777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBP1,Z-DNA-binding protein 1,42650,268,1.17 [0.90-1.52],0.2470298872802085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB16,Zinc finger and BTB domain-containing protein 16,49332,331,1.09 [0.95-1.24],0.2168091928526437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB17,Zinc finger and BTB domain-containing protein 17,49594,325,1.17 [0.95-1.44],0.1385081503061745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZCCHC8,Zinc finger CCHC domain-containing protein 8,42474,270,1.00 [0.82-1.21],0.9989587011233314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZFYVE19,Abscission/NoCut checkpoint regulator,43736,277,1.11 [0.98-1.26],0.1045992879943954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZHX2,Zinc fingers and homeoboxes protein 2,43820,278,1.09 [0.80-1.50],0.572891651223158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF174,Zinc finger protein 174,42650,268,1.00 [0.73-1.37],0.9917462977929544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF75D,Zinc finger protein 75D,43124,274,0.83 [0.67-1.02],0.0815549621047229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF830,Zinc finger protein 830,43716,280,0.98 [0.85-1.14],0.8268653286951891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRD2,Protein ZNRD2,43736,277,0.96 [0.81-1.13],0.6248263709813449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,43716,280,1.18 [0.97-1.44],0.1011934290311408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP3,Zona pellucida sperm-binding protein 3,42761,275,1.01 [0.97-1.06],0.55755179089117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP4,Zona pellucida sperm-binding protein 4,42355,265,1.23 [0.93-1.64],0.1528542476814385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZPR1,Zinc finger protein ZPR1,42497,265,1.00 [0.88-1.13],0.9612441551595194
